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Abstract 
Organization of the plasma membrane into specialised substructures in lymphocytes 
facilitates important biological functions including the initiation of crucial 
intracellular signalling cascades at the plasma membrane. The eukaryotic plasma 
membrane is a lipid bilayer that consists of asymmetrically distributed phospholipids. 
Membrane-bound lipid transporters are believed to generate and dynamically 
maintain the lipid asymmetry between the two leaflets of the cell membranes, but not 
much is known about the role of these transporters in a variety of biological systems 
in mammals. 
This thesis examines the effect of two ENU-induced mutations of the murine Atpllc 
gene, which encodes a member of the P4-type ATPase family thought to serve as 
'flippases' that mediate the translocation of specific aminophospholipids to the 
cytoplasmic leaflet of cell membranes. Loss of A T P l l C in mice led to a severe B 
cell deficiency due to a developmental arrest at the pro-B cell stage during early B 
cell development in the bone marrow. The number of splenic follicular B cells and 
peritoneal B1 cells was also severely reduced in mutant mice. However, marginal 
zone B cells as well as other haematopoietic lineages including T, NK and myeloid 
cells appeared to accumulate normally in mutant mice. Moreover, the requirement 
for A T P l l C in B cells was cell autonomous, and could not be corrected by the 
expression of pre-rearranged immunoglobulin transgenes or enforced expression of 
the pro-survival protein BCL-2 or by transgenic expression of IL-7. Further analysis 
of mutant mice revealed that while the IL-7R-mediated signalling pathway appears 
mostly intact, the ATPl lC ' " ' ' mutation leads to a defect in the expression and/or 
signalling through the pre-BCR, which provides essential signals for the 
development of pre-B cells. In contrast, B cells from B cell receptor (BCR) 
transgenic ATPllC-deficient mice were able to form germinal centres upon 
immunisation when adoptively transferred into wild-type host, indicating an intact in 
vivo signalling through the mature BCR in mutant animals. 
Functional analysis using fluorescently labelled phospholipid derivatives revealed 
that cells of the immune system from ATPl IC-deficient mice exhibit impaired 
aminophospholipid flippase activity compared to those from control animals. 
indicating for the first time that ATP l lC functions as a phospholipid flippase in 
biological membranes. 
Although the first phospholipid transiocase activity was described in erythrocytes 
about 30 years ago, the characterisation of enzyme activity and its effect on the 
membrane asymmetry, development and survival of erythrocytes remains to be 
unveiled. Intriguingly, ATPl IC-deficient mice developed anaemia due to a 
shortened erythrocyte lifespan, exhibited a large proportion of abnormal-shaped 
erythrocytes, and increased phosphatidylserine exposure on their surface due to 
impaired flippase activity. Thus, these findings identified ATPl IC as a candidate for 
aminophospholipid translocation activity in erythrocytes. 
In conclusion, the findings of this thesis provide novel insights into the role of the 
putative phospholipid transporter ATPl lC in B cell development and erythrocyte 
survival, and suggest a new candidate for inherited B cell deficiency and anaemia in 
humans. 
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CHAPTER 1: Literature Review 
1.1 Overview of the M a m m a l i a n I m m u n e System 
The immune system provides the body with an effective defence mechanism against 
any potential infectious agents including bacteria, viruses, fungi and parasites that 
are readily found in our natural environment. There are two arms of the immune 
system to help fight off these infectious agents, namely innate and adaptive immune 
system. 
1.1.1 The innate immune system 
The innate immune system provides the first line defence by a range of different cell 
types (i.e. macrophages, granulocytes, dendritic cells, NK cells, polymorphonuclear 
leukocytes and platelets) and physical and chemical barriers that prevent pathogens 
from entering the body. The roles of the innate immune system also include the 
initial identification and removal of pathogens from the circulation by producing 
antibacterial enzymes and peptides, and alerting cells of the adaptive immune system 
to the presence of a pathogen (Janeway, 2001). However, the cells of the innate 
immune system have no specificity for any individual antigen and they do not 
generate a memory response, which is the hallmark of the adaptive immune response 
(Janeway, 2001). 
1.1.2 The adaptive immune system 
The adaptive immune system in vertebrates evolved approximately 500 million years 
ago (Pancer and Cooper, 2006). It is composed of a population of white blood cells 
termed lymphocytes. There are two main types of lymphocytes called B and T cells 
that are activated if the innate immune system is unable to rapidly eliminate the 
pathogen. Like other cells of the immune system, lymphocytes originate from the 
self-renewing haematopoietic stem cells (HSCs). Each individual T and B cells 
expresses a clonally restricted antigen receptor that is generated by somatic gene 
rearrangements during development within primary lymphoid tissues (Janeway, 
2001). While the multipotent HSCs-derived B cell progenitors reside in the bone 
marrow and complete their development within the bone marrow, T cell progenitors 
must migrate from the bone marrow through the blood to the thymus to complete 
their development (Murphy, 2012). 
B cells play a nonredundant role in the generation of humoral immunity through their 
ability to secrete a large amount of antibodies in response to recognition of a specific 
antigen (Hardy and Hayakawa, 2001). Antibodies can bind to antigens expressed by 
microbes to make them the main targets for phagocytes (Murphy, 2012). However, 
antibodies can only bind to pathogens that are present in the blood and the 
extracellular spaces. In contrast, T cells can destroy cells infected with intracellular 
pathogens derived from either bacteria, parasites or viruses that have an obligate 
requirement to replicate within host cells that antibodies cannot detect (Murphy, 
2012). There are two subsets of T cells, namely CD4'" T helper cells (TH) and CDS'" 
cytotoxic T cells, which represent mediators of cell-mediated immune responses. 
The adaptive immune system has the ability to mount a specific immune response 
against a range of pathogens by recognising specific determinants on proteins 
through their receptors. Once an antigen is recognized by a lymphocyte within the 
secondary lymphoid tissues, the lymphocyte becomes activated, proliferates and 
differentiates into an effector cell (Murphy, 2012). The effector lymphocytes have a 
short lifespan and will persist until the pathogen has been cleared from the 
circulation, and eventually the effector cells die through the programmed cell death 
(Murphy, 2012). 
At the same time when effector cells differentiate, a subset of these cells is selected 
to become a stable population of long-lived memory cells (Murali-Krishna et al., 
1998, Webb et al., 1994). When memory cells re-encounter with the same pathogen 
in the future, they can be reactivated and produce a more rapid and stronger immune 
response to help eliminate the invading pathogen (Murphy, 2012). 
Although both B and T cells play indispensable roles in the protection of host against 
a range of pathogens, the factors that govern their development and function are yet 
to be entirely delineated. Uncovering these factors and the molecular mechanisms 
that control these processes will lead to a better understanding of disease states such 
as B- and T-cell leukaemia, immunodeficiency and autoimmunity syndromes, and 
may help in the development of new clinical treatments. The work presented in this 
thesis will focus primarily on B cells in relation to their development while T cells 
will not be discussed. 
1.2 B Lymphocytes 
B cells are generated from HSCs primarily in the foetal liver before the birth and in 
the bone marrow during the postnatal period (Hardy and Hayakawa, 2001), and play 
a central role in the adaptive immune system. Since their discovery, B cells have 
been considered as antibody-producing cells. However, recent studies suggest that B 
cells have broader roles in the immune system, which include the ability to act as 
antigen presenting cells (Myers, 1991, Rodriguez-Pinto, 2005) and produce 
cytokines (Pistoia, 1997, Lund, 2008). B cell precursors derived from HSCs follow a 
well-defined developmental program in the bone marrow characterised by the 
expression of a variety of specific cell surface molecules driven by the rearrangement 
status of the immunoglobulin (Ig) gene loci (Hardy and Hayakawa, 2001). Upon the 
successful production of a functional B cell receptor (BCR) on the surface, B cells 
exit the bone marrow and enter to the periphery for their further maturation steps 
(Hardy and Hayakawa, 2001). The mature BCRs on B cells are in the form of Ig 
molecules, and possess the transmembrane region. Mature B cells search for their 
cognate antigens during their circulation in the blood and lymph. When a BCR 
recognizes epitopes on a naive antigen, the B cell becomes activated and 
differentiates into either an antibody producing plasma cell that secretes soluble form 
of antigen specific antibodies with no transmembrane region to clear the pathogen, or 
they can differentiate into memory B cells to provide a faster and stronger immune 
response upon a secondary encounter with the same antigen (Murphy, 2012). 
In this section of the thesis, I will review early B cell development in the bone 
marrow and discuss the critical signalling circuits as well as the transcription factors 
that control B cell development. I will further discuss maturation of B cells into 
different peripheral subsets and their functional properties. 
1.2.1 Early B cell development 
Differentiation of B cells from HSCs is one of the best-defined cell differentiation 
processes in vertebrates and different stages (pre/pro-B, pro-B, pre-B, immature B 
and mature B cells) can be characterised on the basis of differential expression of 
surface markers, the status of Ig gene rearrangements, growth factor requirements 
and expression of genes in the developing B cells in the bone marrow and spleen 
(Hardy and Hayakawa, 2001). Its analysis by molecular genetics has illuminated 
fundamental mechanisms for normal immunity, human immunodeficiency diseases, 
DNA transcription, rearrangement and repair, cell signalling and cancer. B cell 
differentiation is currently viewed as proceeding in a graded manner, guided by a 
complex, self-reinforcing network of B cell-specific transcriptional regulators and 
receptor signalling systems (Malin et a l , 2010a, Ye and Graf, 2007, Mandel and 
Grosschedl, 2010, Nutt and Kee, 2007). Understanding how the elements of this 
network are integrated has only begun to be revealed and hinges upon identifying 
essential missing steps. 
The use of cell surface markers as well as the molecular characterisation has defined 
different B cell populations throughout the development in the bone marrow. Several 
terminologies have been used to describe these subsets, including the Philadelphia 
(Hardy and Hayakawa, 2001) and Basel nomenclatures (Osmond et al., 1998). In 
order to avoid confusion, in this thesis the Philadelphia nomenclature will be used 
and the corresponding fractions (fractions A, B, C, C", D and E) defined by Hardy 
(Hardy et al., 1991) will be supplied in brackets. 
The earliest B cell progenitor cells, known as pre/pro-B cells (fraction A) are 
differentiated from Ly6T)* common lymphoid progenitors (CLPs) (Inlay et al., 2009). 
Early studies suggested that pre/pro-B cells express B220 on their surface (Figure 
1.1), but are not yet committed to the B cell lineage and express low levels of RAGl 
and RAG2 proteins (Hardy et al., 1991, Li et al., 1993, Li et al., 1996). Although 
pre/pro-B cells contain the source of more committed B cell precursors (CD 19"" pro-
B cells), they were also shown to be competent to differentiate into other lineages 
including NK cells and plasmacytoid dendritic cells (Relink et al., 1996, Diao et al., 
2004, Pelayo et al., 2005), as well as T cells in vitro (Rumfeh et al., 2006). 
Pre/pro B cells differentiate into pro-B cells (early and late pro-B cells, fraction B 
and C, respectively) that express CD 19 on their surface, which is believed to be one 
of the earliest hallmarks of commitment to the B cell lineage (Figure 1.1) (Rolink et 
al., 1996). Since murine pro-B cells are Interleukin (IL)-7-dependent for their 
proliferation and survival (discussed below) (Corfe and Paige, 2012), they need to 
interact with bone marrow stromal ceils tliat produce IL-7 (Tolcoyoda et al., 2004, 
Kurosaki et al., 2010, Clark et al., 2014). 
Pro-B cells express two signalling components known as Iga (CD79a, mb-1) and IgP 
(CD79b, B29) (Koyama et al., 1997), which together with the molecular chaperone 
calnexin are thought to form the pro-BCR on the surface of pro-B cells (Figure 1,1) 
(Nagata et al., 1997). Although the pro-BCR has been suggested to be a functional 
receptor in pro-B cells (Meffre et al., 2000), a more direct role for pro-BCR 
signalling in B cell development remains to be completely delineated. 
In order for B cells to generate a diverse repertoire of antigen receptors, Ig heavy 
chain D to J rearrangements are initiated at the early pro-B cell stage (fraction B) 
followed by V to DJ rearrangements in late pro-B cell stage (fraction C) to produce a 
functional Ign heavy chain protein in the cytoplasm (Figure 1.1). This VDJ 
recombination is mediated by the RAGl and RAG2 proteins, which are highly 
expressed in pro-B cells (Figure 1.1) (Li et al., 1993), and mice deficient for these 
proteins have a developmental block at the transition from pro-B to pre-B cell stage 
(Mombaerts et al., 1992, Shinkai et al., 1992). Once produced, the functional Ign 
associates with the surrogate light chain (SLC) proteins VpreB and >^ 5, which are 
highly expressed on pro-B cells (Sakaguchi and Melchers, 1986, Kudo and Melchers, 
1987, Li et al., 1993), as well as the signalling subunits Iga and IgP, which non-
covalently associate with Ig|x, to form the precursor (pre)-BCR on their surface 
(Figure 1.1) (Nishimoto et al., 1991, Karasuyama et al., 1996). 
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During the heavy chain gene rearrangements at the pro-B cell stage of B cell 
development in the bone marrow, the rearrangement of DH to JH can occur in three 
possible reading frames due to an inexact joining mechanism. If DH to JH 
rearrangement occurs in-frame, followed by another in-frame rearrangement of VH to 
DHJH, a functional jx chain that can pair with the SLC components is produced. 
However, a truncated n protein called D t^ is produced when the rearrangement of DH 
elements to JH elements occurs in reading frame 2 (Reth and Alt, 1984). D i^ appears 
to have the opposite effect to full-length ^ protein and suppresses pre-B cell 
differentiation as shown by a block in B cell development in the bone marrow of Dn 
transgenic mice (Tornberg et al., 1998). Although D t^ can pair with SLCs, Iga and 
Ig|3, and induce some signals through the D^-preBCR (Home et al., 1996, Gong et 
al., 1996), transgenic expression failed to rescue B cell development in Rag2''' mice 
as opposed to the correction of RAG-deficient phenotype by expression of full-
length pi (Malynn et a l , 2002), indicating a defective pre-BCR signalling caused by 
D(i, production. Interestingly, overexpression of the pro-survival factor BCL-2 did 
not change the inability of the D i^ transgene to promote Rag2"'' pro-B cells into pre-B 
cells (Wikstrom et al., 2006), suggesting that the block in B cell development of D^i 
transgenic mice cannot be explained by impaired survival signals. These findings 
suggest that counterselection against Dfx at the pro-B cell stage is a critical process 
for normal B cell development in the bone marrow. 
The formation of a functional pre-BCR marks the transition to the pre-B cell stage 
(large and small pre-B cells, fraction C and D, respectively), and is an important 
check-point for the survival, proliferation and differentiation of pre-B cells (Hendriks 
and Middendorp, 2004, Herzog et al., 2009, Clark et al., 2014, Reth and Nielsen, 
2014). Animals deficient for any component of the pre-BCR complex exhibit a 
partial or complete developmental arrest at the pro-B cell stage of B lymphopoiesis 
in the bone marrow (Kitamura et al., 1991, Kitamura et al., 1992, Torres et al., 1996, 
Gong and Nussenzweig, 1996, Mundt et al., 2001, Pelanda et a l , 2002). The cells 
that assemble a functional pre-BCR undergo up to 5 rounds of cell division (clonal 
expansion) for the selection and expansion of large pre-B cells in order to expand the 
number of daughter cells with a flinctional Ign (Rolink et al., 2000). Large pre-B 
cells eventually exit the cell cycle and become resting small pre-B cells, which begin 
to undergo Ig light chain V to J rearrangement by reactivating the expression of 
RAG I and RAG2 proteins (Figure 1.1) (Grawunder et al., 1995). Successful 
production of complete and in-frame K or X, light chain marks the second essential 
check-point and allows pre-B cells to express IgM on the cell-surface (Figure 1.1). 
These cells are now called immature B cells (fraction E), which leave the bone 
marrow and emigrate to the periphery to undergo the final steps of B cell maturation. 
1.2.2 Signal l ing events controll ing early B cell development 
Like other stages, the progress of B cell differentiation from pro-B cells into pre-B 
cells is tightly regulated process, and in addition to transcriptional control it is 
dependent on many signalling events in the bone marrow. Especially, signalling 
through the IL-7R and pre-BCR has been long considered to be fundamental for 
differentiation of pre-B cells as any defect in these pathways results in a 
developmental arrest before the pre-B cell stage of B lymphopoiesis (Herzog et al., 
2009, Clark et al., 2014, Reth and Nielsen, 2014). Therefore, the role of signalling 
through the IL-7R and pre-BCR in early B cell development will be discussed in 
more detail. 
1.2.2.1 IL-7R signalling 
IL-7 has been suggested to play critical roles in many processes that are required for 
the survival, proliferation and differentiation of B cells in the adult bone marrow, but 
is less important for B cell development in the foetal liver (Corfe and Paige, 2012). 
IL-7, a member of the common gamma (YC) chain cytokine family, is a type I 
cytokine secreted primarily by stromal cells in the foetal liver, bone marrow, spleen 
and thymus (Tokoyoda et al., 2004). IL-7 binds a heterodimeric receptor that consists 
of the Yc chain and IL-7Ra chain. While the YC chain is shared with IL-2, IL-4, IL-9, 
IL-15 and IL-21 and is crucial for the development of lymphocyte populations as 
mice deficient in YC lack B, T and NK cells (DiSanto et al., 1995, Cao et al., 1995), 
the IL-7Ra chain is shared with thymic stromal lymphopoietin (TSLP) (Jiang et al., 
2005, Alves et al., 2007). 
The importance of IL-7 and IL-7R signalling in B lymphopoiesis is revealed by 
analysis of the phenotype of animals deficient in the genes encoding these proteins, 
which exhibited a profound defect of B cell development beyond the pre/pro-B cell 
stage in the bone marrow (Peschon et a!., 1994, von Freeden-Jeffry et al., 1995, 
Miller et al., 2002). Intriguingly, the defective B cell accumulation in IL-7R"'" mice is 
more severe compared to that observed in animals deficient for IL-7 (Vosshenrich et 
al., 2003). Since IL-7Ra is shared with IL-7 and TLSP, these data suggest a possible 
role for TLSP in early B cell development. In keeping with these findings, TLSP has 
been suggested to drive the generation of IL-7-independent B cells that exist in IL-7' 
and IL-7R"'" mice (Vosshenrich et al., 2003, Vosshenrich et al., 2004). However, 
contrary to this notion is the observation that loss of TLSP in IL-7"'' animals did not 
cause a more severe phenotype compare to those with a single deficiency in IL-7 
(Jensen et al., 2008). 
Despite an essential role for IL-7 in murine B lymphopoiesis, IL-7 has been shown to 
be redundant for B cell development in humans as patients carrying mutations in IL-
7Ra exhibit a normal peripheral B cell compartment (Puel et al., 1998). These data 
support the conclusion that B cell development in humans is IL-7-independent, and 
therefore it remains to be delineated whether human B cells do not require signalling 
through a cytokine receptor or use an as yet undefined receptor signalling to account 
for loss of IL-7R signalling during B cell development. 
IL-7R signalling controls B cell proliferation, survival and development by 
activating three major signalling cascades: the janus associated kinase (JAK)- signal 
transducer and activator of transcription (STAT) pathway, the phosphatidylinositol 
3-kinase (PI3K)-AKT pathway, and the mitogen activated protein kinase (MAPK)-
ERK pathway (Figure 1.2), which will briefly be discussed below. 
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Since the components of the heterodimeric receptor of IL-7 do not possess kinase 
activity, activation of the constitutively associated JAKl and JAK3 are required to 
mediate downstream signalling of the IL-7R. Binding of IL-7 to the IL-7R induces 
heterodimerization of the a and y chains, which brings JAKl and JAK3 together and 
stimulate their phosphorylation and activation (Figure 1.2A) (Corfe and Paige, 2012). 
The activated JAK kinases phosphorylate tyrosines on the IL-7Ra chain, which then 
provide docking sides for STAT family members 5a and 5b (Figure 1.2A) (Corfe and 
Paige, 2012). The recruitment of STAT5 through phosphorylation of the IL-7Ra 
chain is an essential event in the initiation of downstream signalling, and leads to its 
translocation to the nucleus where it functions as a transcription factor (Heltemes-
Harris and Farrar, 2012). The importance of the lL-7R-mediated STAT5 activation 
in the proliferation and survival of B cell precursors has been revealed by studies 
where animals deficient for either JAK3 or STAT5ayb exhibit a developmental arrest 
at the pre/pro-B cells stage of B cell development in the bone marrow, a phenotype 
that mirrors IL-7R-deficient mice (Thomis et a l , 1995, Nosaka et al., 1995, Park et 
al., 1995, Yao et al., 2006). In keeping with these findings, constitutive activation of 
STAT5 rescues B cell deficiency in mice with IL-7R-deficient signalling (Goetz et 
al., 2004). 
IL-7-mediated activation of STAT5 promotes expression of cyclin D3 (Mandal et al., 
2009), whose expression is required for the proliferation of pro- and pre-B cells 
(Figure I.2A) (Cooper et al., 2006, Powers et al., 2012), indicating a critical 
involvement of IL-7R signalling in B cell proliferation. Another important role of 
STATS is the induction of crucial pro-survival factors during early B cell 
development (Figure 1.2A). Using conditional mutagenesis of STATS, Malin et al. 
demonstrated that STATS regulates pro-B cell survival by activating the anti-
apoptotic protein MCL-1 (Malin et al., 2010b). This is consistent with the finding 
that MCL-1 deficient mice display a B cell deficiency due to a developmental arrest 
at the pro-B cell stage of B cell development in the bone marrow (Opferman et al., 
2003). In addition to MCL-1, the IL-7-induced JAK-STATS pathway also controls 
pro-B cell survival by regulating the expression of anti-apoptotic proteins BCL-2 and 
BCL-XL and pro-apoptotic proteins BAX, BAD and BIM (Corfe and Paige, 2012). 
Importantly, IL-7R-STAT5 signalling is also involved in the repression of light chain 
rearrangement in pro-B cells by regulating IgK locus accessibility (Figure 1.2A) 
(Johnson et al., 2008). 
In addition to the roles in the proliferation and survival of B cells, IL-7R signalling 
has been suggested to play a critical in B cell specification and commitment. 
Activation of STAT5 through IL-7R signalling induces expression of EBFl (Kikuchi 
et al., 2005), which in turn promotes PAX5 expression (Figure 1.2A) (O'Riordan and 
Grosschedl, 1999). In agreement with these findings, overexpression of EBFl or a 
constitutively active STATS rescued B cell development in IL-7-deficient mice (Dias 
et al., 2005, Kikuchi et al., 2005). Since EBFl , together with PAX5, is an essential 
transcription factor for the initiation and maintenance of B lineage commitment, 
these findings suggest that IL-7 further plays a nonredundant role in the regulation of 
B cell specification and commitment via controlling important B cell-specific 
transcription factors (Figure 1.2A). Collectively, these data reveal that IL-7R 
signalling through the JAK-STAT5 pathway plays a vital role in the proliferation, 
survival and differentiation of murine B cells in the bone marrow. 
IL-7R signalling in B cells also activates the PI3K-AKT pathway through binding of 
the SH2 domain of the PI3K p85 regulatory subunit to Tyr449 of the IL-7Ra chain 
(Venkitaraman and Cowling, 1994). The activation of PI3K has been shown to be 
critical for early B cell development as disruption of the p85 subunit or treatment of 
B cells with PI3K inhibitors resulted in a defective IL-7-induced proliferation and 
impaired B cell development at the pro-B cell stage (Corcoran et al., 1996, Suzuki et 
al., 1999, Fleming and Paige, 2001). Accordingly, mice double deficient for pi 10a 
and pi 106, the larger catalytic subunits of PI3K, have been recently shown to 
possess a developmental arrest at the pre-B cell stage of B cell development in the 
bone marrow (Ramadani et al., 2010). Interestingly, pro-B cells from these mice 
exhibit impaired proliferation in response to IL-7 (Ramadani et al., 2010). In addition 
to the role in pro-B cell proliferation, the IL-7R-mediated PI3K-AKT pathway has 
also been suggested to play a role in pro-B cell survival through inhibition of pro-
apoptotic proteins by AKT (Corfe and Paige, 2012, Clark et al., 2014). 
The IL-7R/PI3K-AKT signalling pathway is also involved in the regulation of RAG 
proteins that are required for normal B cell development (Corfe and Paige, 2012, 
Clark et al., 2014). Given that FOXOl , a transcription factor negatively regulated by 
the PI3K-AKT pathway, directly controls the expression of Ragl and Rag2 (Amin 
and Schlissel, 2008, Herzog et al., 2008), it is plausible that the IL-7R/PI3K-AKT 
pathway mediates Ragl and Ragl expression by controlling the expression of 
members of the FOXO family (Figure 1.2B). In agreement with this notion, a recent 
study revealed that attenuation of IL-7R signalling leads to robust induction of Ragl 
and Ragl via upregulation of FOXOl due to diminished AKT activation (Ochiai et 
al., 2012). Consistently, in the absence of pi 10a and pi 106 pro-B cells exhibit 
dysregulated Ragl and Ragl expression (Ramadani et al., 2010). These findings 
collectively suggest that IL-7R signalling-mediated PI3K-AKT activation is also 
important for proliferation and differentiation of B cell precursors in the bone 
The binding of IL-7 to its receptor also leads to the activation of the MAPK/ERK 
pathway (Figure I.2B) (Corfe and Paige, 2012), but the mechanism is less clear. 
ERK has been shown to be a target of both IL-7R and pre-BCR signalling, and 
treatment of cells with ERK inhibitors prohibits survival and proliferation of pro- and 
pre-B cells in response to IL-7 (Fleming and Paige, 2001). Consistently, deletion of 
both ERKl and ERK2 in mice caused a developmental arrest at the pro-B cell stage 
of B lymphopoiesis (Yasuda et al., 2008). These findings suggest that IL-7R 
signalling activates the MAPK/ERK pathway, which in turn controls important 
events in B lymphopoiesis in the bone marrow. 
The studies on the role of IL-7R signalling in B cell development absolutely suggest 
a critical involvement of IL-7R signalling in the different signalling processes that 
are required for proliferation, survival and differentiation of B cells in the bone 
marrow. 
1.2.2.2 Pre-BCR signalling 
A functional production of Igfx via in-frame VDJ gene recombination in pro-B cells 
leads to their assembly with the SLC proteins X5 and VpreB, together with signal-
transducing proteins Iga and Ig(3 to form the pre-BCR on their surface (Figure 1.3) 
(Nishimoto et al., 1991, Karasuyama et al., 1996). The expression and signalling 
through the pre-BCR is an important check-point in early B cell development, which 
was apparent by the in vivo studies where mutations in genes encoding components 
of the pre-BCR signalling complex or its associated tyrosine kinases cause a partial 
or complete developmental arrest at the pro-B cell stage of B cell development 
(Kitamura et al., 1991, Kitamura et al., 1992, Torres et a l , 1996, Gong and 
Nussenzweig, 1996, Mundt et al., 2001, Pelanda et al., 2002). Importantly, mutations 
in human X5 cause a severe block in B cell development (Minegishi et al., 1998), 
suggesting that expression and signalling of the pre-BCR is also required for normal 
B cell development in humans. 
Despite the similarities in the formation of signalling complexes, one of the 
fundamental differences between the pre-BCR and mature BCR is how the signalling 
is initiated. Expression of the pre-BCR on the surface is considered to be sufficient 
for the autonomous initiation of signalling (Herzog et al., 2009, Clark et al., 2014, 
Reth and Nielsen, 2014), but this idea remains controversial. Recent studies have 
suggested that pre-BCR activation relies on a soluble extracellular ligand present in 
the bone marrow environment. These studies identified Heparin and Galectin 1 on 
stromal cells as possible natural ligands for the pre-BCR (Bradl and Jack, 2001, 
Gauthier et al., 2002). However, the finding that in vitro proliferation and 
differentiation of pre-B cells mediated by pre-BCR signalling is independent of the 
bone marrow and foetal liver environment contradicts the requirement for the soluble 
ligand for pre-BCR activation (Rolink et al., 2000). An alternative model proposes 
that pre-BCR signalling is initiated upon autoaggregation of pre-BCRs on the cell 
surface (Ohnishi and Melchers, 2003). This notion is supported by the data that the 
positively charged non-immunoglobulin portion of X5 mediates spontaneous pre-
BCR aggregation to facilitate the initiation of signalling (Ohnishi and Melchers, 
2003). 
The pre-B stage is characterised by an initial proliferation stage (large pre-B cells) at 
which the number of cells expressing functional pre-BCRs is increased, followed by 
a maturation stage (small pre-B cells) at which the rearrangements of Ig light gene 
loci occur (Herzog et al., 2009, Clark et al., 2014, Reth and Nielsen, 2014). 
Upon expression of the pre-BCR, the SRC-family protein tyrosine kinases 
phosphorylate tyrosine residues in immunoreceptor tyrosine-based activation motifs 
(ITAMs) in the cytoplasmic tails of Iga and Ig(3 (Figure 1.3) (Sanchez et al., 1993, 
Flaswinkel and Reth, 1994). The SRC-family of kinases include Blk, Lyn and Fyn, 
but animals deficient in any one member of these kinases display normal B cell 
development in the bone marrow (Texido et al., 2000, Hibbs et al., 1995, Nishizumi 
et a l , 1995, Stein et al., 1992). However, Lyn/Fyn/Blk triple knock out mice show a 
developmental arrest at the pro-B cell stage of B lymphopoiesis (Saijo et al., 2003). 
Phosphorylated ITAMs serve as docking sites for the recruitment and activation of 
spleen tyrosine kinase (SYK), which leads to activation of several downstream 
pathways (Figure 1.3). The activation of SYK is crucial for signalling through the 
pre-BCR as mice deficient in SYK have been shown to possess a developmental 
arrest at the pro-B cell stage and exhibit impaired clonal expansion (Turner et al., 
1995, Cheng et al., 1995). T cell receptor associated protein ZAP70, which is mainly 
expressed in T and NK cells (Au-Yeung et al., 2009), has been suggested to 
compensate loss of SYK in pre-BCR signalling as double deficient animals exhibit a 
complete block in B cell development (Schweighoffer et al., 2003). 
In the large pre-B cell stage, activation of SYK leads to a proliferative burst via 
predominantly the MAPK/ERK pathway in order to expand number of cells (Figure 
1.3). As already mentioned, this notion has been supported by the evidence that B 
cells in mice deficient for ERKl/2 display a developmental arrest at the pro-B to pre-
B cell transition, as well as a diminished pre-BCR-mediated expansion of pro-B cells 
(Yasuda et al., 2008). ERK is also activated through IL-7R signalling, which enables 
pre-BCR expressing cells to respond to the limiting concentration of IL-7 (Fleming 
and Paige, 2001). In vivo analysis of mice lacking both receptors confirm the 
requirement of IL-7R and pre-BCR signalling in the initial expansion of pre-B cells 
(Eriandsson et al., 2005). These in vitro and in vivo studies suggest that IL-7R 
signalling and to a lesser extent pre-BCR signalling act synergistically to control the 
expansion of large pre-B cells by activating the MAPK/ERK pathway (Figure 1.3). 
SYK also activates the PI3K-AKT pathway that is required for the survival and 
metabolism of pre-B cells (Reth and Nielsen, 2014). 
The clonal expansion of large pre-B cells is restricted up to 5 rounds of cell division 
(Rolink et al., 2000), after which large pre-B cells exit the cell cycle and differentiate 
into resting small pre-B cells. Although the precise mechanism(s) that controls the 
decision to undergo cell-cycle arrest and differentiate into small pre-B cells are not 
clear, the pre-BCR signalling-mediated downregulation of the expression of SLCs, 
and eventually the expression of the pre-BCR, has been suggested to account for exit 
of cells from the cycle (Parker et al., 2005). However, it was later shown that 
downregulation of pre-BCR expression is not required for the development of pre-B 
cells, nor for the cell-cycle arrest (van Loo et al., 2007). A recent report by Ochiai et 
al. revealed that a self-regulatory network between IL-7R and pre-BCR signalling 
plays a critical role in the decision between clonal expansion and cell-cycle arrest 
and differentiation (Ochiai et al., 2012). The authors demonstrate that attenuation of 
signalling through the IL-7R at the pre-B cell stage leads to the induction of genes 
that are necessary for pre-BCR signalling. The onset of pre-BCR signalling then 
induces a positive feedback loop that further reduces signalling through the IL-7R 
and strengthens signalling through the pre-BCR. Together, the reduction in IL-7 
signalling and the onset of pre-BCR signalling leads to a progression from cell 
proliferation during the large pre-B cell stage to cell differentiation at the small pre-B 
cell stage. The caveat of the study was that the authors used pre-B cell lines from 
IRF4/8"'" mice, which have a developmental block at the pre-B cell stage (Lu et al., 
2003), and it would be interesting to test if a similar mechanism acts in normal pre-B 
cells. 
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The transition of large pre-B cells toward to the small pre-B cells is associated with 
the SYK-mediated activation of BLNK/BTK/PLCY2 pathway (Figure 1.3). SYK 
phosphorylates BLNK on multiple tyrosine residues, and BLNK in turn acts as a 
scaffold protein to provide docking sides for BTK and PLCY2, which come together 
form a complex that induces pre-B cell differentiation (Figure 1.3) (Reth and Nielsen, 
2014). Activation of PLCY2 through BLNK and BTK results in hydrolysis of PIP2 to 
IP3 and diacylglycerol (DAG), which causes intracellular Ca^^ mobilisation and 
activation of Ca^^ dependent enzymes (Figure 1.3) (Reth and Nielsen, 2014). Mice 
deficient for BLNK or BTK display developmental arrest at the large pre-B cell stage 
(Flemming et al., 2003, Middendorp et al., 2002). Moreover, pre-B cells from the 
deficient mice exhibited increased expression of SLC and pre-BCR, and pre-BCR-
dependent expansion (Flemming et al., 2003, Middendorp et al., 2002). These 
findings suggest that BLNK and BTK play a crucial role in the repression of pre-
BCR expression, and thus limit signalling and proliferation emanating from the pre-
BCR at the large pre-B cell stage (Figure 1.3). 
In addition to the activation of BTK/PLCY2 axis, BLNK also participates in the 
activation of IgK germline transcription and recombination by promoting IRF4, 
whose expression is thought to promote IgK recombination (Figure 1.3) (Muljo and 
Schlissel, 2003, Ma et al., 2006, Johnson et al., 2008, Lu et al., 2003). As already 
mentioned, defective activation of PI3K-AKT due to loss of IL-7R signalling results 
in increased FOXO l expression, which also contributes to Ig light gene 
recombination by inducing RAG l and RAG2 expression (Figure 1.3) (Amin and 
Schlissel, 2008, Herzog et al., 2008). Collectively, these findings suggest that SYK-
mediated activation of BLNK/BTK/PLCY2 pathway mainly orchestrates the 
differentiation of large-pre B cells into small pre-B cells by terminating IL-7R-
dependent proliferation and inducing recombination of the Ig light chain loci (Figure 
1.3). 
1.2.3 Transcriptional control of early B cell development 
The development of B cells is a highly ordered process, and in addition to cytokines 
and their receptors it is mediated by several transcriptional factors, which are DNA 
binding proteins that orchestrate many important events in cells through the 
induction or suppression of target genes. The transcriptional regulatory factors are 
thought to function in a sequential and interdependent manner (Mandel and 
Grosschedl, 2010, Nutt and Kee, 2007). Ahhough recent advances in flow cytometric 
analysis of B cell development using additional surface markers have enabled 
scientists to dissect different stages of B cell development from HSCs, the 
transcriptional regulation of these stages remains to be fully resolved (Mandel and 
Grosschedl, 2010, Nutt and Kee, 2007). The well-determined transcription factors 
that play essential roles in priming of the lymphoid lineages as well as the B cell 
lineage will be briefly discussed below. 
The transcription factor PU.l (encoded by Sfpil), a member of the ETS family of 
transcription factors, plays an indispensable role in the generation of early 
progenitors of lymphocytes and myeloid cells. PU.l is exclusively expressed in early 
progenitors with a similar expression profile in HSCs, CLPs and common myeloid 
progenitors (CMPs) (Back et al., 2005, Nutt et al., 2005). Mice deficient for Sfpil 
lack B and T lymphocytes, monocytes and granulocytes, but have normal 
megakaryocytes and erythroid progenitors (Scott et al., 1994, McKercher et al., 
1996), suggesting a role for PU.l in the generation of lymphoid and myeloid 
progenitors. Consistent with this idea, muhipotent progenitors (MPPs) expressing a 
PU.l transcriptional reporter can develop into monocytes, granulocytes and 
lymphoid progenitors, but not into megakaryocyte and erythroid cells (Arinobu et al., 
2007). Further analysis of Sfpil'^' animals revealed that loss of PU.l results in a 
reduction in the number of lymphoid-primed multipotent progenitor (LMPPs), which 
are unable to give rise to B cell precursors (Scott et al., 1997). Evidence supporting 
this is the study where PU. 1 -deficient haematopoietic progenitors was shown to fail 
to express Flt3 and IL-7R transcripts, whose expression is vital for the generation of 
LMPPs and survival of early B-cell progenitors, respectively (DeKoter et al., 2002). 
Consistently, mice with conditional inactivation of PU.l possess a defect in the 
accumulation of CLP cells (Dakic et a l , 2005). 
With respect to the B cell lineage, studies with PU.l conditional knockout mice at 
the pro-B cell stage revealed a normal B cell development and function (Polli et al., 
2005, Ye et al., 2005). Moreover, sorted CLPs with an inactivated PU.l also 
differentiate into the B cell lineage in vitro (Iwasaki et al., 2005). Collectively, these 
findings suggest that PU.l is required for normal B cell accumulation at or before the 
CLP stage during the development from HSCs, but is not essential for further B cell 
differentiation. 
Ikaros (encoded by Ikzfl), the founding member of a small family of transcription 
factors, is also critical for specification in lymphoid and B cell lineages as it is 
expressed in all haematopoietic lineages including HSCs and MPPs (Georgopoulos 
et al., 1992, Morgan et al., 1997, Klug et al., 1998, Kelley et al., 1998, Papathanasiou 
et a l , 2009). Ikaros deficient MPPs display impaired differentiation of CLPs, which 
results in a defect in the accumulation of lymphoid lineages including B, NK and 
foetal T cells despite the presence of some T cell progenitors in the thymus and 
mature T cells in the periphery (Georgopoulos et al., 1994, Wang et a l , 1996). Like 
PU.l-deficient mice, loss of Ikaros in haematopoietic progenitors fail to express Flt3 
(Nichogiannopoulou et a l , 1999), suggesting a role for Ikaros in the accumulation of 
LMPPs. However, a recent study using an Ikaros promotor-driven reporter gene 
illustrated a normal generation of the LMPP population in the bone marrow of 
Ikaros-deficient mice, but these cells were unable to generate B and T cells, and have 
reduced expression of IL-7R and RAGl (Yoshida et al., 2006). These studies suggest 
that Ikaros is most likely dispensable for the development of LMPPs, but required for 
their progression into lymphoid lineages. 
In addition to its role in priming lymphoid lineages, Ikaros also plays a direct role in 
B cell development. Mice with a hypomorphic allele of Ikaros exhibit a 
developmental block at the pro-B cell stage of B cell development in the bone 
marrow (Kirstetter et al., 2002). Additionally, pro-B cells from these mice fail to 
form IL-7 dependent colonies in vitro, and display diminished levels of transcript for 
the genes encoding RAGl , RAG2, TdT and X5 as well as Flt3 and IL-7R (Kirstetter 
et al., 2002, Yoshida et al., 2006). More recently three independent studies confirmed 
the vital role for Ikaros in early B cell development in the bone marrow (Heizmann 
et al., 2013, Schwickert et al., 2014, Joshi et al., 2014). These studies identified 
crucial roles for Ikaros in activating the downstream of pre-BCR signalling, 
controlling cell migration and adhesion (Schwickert et al., 2014, Joshi et al., 2014). 
Collectively, these studies reveal that Ikaros is a critical transcription factor in 
various aspects of early B cell development from HSCs. 
Another transcription factor that plays a crucial role in priming of the lymphoid 
lineage from MPPs is the basic helix-loop-helix transcription factor E2A (encoded 
by Tcfela), which occurs in two splice variants El2 and E47. Animals deficient for 
E2A have reduced numbers of LMPPs and CLPs (Borghesi et al., 2005, Dias et al., 
2008, Semerad et al., 2009). In cooperation with the other transcription factors PU.l 
and Ikaros, E2A has been suggested to activate lymphoid-specific genes in LMPPs 
(Ramirez et al., 2010). 
In regard to B cell differentiation, E2A-deficient mice exhibit a block during early B 
cell development prior to onset of Ig gene rearrangements (Bain et al., 1994, Zhuang 
et al., 1994, Bain et al., 1997, Beck et al., 2009), revealing a critical role for E2A in 
B cell development in the bone marrow. E2A also plays a role in the specification of 
the B cell lineage by initiating and maintaining the expression of the B cell fate 
transcription factors EBFl and PAX5 (discussed below) (Bain et al., 1994, Seet et al., 
2004, Kwon et al., 2008). The E2A transcription factor can bind to the EBF promoter 
to regulate EBFl expression (Smith et al., 2002). Moreover, the E2A proteins, 
together with HeLa E-box binding protein (HEB), activate the expression of FOXOl 
in CLPs (Welinder et al., 2011), whose expression together with E2A induces EBFl 
expression. EBFl and FOXOl, in turn, activate a positive intergenic feedback 
circuitry, which is important for the establishment of B cell identity (Mansson et al., 
2012). These findings suggest that E2A plays a vital role in B cell development 
through transcriptionally priming of lymphoid lineages as well as initiation of the B 
cell gene program. 
EBFl, an essential B-lineage specification factor, is expressed exclusively in early B 
cell stages, but not in late stages of B cell development or T and non-lymphoid cells 
(Hagman et al., 1991, Feldhaus et al., 1992, Hagman et al., 1993). The expression of 
EBFl is controlled by the transcription factor E2A (Smith et al., 2002) and IL-7R 
signalling (Kikuchi et al., 2005). Analysis of mice lacking EBFl revealed a 
requirement for EBFl in B cell development beyond the pre/pro-B cell stage in the 
bone marrow (fraction A) (Lin and Grosschedl, 1995). Pre/pro-B cells from EBFl 
deficient mice failed to express B cell specific genes including Cd79a, Cd79b, Iglll 
and VpreBl (Lin and Grosschedl, 1995). The crucial role of EBFl in early B cell 
development was further revealed by studies where ectopic expression of EBFl 
alone was sufficient to compensate for loss of IL-7, IL-7Ra, PU.l , Ikaros or E2A 
during early B cell development in the bone marrow (Seet et al., 2004, Dias et a!., 
2005, Kikuchi et a!., 2005, Medina et a!., 2004, Reynaud et a!., 2008). Recently, 
conditional inactivation of Ebfl in vitro and in vivo at various B cell stages also 
identified a crucial role for EBFI in pro-B cell survival, proliferation and signalling 
(Gyory et al., 2012, Vilagos et al., 2012). Moreover, multiple lines of evidence 
demonstrate that EBFI also regulates B cell gene networks, maintain B cell identity 
and prevent development of non-B cell lineages through repression of genes 
encoding various transcription factors of alternative cell fates (Pongubala et al., 2008, 
Thai et al., 2009, Treiber et a l , 2010, Lukin et al., 2011, Nechanitzky et al., 2013). 
Collectively, these studies suggest that EBFI functions as a key transcription factor 
at multiple stages of B cell development in the bone marrow via regulation of 
important compartments of transcription factor and signalling networks. 
The transcription factor PAX5 is only expressed in B cells (from the pro-B cell to 
mature B cell stage) within the haematopoietic lineage (Barberis et al., 1990, Adams 
et al., 1992, Fuxa and Busslinger, 2007), and is considered to be a master regulator 
gene for B cell development. Early studies showed that PAX5-deficient mice failed 
to accumulate B cell progenitors in the foetal liver, but B cell development in the 
adult bone marrow progressed up to the pro-B cell stage (Urbanek et al., 1994, Nutt 
et al., 1997b, Nutt et al., 1997a), indicating an essential requirement for PAX5 
beyond the pro-B cell stage of adult B lymphopoiesis. The expression of genes 
encoding the transcription factors PU.l , Ikaros, E2A and EBFI is unaffected in 
PAX5-deficient pro-B cells (Nutt et al., 1997b), suggesting that PAX5 functions 
downstream of these transcription factors. Like EBFI, PAX5 was reported to 
maintain B cell identity and thus promotes B cell development through activation of 
genes involved in BCR signalling, adhesion and migration, as well as suppression of 
genes that are required for differentiation into non-B cell lineages. This was 
confirmed by analysis of PAX5-deficient pro-B cells that were able to differentiate 
into different haematopoietic cell types (Kozmik et al., 1992, Nutt et al., 1999, 
Souabni et al., 2002, Schebesta et a l , 2002, Mikkola et al., 2002, Delogu et al., 2006, 
Schebesta et al., 2007). This notion has been further confirmed by a study where 
mature B cells from mice with a conditionally inactivated PAX5 were shown to 
dedifferentiate into early uncommitted progenitors, which eventually give rise to T 
cells in the thymus of T-cell deficient mice (Cobaleda et al., 2007). 
As already mentioned, EBFl expression is controlled by the transcription factor E2A 
as well as by the IL-7R signalling (Smith et a l , 2002, Kikuchi et al., 2005). E2A-
induced EBFl binds to the Pax5 promoter region and activates PAX5 expression in 
pro-B cells (Decker et al., 2009). PAX5 in turn promotes EBFl expression by 
binding to the Ebfl promoter (Roessler et al., 2007). This provides a positive 
feedback loop between EBFl and PAX5 to enable pro-B cells to reinforce the B cell 
genetic program and to commit these cells to the B cell lineage. These studies 
suggest that PAX5, in concert with EBFl , is a vital transcriptional factor for B cell 
fate specification and commitment. They play critical roles in activation of B cell-
specific genes and suppression of non-B cell lineage genes as well as maintenance of 
B cell identity and control of multiple determinants of B cell development. 
The transcription factors interferon regulatory factors 4 and 8 (IRF4,8) are mainly 
expressed in the immune system, and were shown to play a critical role in B cell 
development via multiple mechanisms (Lu et al., 2003, Ma et al., 2006, Ma et al., 
2008). IRF4, whose expression is elevated by pre-BCR signalling, alone is vital for 
the promotion of light chain rearrangement and transcription in pre-B cells in the 
bone marrow (Ma et al., 2006, Johnson et al., 2008, Pathak et al., 2008). Similarly, 
IRF8 alone also plays a role in the specification, commitment and differentiation of 
B cells from HSCs through regulation of a transcriptional network including PU.l 
and EBFl (Wang et al., 2008). Furthermore, animals deficient for both IRF4 and 8 
(IRF4,8"'") exhibited a developmental arrest at the cycling pre-B cell stage in the 
bone marrow, and failed to down-regulate the pre-BCR (Lu et al., 2003). These 
results suggest that transcription factors IRF4 and 8, both alone and together, control 
different aspects of B cell development in the bone marrow. 
1.2.4 Generation of a functional B cell population in the periphery 
Upon productive rearrangement of the Ig heavy and light chain loci IgM is expressed 
on the surface of immature B cells, which are ready to leave the bone marrow and 
enter the periphery to complete their maturation (Figure 1.4) (Samitas et al., 2010). 
Occasionally, immature B cells that possess an autoreactive receptor are not deleted 
during the earlier stages of B lymphopoiesis. Therefore, immature B cells need to be 
checked first for self-reactivity before they leave the bone marrow, and the 
clonotypes bearing receptors with high affinity for self-antigens must be either 
eliminated or silenced in order to maintain self-tolerance (Figure 1.4). Several 
studies using transgenic mice have shown that mechanisms for censoring the 
autoreactive BCRs include receptor editing (secondary gene rearrangement) (Gay et 
al., 1993, Tiegs et al., 1993, Radic et al., 1993, Halverson et al., 2004), clonal 
deletion (Nemazee and Burki, 1989) and anergy (Goodnow et al., 1988). Relevant to 
the existence of the self tolerance check-point at the immature stage of B cell 
development in the bone marrow is the observation that only 10 to 20% of all newly 
produced B cells have been estimated to enter the mature B cell compartment in mice 
(Allman et al., 1993, Relink et al., 1998), and this ratio was shown to be between 25 
and 45% of all immature B cells in humans (Wardemann et al., 2003). 
Immature B cells that pass the self-reactivity check-point leave the bone marrow as 
recent immigrants called transitional (T)-l cells and migrate to the spleen for their 
final stages of maturation (Figure 1.4) (Loder et al., 1999). Multiple lines of evidence 
suggest that negative selection of immature B cells by clonal deletion in response to 
basal (tonic) BCR signalling continues to occur at the Tl stage of the peripheral 
maturation as BCR crosslinking induces increased apoptosis at this stage (Carsetti et 
al., 1995, Su and Rawlings, 2002, Petro et al., 2002). Tl cells express high level of 
IgM but low levels of IgD and CD21, and give rise to T2 cells, which represent a 
distinct population of IgM'"IgD'''CD2l'"CD23^ (Figure 1.4) (Loder et al., 1999). T2 
cells are exclusively found in the primary follicles of the spleen but not in the lymph 
node or bone marrow, and they possess the ability to further differentiate into mature 
B cell subpopulations (Loder et al., 1999, Teague et al., 2007). A subsequent study 
by Allman et al. suggested the existence of a third transitional population of 
immature peripheral B cells, and re-defined the three distinct subsets based on the 
surface phenotype of CD93"lgM'''CD23- (Tl), CD93ngM'"CD23" (T2) and 
CD93'^IgM'°CD23'' (T3) (Figure 1.4) (Allman et al., 2001). The authors confirmed 
the existence of a developmental sequence in which Tl cells differentiate into T2 B 
cells, which constitute the mature B cell compartments (Allman et al., 2001). 
Importantly, several lines of evidence suggest that all T3 cells are naturally anergic B 
cells as these cells were unable to give rise to mature B cells and were 
hyporesponsive to BCR stimulation (Figure 1.4) (Merrell et al., 2006, l eague et al., 
2007, Liubchenko et al., 2012). 
Similar to early B cell development in the bone marrow, the peripheral maturation of 
immature B cells also possesses distinct requirements for their survival and 
differentiation. A self-antigen-induced BCR signalling is suggested to be 
indispensable for B cell survival as well as for the differentiation of transitional B 
cells into mature B cells. This notion is supported by studies where ablation of BCR 
signalling via deletion or inactivation of genes encoding BCR signalling components 
including Btk, Blnk, PikSapl, Plcg2 and Vavl/Vav2/Vav3 resulted in a failure in the 
accumulation of mature B cells in the periphery (Khan et al., 1995, Pappu et a l , 1999, 
Hashimoto et al., 2000, Yamazaki et al., 2002, Fujikawa et al., 2003, Kraus et al., 
2004, Vigorito et al., 2005). These findings reveal the importance of tonic signalling 
in the survival of transitional immature B cells and their differentiation into mature B 
cell populations. 
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F i g u r e 1 .4 A s c h e m a t i c r e p r e s e n t a t i o n of B cel l m a t u r a t i o n in the p e r i p h e r y 
I m m a t u r e B ce l l s tha t e x p r e s s I g M on the i r s u r f a c e l eave b o n e m a r r o w and m i g r a t e to t h e 
p e r i p h e r y a s t r a n s i t i o n a l ( T ) I ce l l s . N e w l y f o r m e d T ! ce l l s g i v e r ise to T 2 ce l l s , w h i c h 
e v e n t u a l l y d i f f e r e n t i a t e in to m a t u r e B cell s u b s e t s i n c l u d i n g F O B cel ls and M Z B ce l l s . 
W h i l e s o m e T 2 ce l l s d i f f e r e n t i a t e in to T 3 ce l l s , w h i c h m a i n l y cons i s t o f a n e r g i c B ce l l s , 
s o m e o f t h e m a re t h o u g h t to d i f f e r e n t i a t e in to B l ce l l s ( m a i n l y B i b cel ls) . R e c e n t e v i d e n c e 
s u g g e s t s t h a t t h e d e v e l o p m e n t o f B l ce l l s c a n a l so b e de r ived f r o m the p r e c u r s o r s in the 
f o e t a l l iver a n d b o n e m a r r o w . T h e p h e n o t y p i c cha rac t e r i s t i c s o f the d i f f e r e n t s u b s e t s a re 
s h o w n . F O B, f o l l i c u l a r B ce l l s ; M Z B, m a r g i n a l z o n e B ce l l s ( M o d i f i e d f r o m S a m i t a s et al. , 
2010). 
In addition to the tonic BCR signalling, immature B cells depend on growth factors 
for their survival. In particular, the cytokine B cell-activating factor (RAFF), which 
is predominantly produced by neutrophils, monocytes and macrophages, is essential 
for survival of T2 cells as well as mature B cells via the alternative NFKB pathway 
(Mackay et al., 2010, Gardam and Brink, 2014). Mice deficient for BAFF exhibit a B 
cell developmental arrest at the T1 stage and have almost no mature B cells despite a 
normal B cell development in the bone marrow (Batten et al., 2000, Schiemann et al., 
2001, Gross et al., 2001). Conversely, overexpression of BAFF resulted in an 
expansion in the number of peripheral B cells, which led to severe autoimmune 
diseases (Mackay et al., 1999, Groom et al., 2002). Although BAFF is able to bind to 
three TNF family receptors, BCMA, TACI and BAFFR, the latter appears to be the 
crucial receptor for governing the effects of BAFF (Ng et al., 2004). This notion was 
further supported by evidence that BAFFR-null mice exhibit a very similar 
phenotype to that observed in BAFF-deficient animals (Shulga-Morskaya et al., 
2004). 
The generation and maintenance of functional mature B cell populations in the 
periphery is important for the effective protection against a vast range of infectious 
agents. Mature B cells can be divided into three subsets that differ with respect to 
their localisation, expression of different surface markers and function, namely 
follicular (FO) B cells, marginal zone (MZ) B cells and B1 cells (Figure 1.4). The 
strength of the ligand-independent tonic BCR signalling appears to play a key role in 
the commitment of immature B cells to a mature FO versus MZ B cell fate, with 
weak signalling favours the development of MZ B cells while strong signalling 
favours the development of FO B cells (Pillai and Cariappa, 2009). 
FO B cells that differentiate from T2 cells (Figure 1.4) are the main effector B cells 
that make up the majority of mature B cells in the periphery. They are localised into 
the primary follicles of B cell zones in the spleen, and are responsible for immune 
responses against T-dependent antigens (Allman and Pillai, 2008). Once FO B cells 
become activated and with the help from Th cells they differentiate into short-lived 
extrafollicular plasma cells that produce IgM, which is the first line of humoral 
immune responses (Goodnow et al., 2010, Hamel et al., 2012). Alternatively, 
activated FO B cells can migrate into the specialized microenvironments within the 
secondary lymphoid tissues, known as germinal centres (GC), where B cells undergo 
clonal expansion, somatic hypermutation and affinity maturation for effective 
humoral immune responses and for the generation of memory B-lymphocytes 
(Goodnow et al., 2010, Hamel at al., 2012). 
MZ B cells, on the other hand, localise in the marginal sinus regions of the spleen 
and they play a crucial role in host protection against T-independent antigens such as 
blood-borne antigens. Like FO B cells, MZ B cells also originate from T2 immature 
B cells (Figure 1.4), which contain substantial numbers of MZ precursors (Srivastava 
et al., 2005). MZ B cells are considered to be innate-like cells as upon T-independent 
activation they are able to rapidly proliferate and differentiate into low-affinity 
antibody-producing plasmablasts with 3-4 days (Oliver et al., 1999, Martin et al., 
2001). In addition to their role in T-independent immune responses, MZ B cells also 
function as antigen-presenting cells by transporting immune complexes that contain 
antigens from the marginal sinus to follicular dendritic cells in the splenic follicles 
(Ferguson et al., 2004, Cinamon et al., 2008). Moreover, MZ B cells have been 
shown to present antigen to T cells and activate them far better than FO B cells 
(Attanavanich and Kearney, 2004). These data suggest a potential role for MZ B 
cells in T-dependent immune responses. 
B1 cells have self-renewal ability and are mainly found in the pleural and peritoneal 
cavities. They account for nearly 5% of the total B cell population with fewer 
numbers in the spleen (Hayakawa et al., 1983). The chemokine CXCL13 has been 
shown to control B1 cell homing to the peritoneal cavities as CXCL13-deficient B1 
cells were largely found in the spleen and exhibited a defective antibody response 
(Ansel et al., 2002). Although initially CDS expression on their surface was thought 
to distinguish B1 cells from the conventional B (B2) cells (Hayakawa et al., 1983), it 
was later found that not all B1 cells express CD5 on their surface, and B1 cells can 
be divided into two subpopulations, namely Bla cells (CD5^) and B ib cells (CDS') 
(Kantor et al., 1992). 
The development of B1 cells takes place earlier than FO B cells in ontogeny (Godin 
et al., 1993), and occurs both before the birth and in the first weeks of post-natal life 
(Baumgarth, 2011). B1 cell development is believed to be different from the 
development of B2 cells, but it is less understood and different models have been 
suggested to explain. The first model is known as the "lineage hypothesis", which 
proposes existence of two distinct B cell precursors that give rise to different B cell 
subpopulations (Figure 1.4) (Herzenberg, 2000, Dorshkind and Montecino-
Rodriguez, 2007). Evidence supporting this notion was shown by studies where a 
precursor population in the foetal liver and bone marrow was shown to give rise to 
B1 cells (Montecino-Rodriguez et al., 2006, Tung et al., 2006, Esplin et al., 2009). 
The second model, known as the "induced differentiation hypothesis", proposes that 
all B cells derive from a common precursor (Figure 1.4) and the appearance of B1 
cells is dependent on the encounter with naturally occurring antigens (Berland and 
Wortis, 2002). Baumgarth recently proposed a third hypothesis named the "two-
pathway model" for B1 cell development in which both the lineage and induced 
differentiation hypothesis coexist to warrant the generation of a functional B1 cell 
population (Baumgarth, 2011). With respect to their functional properties, B1 cells 
participate in the antigen-stimulated T-independent antibody responses with their 
ability to produce natural antibodies (IgM) and thus provide the earliest antibody 
response against antigens (Berland and Wortis, 2002, Allman and Pillai, 2008). B1 
cells have also been suggested to participate in T-independent immune responses at 
the mucosal sites by producing IgA (Berland and Wortis, 2002, Allman and Pillai, 
2008). 
1.2.5 B cell activation and formation of GC B cells 
Once a functional mature B cell population is generated in the periphery, mature B 
cells search their cognate antigen by circulating through the blood and the lymph. 
The encounter of antigen with naive B cells occurs in the secondary lymphoid tissues 
in most cases. Engagement of the BCR by its cognate antigen is not sufficient for B 
cell activation, as B cells need a second signal from Th cells, and recognition of the 
antigen with its cognate BCR leads to migration of B cell to the T cell zone near the 
follicle to receive this help. The membrane protein CD40 ligand, which is highly 
expressed by activated Th cells, activates the B cell surface receptor CD40 to 
promote the survival and proliferation of B cells (Elgueta et al., 2009). The gain of a 
second signal from Th cells is central for the activation and proliferation of B cells as 
cells that fail to receive this signal undergo apoptotic death or anergy in a T-
dependent response (Goodnow et al., 2010). The activated B cells express the CD28 
ligands CD80 and CD86 to activate CD4 Th cells (Goodnow et al., 2010), which 
upon activation proliferate and produce cytokines, which in turn enable B cells to 
survive and proliferate (Goodnow et al., 2010). 
Activation of B cells through the BCR results in either differentiation into GC B cells 
or becoming short-lived plasma cells producing IgM antibodies with low affinity 
(Goodnow et al., 2010). GCs are specialized microenvironments within the 
secondary lymphoid tissues where B cells undergo clonal expansion, somatic 
hypermutation and affinity maturation for effective humoral immune responses and 
for the generation of memory B-lymphocytes (Vinuesa and Cyster, 2011, Crotty, 
2011). In GCs, B cells undergo an extensive proliferation phase. Class switch 
recombination also mainly occurs in GCs in order for B cells to switch their Igs to a 
different constant region for different effector functions (Goodnow et al., 2010). 
Furthermore, within the GCs, B cells also undergo somatic hypermutation, resulting 
in an increase in antigen affinity (Goodnow et al., 2010). Some of the activated cells 
eventually either differentiate into antibody secreting plasma cells or become 
memory B cells (Goodnow et al., 2010). 
T Follicular helper (TFH) cells are a recently identified subset of CD4^ T cells that 
provide essential help to B cells to trigger formation of GCs (Vinuesa and Cyster, 
2011, Crotty, 2011). During a T-dependent immune response, the differentiation of 
normal numbers of TFH cells is a crucial step as failure of TPH-cell differentiation 
resuhs in impaired GC formation and a lack of high-affinity antibody production 
(Johnston et al., 2009, Nurieva et al., 2009, Yu et al., 2009). In contrast, increased 
numbers of TFH cells results in aberrant production of autoantibodies and the 
development of autoimmune diseases (Hu et al., 2009, Linterman et al., 2009). 
In conclusion, the formation of GC B cells as well as TFH cells is an important step 
for the effective humoral responses, and dysregulation of the GC responses is 
associated with several immune system disorders (Vinuesa et al., 2009, Klein and 
Dalla-Favera, 2008). 
1.3 Plasma M e m b r a n e Lipid Asymmetry 
The plasma membrane in eukaryotes envelops cells and consists of a bilayer 
structure based on the distribution of aminophospholipids, which was first shown in 
human erythrocytes (Gorter and Grendel, 1925). One of the unique features of the 
plasma membrane is the asymmetric distribution of the specific phospholipids 
between the two leaflets of the bilayer. While most of the plasma membranes contain 
phosphatidylcholine (PC) and sphingomyelin (SM) on the exoplasmic leaflet, 
phosphatidylserine (PS) and phosphatidylethanolamine (PE) are mainly confined to 
the cytoplasmic leaflet (Bretscher, 1972, Gordesky and Marinetti, 1973). PC is the 
most prevalent lipid, which constitutes 40 - 50% of total lipids in the plasma 
membrane, whereas PE and PS only account for 25% and 12% of the total membrane 
lipids, respectively (Daleke, 2008). The presence of other lipids such as 
phosphatidylinositol (PI) and phosphatidic acid (PA) is less abundant and restricted 
to the cytoplasmic leaflet (Butikofer et al., 1990, Gascard et al., 1991). 
The establishment and dynamic maintenance of the non-random distribution of 
phospholipids is important for normal membrane functions, and has been implicated 
in many cellular processes including blood coagulation, apoptosis and vesicle 
formation (Leventis and Grinstein, 2010). The restriction of PS in the cytoplasmic 
leaflet is particularly important as it mediates important biological functions. PS in 
the cytoplasmic leaflet activates Protein Kinase C beta and provides a docking site 
for a range of other signalling proteins including GTPases (Ras and Rho) and non-
receptor tyrosine kinases (e.g. Src) (Leventis and Grinstein, 2010). In contrast to 
their role in the cytoplasmic leaflet, PS also initiates important biological processes 
upon exposure on the surface. During the platelet activation PS accumulates on the 
exoplasmic leaflet via the scramblase activity (discussed below), which initiates the 
blood coagulation cascade through the activation of several blood proteins like 
clotting factor V, VIII and X (Leventis and Grinstein, 2010). Exposure of PS on the 
surface of cells is also critical for the recognition and clearance of apoptotic cells. 
During the early stages of cell death, PS is no longer restricted to the inner leaflet 
and is exposed on the exoplasmic leaflet, which provides an "eat-me" signal that can 
be recognized by specific PS receptors expressed on macrophages for their 
engulfment (Fadok et al., 1992). 
As mentioned above, asymmetry of the plasma membrane is critical but it does not 
exist autonomously, and has to be actively generated by two groups of ATP-
dependent transporters embedded in the membrane (Figure 1.5A). ATP-binding 
cassette (ABC)-type transporters (floppases) are responsible for active transport of 
specific lipids such as PC to the exoplasmic leaflet (Pomorski and Menon, 2006). 
"Flipping" of PS and PE into the inner leaflet against their concentration gradient is 
greatly accelerated by flippases, which are members of the P4-type ATPase family of 
10-transmembrane domain proteins (Figure 1.5B) (Tang et al., 1996, van der Velden 
et al., 2010, Paulusma and Elferink, 2010). The third group of transporters, known as 
scramblases, are believed to disrupt the lipid asymmetry generated by energy-
dependent transporters via mediating the rapid bidirectional movement of all types of 
phospholipids (Figure 1.5A) (Severs and Williamson, 2010). In contrast to energy-
dependent flippases and floppases, scramblases become activated by elevation of 
intracellular Ca^^ concentration (Severs and Williamson, 2010). 
1.3.1 Phospholipid flippases 
The presence of an asymmetric distribution of phospholipids was first shown in 
human erythrocytes (Bretscher, 1972, Gordesky and Marinetti, 1973), which provide 
a great model for the study of membrane lipids as erythrocytes lack nuclei and they 
are closely associated with their plasma membrane (Daleke, 2008). In 1984, 
Seigneuret and Devaux were the first to identify the existence of an phospholipid 
translocase that catalyses the movement of specific spin-labelled lipid analogues 
from the outer leaflet of the plasma membrane to the inner leaflet in human 
erythrocytes (Seigneuret and Devaux, 1984). This process requires ATP for function, 
as vanadate inhibits translocation (Seigneuret and Devaux, 1984), and selectively 
transports PS and, to lesser extent PE. Since the first evidence for the phospholipid 
translocase activity, a huge amount of work has been done for the molecular 
identification and characterisation of these transporters, and it was later shown that 
proteins belong to the P4-type ATPase family catalyse the flipping of phospholipids 
(Tang et al., 1996, van der Velden et al., 2010, Paulusma and Elferink, 2010). 
The P4-type ATPases are integral membrane proteins and expressed in eukaryotes 
(van der Mark et al., 2013). The proteins consist of 10 transmembrane segments with 
a phosphorylation domain, a nucleotide binding domain, an actuator domain and 
both N- and C-terminal tails (Figure 1.5B). While there are 14 members in humans 
(ATP8A1, ATP8A2, ATP8B1, ATP8B2, ATP8B3, ATP8B4, ATP9A, ATP9B, 
ATPlOA, ATPlOB, ATPIOD, ATPl 1 A, ATPl IB and ATPl IC) and 15 in mice (all 
present in humans and ATP8B5), there are only 5 members in yeast (Drs2, Dnf l , 
Dnf2, Dnf i and Neo l ) (Sebastian et al., 2012). 
Like other P-type ATPases, the proper function of the P4-type ATPases requires the 
formation of a heterodimeric complex with a p-subunit. The members of the cell 
divisional control 50 (CDC50) protein family, that is evolutionary conserved in yeast, 
plants and mammals, have been suggested to act as the |3-subunit (Saito et al., 2004). 
CDC50 proteins possess two putative transmembrane domains separated by a large 
glycosylated extracellular domain (Figure 1.5B). Although the p-subunit is believed 
to be required for the release of the P4-type ATPase from the ER (van der Mark et al., 
2013, Lopez-Marques et al., 2013), their contribution to the subcellular localisation 
and the determination of substrate specificity is still unclear. Recent studies in 
Arabidopsis thaliana and yeast revealed that the CDC50 is not involved in the 
recognition of different phospholipid substrates, and the P4-type ATPase itself 
determines the substrate specificity (Lopez-Marques et al., 2010, Baldridge and 
Graham, 2012). Despite the existence of 14 the P4-type ATPases in humans (15 in 
mice), there are only 3 CDC50 proteins expressed in mammals (CDC50A-C) (Katoh 
and Katoh, 2004), indicating that one CDC50 protein can associate with muhiple P4 
ATPases. However, the specific role of CDC50 proteins in the localisation and the 
determination of substrate specificity of the P4-type ATPases in mammals remains 
elusive. 
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Figure 1.5 T h e generat ion and dynamic maintenance of phospholipid asymmetry by 
lipid transporters 
(A) Asymmet r i c distr ibution of phosphol ipids in the biological membranes is a hal lmark of 
cell survival and funct ion . Three d i f ferent groups of enzymes are involved in the movemen t 
of phosphol ip id molecules be tween the two leaflets of the plasma membranes . While A T P -
dependent f l ippases catalyse the inward movement of predominantly phosphat idylser ine 
(PS), and to a lesser extent phosphat idyle thanolamine (PE), ATP-dependent f loppases 
t ransport phosphat idylchol ine (PC) and sphingomyel in (SM) f rom the cytosolic leaflet to the 
exop lasmic leaflet of the bilayer. Scramblases , on the other hand, are activated by Ca^*, and 
media te bidirect ional m o v e m e n t of lipids without substrate specificity. (B) The predicted 
topology of the P4-type ATPases (a - subun i t ) and C D C 5 0 (p-subunit) is shown. The P4-type 
A T P a s e s have ten t r ansmembrane domains , cytosolic actuator (A), phosphorylat ion (P), the 
nucleot ide b inding (N) domains and N- and C-termini . C D C 5 0 subunit possesses two 
t r ansmembrane domains , short cytosolic N - and C-termini , and multiple putat ive 
glycosyla t ion sites as indicated by asterisks. 
1.3.1.1 Evidence that the P4-type ATPases are phospholipid flippases 
Although the biochemical activity of flippases has been known for a long time, their 
identification and characterisation is still unclear. The evidence that the P4-type 
ATPases are involved in the inward movement of lipids originates from studies in 
yeast. In 1996, Tang et al. showed in yeast that a Drs2 null mutant is defective in 
ATP-dependent transport of NBD-labelled PS (Tang et al., 1996). Subsequent 
studies revealed that other members, Dnfl and Dnf2 reside in the plasma membrane 
and mediate the transport of NBD-labelled PE, PS and PC from the outer to the inner 
leaflet of plasma membrane (Pomorski et al., 2003). Recently, reconstitution of 
flippase activity with purified Drs2 has also been implicated in the translocation of 
PS (Zhou and Graham, 2009). 
Further evidence for the involvement of P4-type ATPases in the translocation of 
phospholipids came from the studies in higher eukaryotes. For instance, the 
Arabidopsis protein ALAl , which is homologous with Drs2 in yeast, has been shown 
to act as a flippase (Gomes et al., 2000). Consistently, the P4-type ATPase TAT-1 in 
Caenorhabditis elegans facilitates the inward transport of PS in germ cells (Darland-
Ransom et al., 2008). As discussed further below, mammalian flippases ATP8A1, 
ATP8A2, ATP8B1 and ATP8B3 have been shown to be involved in the translocation 
of phospholipid between the two leaflets of the bilayer in different cell types (Levano 
et al., 2012, Zhu et al., 2012, Cai et al., 2009, Wang et a l , 2004). These findings 
collectively suggest that members of the P4-type ATPase family have the ability to 
translocate specific phospholipids (predominantly PS) from the cytoplasmic leaflet to 
the exoplasmic leaflet of biological membranes, thereby acting as a flippase. 
1.3.1.2 Evidence that the P4-type ATPases are involved in vesicle-mediated 
protein transport 
In addition to phospholipid translocase activity, the P4-type ATPases have been 
suggested to play an important role in vesicle-mediated protein trafficking in the 
Golgi and endosomal systems (Graham, 2004). The first evidence for involvement of 
the flippases in vesicular transport was demonstrated in yeast. The mutant Drs2, 
which predominantly localises to the /ra«5-Golgi network where clathrin-coated 
vesicles bud, exhibited impaired formation of clathrin-coated vesicles (Chen et al., 
1999). Using different mutant flippases in yeast, subsequent studies confirmed that 
the P4-type ATPases were involved in tiie vesicle-mediated protein transport (Hua et 
al., 2002, Pomorski et al., 2003). The involvement of the flippase family in the 
biogenesis of intracellular transport vesicles within the endocytic and secretory 
pathways has also been demonstrated in higher organisms including Arabidopsis 
thaliana and Caenorhabditis elegans (Poulsen et al., 2008, Ruaud et al., 2009, Chen 
et al., 2010) as well as in mammalian cells (Xu et al., 2009). These findings suggest a 
nonredundant function for the P4-type ATPases in secretory vesicle formation, but 
their physiological functions in mammalian systems remain to be fully uncovered. 
1.3.1.3 Physiological importance of the P4-type ATPases in mammals 
As already mentioned, the cellular functions of the P4-type ATPases have mostly 
been pinpointed by genetic analysis in yeast and the role of the 15 P4-type ATPases 
in mice (14 in humans) (Sebastian et al., 2012) and other mammals is mostly 
unexplored (van der Mark et al., 2013). The flippases that have been linked to the 
physiological functions in mammals will be briefly highlighted below. 
The plasma membrane aminophospholipid translocase activity of ATP8A1 has been 
recently shown using knock out mice. ATP8A1 knock-out hippocampal cells 
displayed increased PS exposure on their surface compared to cells from 
heterozygous and control mice (Levano et al., 2012). ATP8A1-deficient animals also 
showed a delayed hippocampus-dependent learning, and hyperactivity. Interestingly, 
despite the expression of ATP8A1 in erythrocyte membranes (Soupene and Kuypers, 
2006), erythrocytes from the deficient mice exhibit no increased exposure of PS at 
the surface, and this was explained by a compensatory increase of ATP8A2 in 
erythrocytes from AlpSaf'' mice (Levano et al., 2012). 
A homologue of ATP8A1, ATP8A2 is highly expressed in photoreceptor outer 
segments of retina, brain, spinal cord and testis (Coleman et al., 2009, Cacciagli et al., 
2010, Zhu et al., 2012). Loss of ATP8A2 in mice led to the development of 
neurodegeneration in the central and peripheral nervous system, and deficient mice 
exhibited an impaired flippase activity (Zhu et al., 2012). In vitro transfection of cells 
defective in non-endocytic uptake of PS with ATP8A2 revealed an increase in PS 
translocation activity, confirming that ATP8A2 is a phospholipid flippase (Zhu et al., 
2012). Moreover, a recent study illustrated that AtpSal" mice displayed shortened 
retinal photoreceptor outer segments and decreased photoreceptor viability (Coleman 
et al., 2014), indicating a role for ATP8A2 in normal visual and auditory function as 
well as the survival of photoreceptor and spiral ganglion. In agreement with murine 
findings, patients with a mutation in ATP8A2 have been shown to display cerebellar 
ataxia, mental retardation and disequilibrium syndrome (Cacciagli et al., 2010, Onat 
et al., 2013). These data collectively suggest a critical role for the P4-type ATPase 
ATP8A2 in the development of neurological disorders as well as in normal vision. 
ATP8B1 is the first member of the P4-type ATPase family that has been related to a 
human disease. It is expressed in many tissues such as liver, pancreas, small intestine, 
bladder and prostate (van der Mark et al., 2013). Mutations in human ATP8B1 have 
been associated with familial intrahepatic cholestasis characterised by a defective 
bile salt extraction from liver into bile (Bull et al., 1998, Klomp et a l , 2004). Further 
mouse studies revealed that ATP8B1 is important for normal phospholipid 
asymmetry of the canalicular membrane, and hepatocytes from ATP8B1-deficient 
animals were shown to be more sensitive to bile salt-induced membrane damage 
(Paulusma et al., 2006, Cai et al., 2009). 
ATP8B3 is expressed in spermatozoa, and is required for asymmetric distribution of 
PS between the two leaflets of the sperm plasma membrane (Wang et al., 2004, 
Gong et al., 2009). Despite normal sperm morphology and motility, sperm from the 
deficient animals exhibited compromised in vitro fertilization capability (Wang et al., 
2004), suggesting a possible role for ATP8B3 in the formation of acrosome and 
sperm function during fertilization. 
The heterozygous deletion of ATP 1 OA (also known as ATP IOC) in mice is 
associated with diet-induced obesity, type-2 diabetes, non-alcoholic fatty liver 
disease and as well as the development of insulin resistance and regulation of 
glucose uptake in adipose tissue and skeletal muscle (Dhar et al., 2004, Dhar et al., 
2006). Similarly, C57BL/6J mice carrying a stop codon in exon 12 of AtplOd 
(Flamant et al., 2003) have been shown to be prone to develop obesity, 
hyperglycemia and hypertension upon a high-fat diet (Surwit et al., 1988, Surwit et 
al., 1991, Rebuffe-Scrive et a l , 1993), suggesting a potential role for flippases in the 
development of obesity and type-2 diabetes. 
Despite the studies revealing the physiological importance of flippases in mammals, 
further characterisation and functional properties of different flippases are needed to 
fully understand pathophysiology of flippase-related diseases such as intrahepatic 
cholestasis in humans. 
1.3.2 Phospholipid floppases 
The second group of lipid transporters, known as floppases, which mediate the 
movement of phospholipids from the inner leaflet to the outer leaflet of biological 
membranes, has been identified in erythrocytes using spin- or NBD-labelled lipids 
(Bitbol and Devaux, 1988, Connor et al., 1992). ABC-type transporters catalyse 
active transport of specific lipids to the exoplasmic leaflet, and the most 
characterised members are ABCAl . ABCBl (also known as MDRl) , ABCB4 (also 
known as MDR2 in mice or MDR3 in humans) and ABCCl, but the role of these 
transporters in mammals is largely unknown. ABCB4 has been implicated in the 
secretion of PC into the bile (Smit et a l , 1993). Subsequent studies further 
demonstrated a critical involvement for ABCBl and ABCB4 in the outward 
translocation of different lipids including platelet activation factor, PC, PE, and SM 
(van Helvoort et al., 1996, Ernest and Bello-Reuss, 1999, Raggers et al., 2001, 
Morita et al., 2007). Other members of the ABC-type transporter family, ABCBl 1 as 
well as ABCG5 and ABCG8 have also been implicated in intrahepatic cholestasis 
(Wang et al., 2001), and biliary excretion of cholesterol (Berge et al., 2000). In 
conclusion, despite that many ABC transporters have been suggested to exist (Nagao 
et al., 2010), their characterisation and mechanism of action needs further evaluation 
to be fully delineated. 
1.3.3 Phospholipid scramblases 
The physiological importance of phospholipid scrambling has been documented in 
several important events (Bevers and Williamson, 2010). As already mentioned, loss 
of plasma phospholipid asymmetry and subsequent exposure of PS on the surface is 
a feature of the activation of blood coagulation cascades as well as recognition of 
apoptotic cells, and dependent on the activity of lipid scrambling (Williamson et al., 
1992). The disruption of plasma membrane lipid asymmetry via scramblase activity 
was first discovered in blood platelets (Bevers et al., 1983). This activity has been 
suggested to be important for exposure of PS on the surface that provides a platform 
for the assembly of complexes of the blood coagulation cascade (Severs et al., 1983, 
Bevers and Williamson, 2010). Exposure of PS on the surface has also been shown 
to be critical for the recognition and clearance of apoptotic cells by macrophages 
(Fadok et al., 1992), and subsequent studies have shown that PS extemalisation on 
apoptotic cells is mediated by scramblases (Verhoven et al., 1995, Bratton et al., 
1997). These results suggest that a fine-tuned scramblase activity is vital for normal 
blood coagulation and recognition and clearance of apoptotic cells. 
Activation of scramblases is regulated by cytoplasmic Ca^ "" concentration, and 
alterations in Ca^"' concentration can disrupt lipid asymmetry, followed by an 
accelerated flippase activity within human erythrocytes (Henseleit et al., 1990). 
Consistently, Ca^"^-induced loss of lipid asymmetry can be regenerated by 
reactivation of flippases that can pump phospholipids such as PS back to the 
cytoplasmic leaflet upon removal of Ca^ "" (Comfurius et al., 1990, Verhoven et al., 
1992). Moreover, the duration of Ca^'^-triggered scramblases activity in erythrocytes 
has been shown to depend on Ca "^" levels (Williamson et al., 1992), and has also been 
observed in different cell types including lymphocytes (Williamson et al., 2001). 
These results suggest that asymmetric distribution of specific phospholipid can be 
established and maintained by energy-dependent transporters, and this asymmetry is 
disrupted by the activity of Ca^^-induced scramblases. 
The physiological importance of phospholipid scrambling has been first shown in a 
patient with Scott syndrome in which platelets are unable to form a procoagulant 
activity due to a reduced surface exposure of PS resulting in moderate to severe 
bleeding (Weiss et al., 1979, Rosing et al., 1985). In addition to platelets, 
erythrocytes and lymphocytes from these patients exhibited an impaired Ca "^^ -
induced PS exposure on the surface (Bevers et al., 1992). EBV-transformed B cells 
from patients with Scott syndrome also displayed a defective Ca^"'-induced lipid 
scrambling (Williamson et a l , 2001). Intriguingly, when these cells were driven into 
apoptosis, they were able to expose PS normally on their surface, suggesting the 
existence of two different activation pathways determined by their dependency on 
intracellular Ca^"" (Williamson et al., 2001, Bevers and Williamson, 2010). 
Despite that biochemical activity of scramblases has been known for a long time, 
their characterisation is incomplete. Several studies attempted to purify the putative 
scramblases in erythrocytes and platelets (Basse et al., 1996, Comfurius et al., 1996, 
Zhou et al., 1997, Wiedmer et al., 2000), but whether the isolated proteins exert 
scramblese activity is controversial. A potential phospholipid scrambles 
(TMEM16F) has recently been identified, and shown to play an important role in 
lipid scrambling in platelets during blood coagulation by forming a Ca^"'-activated 
cation channel (Suzuki et al., 2010, Yang et al., 2012). In keeping with these findings, 
mutations in TMEM16F were found in patients with Scott syndrome (Suzuki et al., 
2010, Castoldi et al., 2011), suggesting a critical role for TMEM16F in lipid 
scrambling. 
1.3.4 Role of lipid transporters in the immune system 
As mentioned above, the plasma membrane is organised into specialized 
substructures, such as asymmetrical concentration of specific phospholipids between 
the exoplasmic and cytoplasmic leaflets in eukaryotic cells that facilitates many 
immunological signalling events (Lingwood and Simons, 2010, Leventis and 
Grinstein, 2010). Despite the importance of lipid transporters in the establishment 
and maintenance of the membrane lipid asymmetry, their direct or indirect 
involvement in the development and function of cells of the immune system remains 
to be uncovered. This is basically due to the paucity of in vivo genetic tools. 
Therefore, it is crucial to develop in vivo animal models to be able to study the role 
of the aminophospholipid transporters within the immune system. 
1.4 Discovery of Novel Immune Regulatory Genes by A^-Ethyl-TV-
nitrosourea (ENU) Mutagenesis 
1.4.1 Developing model organisms 
Despite an extensive research in cellular, molecular and clinical immunology in 
recent decades, there remain many important questions to be resolved. For instance, 
what factors control the development, homeostasis and function of immune cells? 
How are the important signalling pathways in the immune system initiated and 
terminated? How does organization of the eukaryotic plasma membrane into 
specialized substructures in lymphocytes facilitate important biological functions? 
How can immunological diseases such as autoimmunity, allergy and transplant 
rejection develop in human and is it possible to find potential cures and therapies for 
these devastating diseases? 
Scientists have been striving to answer these questions by examining the biological 
function of genes in humans. However, human studies have been hampered by the 
difficulties in accessing the human biological samples and genetic heterogeneity in 
families. In order to overcome these limitations, scientists have made use of a variety 
of model genetic organisms (e.g. Drosophila melanogaster, Caenorhabditis elegam, 
Danio rerio and Mus musculus) to study mutations that affect the pathogenesis and 
biochemical pathways of immunological disorders that have clinical relevance in 
humans. 
In particular the laboratory mouse, Mus musculus, has gained the most attention in 
biomedical research as comparative genomics revealed that nearly 90% of mouse 
genes are conserved in the human genome (Waterston et al., 2002), suggesting that 
most findings in mice possibly have a corresponding effect in humans. In addition to 
the genomic and physiological similarities between mice and humans, their 
availabilities, ease of handling, high reproductive rates in a relatively short time 
frame and low cost make the laboratory mice a suitable model organism for 
biomedical research. Therefore, the generation of mouse models through genetic 
engineering enables the scientists not only to identify genes involved in different 
biological processes, but also to develop novel therapies for human diseases based on 
a detailed pathophysiological understanding. 
1.4.2 Genomic approaches for modifying the mouse genome to study immune 
system disorders 
Two distinct approaches have been widely used to generate mouse models for 
identification and functional characterisation of novel genes in human diseases and 
immunity studies; gene-driven (reverse genetic) and phenotype-driven (forward 
genetic). The gene-driven approach mainly involves the use of "knock out" models 
in which a target gene is completely or partially deleted from the mouse genome 
followed by analysis of the resulting phenotype (Thomas and Capecchi, 1987). 
Recently, an alternate gene modification method has been described harnessing the 
adaptive immune system of bacteria and archaea termed clustered regularly 
interspaced short palindromic repeats (CRISPR)/CRISPR-associated systems (Cas) 
(Cong et al., 2013, Mali et al., 2013). This evolved immune system uses short RNA 
to directly target the foreign nucleic acids (Horvath and Barrangou, 2010), and this 
feature has been used for gene modifications in mammals (Cong et al., 2013, Mali et 
al., 2013). Employing the CRISPR/Cas9 system, it was shown that mice carrying 
mutations in multiple genes can be obtained through only one-step generation within 
weeks (Wang et al., 2013). Moreover, mice that contain both reporter and conditional 
mutations can also be created (Yang et al., 2013). 
The generation of mouse models using gene-driven approach is particularly valuable 
when a single gene is known to be the primary cause of a disease so that an animal 
model can be generated to examine the function of the gene. However, gene-driven 
approaches sometimes result in homozygous lethality during embryonic development, 
because target genes might be crucial for the early embryogenesis, thereby 
preventing postnatal analysis of mice. Another limitation of the "knock out" 
technology is the examination of only one gene at a time. 
On the other hand, phenotype-driven screens for example ENU mutagenesis have 
gained enormous attention in the last two decades as they provide a unique, unbiased 
approach to discover new genes of previously unknown functions in major 
physiological systems including the immune system, the reproductive system and 
behavioural studies (Nelms and Goodnow, 2001, Hoyne and Goodnow, 2006, Gondo, 
2008, Yates et al., 2009, Jamsai and O'Bryan, 2010, Liu et al., 2011, Oliver and 
Davies, 2012, Moresco et al., 2013). A number of laboratories around the world have 
been harnessing ENU mutagenesis to unveil new genes and characterise novel 
disease pathways. One of the major advantages of ENU mutagenesis over the "knock 
out" technology is the introduction of point mutations in the germline, which 
inactivates or alters the function of individual protein domains or splice products 
rather than making a null allele (Nelms and Goodnow, 2001). Moreover, ENU 
mutagenesis does not require prior knowledge or assumption about a particular gene; 
therefore the possibility of identifying a novel gene with important functions in 
physiological systems is relatively high. 
A phenotype-driven ENU mutagenesis screen has also been used at the 
Immunogenomics Laboratory at the John Curtin School of Medical Research to 
identify novel genes with important roles in the immune system. For the last decade, 
using ENU mutagenesis our laboratory has discovered many genes with previously 
unknown function or they revealed novel functions of well known target genes 
including Carmal, Ikaros, Roquin, Zap70. Hnrpll, DockS, Zbtb7b, Sppl2a, Prkcb 
and Zfp3l8 (Jun et al., 2003, Papathanasiou et al., 2003, Vinuesa et al., 2005, Siggs 
et al., 2007, Wu et al., 2008, Randall et al., 2009, Enders et al., 2012, Bergmann et al., 
2013, Teh et al., 2013, Enders et al., 2014). These genes have been shown to control 
many different immunological processes. 
1.4.3 ENU mutagenesis screen 
ENU, the alkylating agent, was found as a strong chemical mutagen in mice (Russell 
et al., 1979) that induces a high rate of random base-pair substitutions, typically 
A - ^ T or A ^ G transversions in mouse spermatogonial stem cells (Hitotsumachi et 
al., 1985, Nelms and Goodnow, 2001, Moresco et al., 2013). 
For the ENU screen at the John Curtin School of Medical Research, 90 mg ENU / kg 
mouse body weight is intraperitoneally administered to the male wild-type C57BL/6 
mice. This induces one point mutation per 1.54 Mb in spermatogonial stem cells of 
Generation (G) 0 mice (Andrews et al., 2012, Bull et al., 2013). The ENU-treated GO 
males are then bred with wild-type females to generate G1 offspring bearing various 
independently induced mutations (Figure 1.6). While a screen of dominant mutations 
with visible phenotypes or detectable changes can be carried out in the G1 founders, 
G3 mice derived from the interbreeding of G1 and G2 populations is used to screen 
for recessive traits (Nelms and Goodnow, 2001). In the three-generation scheme to 
conduct genome wide recessive screens, a G1 male mouse is paired with an unrelated 
G1 female (Figure 1.6). Since each of these G1 parents carries approximately 45 
protein variants, a total of - 4 5 protein variants are brought into each G2 mouse 
(Figure 1.6). By intercrossing the G2 progeny as brother-sister pairs, a total of - 4-5 
recessive mutations are brought to homozygosity in each offspring and the remaining 
genetic mutations (40-41 variants) remain as heterozygous traits in G3 animals 
(Figure 1.6) (Nelms and Goodnow, 2001, Moresco et al., 2013). 
The screening in our laboratory is based on the collection of the peripheral blood 
from the mutagenised G3 mice, followed by a multi-colour flow cytometry 
phenotypic screen to detect abnormalities in the development of different immune 
cell subsets including B cells, T cells and natural killer (NK) cells. 
Once a phenotype of interest is uncovered in the G3 offspring it must be confirmed 
with more technical and biological replicates. Once the trait is established, the 
underlying mutation has to be identified. In the past, this involved a two generation 
mapping cross between an affected mouse and a mouse from a different inbred strain, 
followed by detection of a linked chromosomal region and PCR amplification and 
Sanger sequencing of all coding regions within the linked interval. However, recent 
advances in the technology of DNA sequencing have significantly reduced the costs 
and time required for sequencing and largely abolished the need for extensive 
mapping crosses (Mardis, 2011, Andrews et al., 2012, Andrews et al., 2013, Bull et 
al., 2013). Therefore, our laboratory currently uses whole-genome or whole-exome 
sequencing of individual or multiple affected mice to identify the probable causative 
variant (Andrews et a l , 2012). 
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Flow cytometric screening of 
peripheral blood from G3 mice 
Figure 1.6 The three generation scheme for genome wide screening of recessive 
phenotypes induced by ENU mutagenesis 
The ENU-treated GO males are bred with females from the same inbred strain to generate G1 
offspring bearing various independently induced mutations. In order to conduct genome 
wide recessive screen, a 0 1 male mouse is paired with an unrelated 0 1 female, followed by 
intercrossing the 0 2 progeny as brother-sister pairs. Lymphocytes in the peripheral blood of 
0 3 offsprings are then collected and stained with a range of fluorescent antibodies and 
analysed on flow cytometry for specific phenotype (Modified from Andrews et al., 2012). 
1.4.4 Discovery of Ambrosius mouse strain with a point mutation in Atpllc 
1.4.4.1 ENU mutagenesis identifies mice with severe B cell deficiency 
During the above mentioned flow cytometry screen, a G3 male mouse from the 
ENU11B6:221 strain was identified with severely reduced 8220"" B cell frequency in 
blood (Figure 1.7). 
The strain was named ''Ambrosius", and mutant male mice on the 8 6 background 
were out-crossed to the CBA mapping strain to facilitate mapping of the ENU-
induced mutation. F1 hybrid mice were intercrossed to produce F2 progeny that 
could be used to map the mutant locus. Hemizygous mutant males or homozygous 
mutant females and their wild-type littermates were, however, maintained on a 
C57BL/6 background for further studies reported in this thesis. 
WT Mutant 
Figure 1.7 Identiflcation of a strain with fewer B cells after ENU-induced mutagenesis 
Flow cytometry of 3220"^ B cells in the blood of wild-type (WT) and mutant mice. Numbers 
adjacent to outlined areas indicate percentage of B220"CD3' B cells (top left) or B220'CD3^ 
T cells (bottom right). 
1.4.4.2 Next-generation DNA sequencing reveals Atpllc mutation in Ambrosim 
mice 
Linkage analysis in (B6xCBA)F2 offspring mapped the mutation to an X-
chromosomal region distal to marker rsl3483763 at 54,012,901 base pairs (Build 
NCBI37.1). To capture and sequence Refseq annotated exons in this region of the X-
chromosome, a custom Agilent Sureselect targeted DNA capture array was designed 
and hybridized with fragmented genomic DNA from an Ambrosius male mouse 
(Figure 1.8A). The enriched DNA was sequenced in paired-end mode for 100 cycles 
on a single lane of an Ilumina GAIIx sequencer. For the bait-targets, the median read 
depth from a single lane of data was 138 and 96% of the nucleotides were covered 
with a read depth of 5 or greater. A median read depth of 137 was obtained across all 
RefSeq exons in the mutation-containing region and a read depth of 5 or greater for 
approximately 93% of the nucleotides in these exons. Capture and sequencing was 
performed in replicate at two facilities, yielding highly reproducible results (Yabas et 
al., 2011). 
Within the interval a single mutation was identified in both capture datasets and 
confirmed by Sanger sequencing, lying in a previously uncharacterised gene, Atpllc. 
This was a G to A substitution in the exon 27 splice donor sequence at the +1 
position of intron 27 (Figure 1.8B, C). The normal +1 G nucleotide is invariant in 5' 
splice donor sequences and its substitution would be predicted to abolish splicing, 
either yielding an in-frame UGA stop codon at the 3' end of exon 27 (Figure 1.8C) or 
aberrant use of alternative splice donors. Further experiment confirmed skipping of 
exon 27 and the resulting deletion of 104 bp introduced a frame-shift after amino 
acid 1010, abolishing the C-terminal residues encoding the last two transmembrane 
domains and cytoplasmic tail of the ATPl IC protein (Yabas et a l , 2011). 
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Figure 1.8 Identi f icat ion of a splice-site mutation in Atpllc by next-generation D N A 
sequenc ing 
(A) Read depth f rom a single G A 2 x sequencer lane across the tiled region between 54 and 
59 M b on the X - c h r o m o s o m e . Blue lines below denote all annotated exons on the + and -
strand, red lines denote exons with a read depth of less than 5, and black lines denote capture 
baits used to enrich exons f rom genomic D N A . Atpllc gene is boxed and shown in greater 
magni f ica t ion in (B) with read depth and chromosomal coordinates (NCBl build 37.1). (C) 
View of Atpllc exon 27 splice donor at single nucleotide resolution, read depth across these 
nucleot ides , and sequence of first 30 reads. The C to T change, representing an intronic +1 G 
to A subst i tut ion in the Atpllc sense strand and R N A transcript was the only identified 
d iscrepancy be tween ambros ius D N A and the C57BL /6J mouse reference sequence in two 
independent capture and sequencing runs, and was conf i rmed by Sanger sequencing. 
As mentioned earlier, ATPl IC is an integral membrane protein that consists of 10 
transmembrane segments, and a member of the P4-type ATPase family, which 
selectively catalyses the flipping of PS and to lesser extent PE from the exoplasmic 
to the cytoplasmic leaflet of the plasma membrane (Sebastian et al., 2012, van der 
Mark et al., 2013). Microarray profiling of Atpllc mRNA shows that it is equally 
expressed in B and T lymphocytes as well as other immune cells (Figure 1.9A, B), 
and most other tissues with highest expression in liver (Figure 1.10) (Heng and 
Painter, 2008, Wu et al., 2009), suggesting a possible role for A T P l l C in the 
development and/or function of the immune system as well as other biological 
systems, which is subject to examination within this thesis. 
Figure 1.9 The expression profile of Atpllc in immune cell subsets 
(A) The expression profile of Atpllc in tlie major immune cell groups in the bone marrow, 
thymus and periphery. (B) A detailed graph of Atpllc expression in B cell populations in the 
bone marrow and periphery. Data from the Immunological genome project (Heng and 
Painter, 2008), and methods of isolation and expression measurement are described on 
website (www.immgen.org). 
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Figure 1.10 The expression profile of Atpllc in different tissues 
BioGPS microarray data companngAtplIc mRNA abundance in the indicated mouse tissues, 
using tlie indicated Affymetrix probeset (For details, see Wu et al., 2009). 
1.5 Aims of the thesis 
In this thesis, I describe two novel ENU variant mouse strains called Ambrosius and 
I8NIH30. Both strains were identified through a peripheral blood lymphocyte screen 
using flow cytometry, and carry mutations in the gene encoding the 
aminophospholipid translocase A T P l l C , which is thought to play a role in the 
establishment and maintenance of lipid asymmetry in biological membranes. The 
affected mice had significantly reduced numbers of B cells in the bone marrow and 
periphery due to a developmental block in the early B cell development. In addition, 
ATP I IC-deficient mice were anaemic. 
Both mutant strains provide a unique resource and have enabled me to address the 
fundamentally important question of the role of the putative lipid transporter 
A T P I I C within the immune system as well as erythrocyte biology. The studies 
presented in this thesis provide new insights into the control of B cell development 
by the distribution and turnover of phospholipids in membranes through the putative 
phospholipid transporter ATPl IC. Moreover, the findings of this thesis also suggest 
ATP I I C as a candidate for flippase activity in erythrocytes. 
By analysing the particular cellular phenotypes and molecular mechanisms impaired 
in mutant mice, this study aims to: 
• Characterise the immunological phenotype of Ambrosius and 18NIH30 
mice, and attempt to identify the molecular mechanisms underlying the 
cellular phenotype observed, 
• Investigate if the ATPl iC""* mutation has any effect on the generation of 
immune responses, 
• Determine if A T P l l C functions as a flippase in cells of the immune 
system, 
• Investigate if ATP 11C has any impact on the development and survival of 
erythrocytes. 
CHAPTER 2: Materials and Methods 
2.1 M i c e 
Mouse strains used in this study are described below: 
C57BL/6J (B6): Inbred mouse strain was originally obtained from Jackson 
Laboratories, USA. 
C57BL/6-SJL.Ptpc (CD45.1): B6 strain congenic for CD45.1 (Ly5a). 
Atpllc""""' (Ambrosius) and Atpllc'"""""" {18NIH30y. These mouse strains with 
a point mutation in Atpllc were generated through ENU mutagenesis. The strains 
were largely maintained either by breeding heterozygous females with wild-type 
littermates or with wild-type C57BL/6J. For mapping purposes heterozygous females 
were crossed to the CBA/H strain. 
Ragl'^': This mouse strain lacks mature B and T cells due to their inability to activate 
V(D)J recombination (Mombaerts et al., 1992). 
Fav-Bc/2-Tg: This mouse strain has a transgenic expression of the gene encoding 
the prosurvival protein BCL-2 driven by the promoter of the gene encoding the 
adaptor VAV (Ogilvy et al., 1999). 
H2Ea-Il7-Tg: This mouse strain has a transgenic expression of 117 by the E a 
promoter of the gene encoding mouse MHC Class II (H2Ea-Il7) (Mertsching et al., 
1996), and was a kind gift of Professor Jonathan Sprent (Garvan Institute, Sydney). 
MD4-Tg: This mouse strain carries rearranged heavy and light chain transgenes 
encoding the hen egg lysozyme (HEL)-specific monoclonal antibody (Goodnow et 
al., 1988). 
S W H E L : This mouse strain carries a heavy-chain VDJ knock-in gene combined with 
a HEL-specific K-light chain transgene (Phan et al., 2003), and was a kind gift of 
Professor Robert Brink (Garvan Institute, Sydney). 
Cd79a''-. This mouse strain has a point mutation in Cd79a that leads to a premature 
stop codon in exon 2 (Lina Tze and Anselm Enders, unpublished data). 
Mice were genotyped by PCR amplification of DNA isolated from mouse-ear 
punches. In some experiments, the phenotype of mice was confirmed by analysing 
lymphocytes in the peripheral blood by flow cytometry. 
Except when noted specifically all mice used for this study were between 8-12 weeks 
old. All experimental mice were maintained on a C57BL/6 background and housed 
in specific pathogen free conditions at the Australian Phenomics Facility and all 
animal procedures were approved by the Australian National University Animal 
Ethics and Experimentation Committee. 
2.2 Buffers , solut ions and media 
Buffers, solutions and media were sourced and/or prepared as described in Table 2.1. 
2.3 Flow cytometry analysis 
2.3.1 Cell preparation 
2.3.1.1 Preparation of lymphoid tissues 
Bone marrow, spleen, lymph node and thymus were collected from sacrificed mice 
into 3 ml of ice-cold cell culture medium or flow cytometry buffer. Bone marrow 
cells were extracted by pressurised flow of sterile flow cytometry buffer through 
dissected femurs and tibias. Single cell suspensions from spleen, lymph node and 
thymus were prepared by passing the tissues through 70 nm nylon mesh filters (BD 
Biosciences). Red blood cells (RBC) in the spleen samples were removed by 
incubating splenocytes with 3 ml of RBC lysis buffer in 15 ml centrifuge tubes for 1-
2 min at room temperature. Samples were then centrifuged for 4 min at 1340 rpm at 
8 °C, followed by discarding the supernatant. The pellets were washed once in 10-13 
ml of ice-cold flow cytometry buffer followed by centrifugation and resuspension in 
3 ml of flow cytometry buffer. 
White blood cells were counted using the ViCELL cell counter (Beckham Coulter 
Inc.). After cell counting of cells from the bone marrow, spleen, lymph node and 
thymus, equal number of cells was transferred into the 96-well round-bottom plates 
at a density of 2 - 2.5x10^ cells/well and stained with antibodies as detailed below for 
flow cytometric analysis. 
2.3.1.2 Preparation of blood samples 
For preparation of peripheral blood samples, 100-150 |il of blood was collected by 
retro-orbital bleeding into cluster tubes containing 20 |il of 1000 U/ml heparin by the 
animal technicians at the Australian Phenomics Facility. 160 |il RBC lysis buffer was 
added to 40 |il of the blood sample in the 96-well round-bottom plates, and was 
gently mixed and incubated for 3-5 min at room temperature. Samples were 
centrifuged for 4 min at 1340 rpm at 8 "C, followed by the second lysis with 160 i^l 
RBC lysis buffer, incubation 3-5 min at room temperature and centrifugation for 4 
min at 1340 rpm at 8 °C. The pellets were then washed twice in 150-200 [il of ice-
cold flow cytometry buffer and stained with antibodies as detailed below for flow 
cytometric analysis. 
For erythrocyte analysis shown in Chapter 9, red blood cell lysis in the bone marrow, 
spleen and blood samples was not performed. 
Phosphate Buffer 
Saline (PBS) and 
ddHzO 
Obtained from the John Curtin School of Medical Research 
Media Facility, the Australian National University or 
purchased (Life Technologies). 
Culture Medium 
RPMI 1640 (Life Technologies) supplemented with 10 mM 
HEPES (Sigma-Aldrieh), 0.1 mM Non-Essential Amino 
Acid solution (Life Technologies), 1 mM Sodium Pyruvate 
(Sigma-Aldrich), 55 |iM 2-Merchapthoethanol (Life 
Technologies), 2% L-glutamate and penicillin/streptomycin 
(Life Technologies) and 10% heat-inactivated Foetal Calf 
Serum (FCS) (Life Technologies). 
Flow Cytometry 
Buffer 
2% Bovine Serum (BS) (Thermo Fisher Scientific Australia 
Pty. Ltd.) and 0.1% sodium azide (Australian Chemical 
Reagents) in PBS. 
Red Blood Cell 
(RBC) Lysis 
Buffer (lOX) 
8.99 g ammonium chloride (Sigma-Aldrich), 1 g potassium 
bicarbonate (Sigma-Aldrich), 37 mg sodium EDTA in 100 
mL ddHjO. 
Buffer was diluted with ddH20 to 1 x prior to use and 
adjusted to pH 7.3 with hydrochloric acid solution (Sigma-
Aldrich). 
Conjugation 
Buffer 
0.35 M Mannitol (Univar) and 0.01 M sodium chloride 
(Chem Supply) in ddHjO. 
ELISA Coating 
Buffer 
0.05 M Carbonate from Na2C03 and NaHCOs diluted in 
ddHiO (pH 9.6). 
ELISA Blocking 
Buffer 
1%BS in PBS. 
ELISA Dilution 
Buffer 
0.05% Tween 20 (Sigma-Aldrich) and 1% BS m PBS. 
ELISA Washing 
Buffer 
0.05% Tween 20 in PBS. 
ELISA 
Developing 
Buffer 
100 mM glycine (BioRad), 0.1 mM of zinc chloride and 1 M 
of Magnesium chloride (Sigma-Aldrich) in ddH20, adjusted 
to pH 10.4 with sodium hydroxide solution. 
ELISA 
Substrate 
Solution 
Two pNPP tablets (Sigma-Aldrich) dissolved in 10 ml of 
alkaline phosphatase buffer. 
2.3.2 Surface antibody staining 
Cell suspensions were prepared, counted and equal number of cells aliquoted into the 
96-well round-bottom plates as described above. Cells were then incubated with a 
purified antibody against Fey II and III receptors (CD 16/32 - BD), that are expressed 
by B cells, monocyte/macrophages, NK cells and neutrophils in order to block 
nonspecific binding together with biotinylated antibodies, if applicable. After 30 min 
incubation at 4 °C in the dark, cells were washed with flow cytometry buffer and 
centrifuged for 4 min at 1340 rpm at 8 °C. Cells were then incubated with a primary 
antibody cocktail containing an appropriate combination of the antibodies as well as 
streptavidin that binds to biotinylated antibody (Table 2.2) each diluted to its optimal 
concentration in flow cytometry buffer and incubated for 30 min at 4 °C in the dark. 
Samples were washed with flow cytometry buffer and resuspended in flow 
cytometry buffer and kept at 4 °C until use. 
For erythrocyte analysis shown in Chapter 9, cells from the bone marrow, spleen and 
blood samples were washed once with flow cytometry buffer followed by 
centrifugation for 4 min at 1340 rpm at 4 "C. Cells were then stained with a primary 
antibody cocktail as detailed above and kept at 4 °C until use. 
2.3.3 Annexin-V staining 
For Annexin-V staining, once cell surface staining was performed cells were washed 
once with flow cytometry buffer and once with Annexin-V binding buffer 
(Biolegend). Annexin-V and 7-Aminoactinomycin D (7-AAD) staining were 
performed in Annexin-V binding buffer at room temperature for 15 min and washed 
and resuspended in Annexin-V binding buffer and kept at 4 °C until use. 
2.3.4 Intracellular staining 
Intracellular IgM staining was performed using the Foxp3/Transcription Factor 
Staining Buffer set from cBioscience. Cell surface staining was performed as 
detailed above, and cells were washed once with flow cytometry buffer followed by 
resuspension of the pelleted cells in 50 |il of Fix/Perm solution for 30 min. After one 
wash with Ix Permeabilisation/wash buffer solution, cells were incubated with 
appropriately conjugated intracellular antibodies for 30 min. After a final wash step 
once with the permeabihsation/wash buffer and once with flow cytometry buffer, 
cells were resuspended in flow cytometry buffer and kept at 4 °C until use. 
For DNA content analysis, bone marrow cells were stained with surface markers and 
fixed using the eBioscience kit as described above. Cells were then intracellular^ 
stained with 7-AAD. 
2.3.5 Phospho-STATS staining 
Bone marrow cells were prepared as detailed above and were cultured in the absence 
or presence of various concentrations of IL-7 for various time points. At the end of 
the culture period, the cells were harvested and stained with cocktail containing 
antibodies as detailed above. The samples were then fixed by adding 
paraformaldehyde (final concentration 2-4%) and incubated for 10 min at room 
temperature. Samples were then washed with PBS followed by centrifugation for 5 
min at 1500 rpm at 25 °C and the supernatant was discarded. 1 ml cool methanol was 
added and samples were incubated at - 80 °C over night. On the next day, cells were 
incubated an antibody specific for phospho-STAT5 and incubated for 30 minutes at 
room temperature in the dark. Samples were washed with flow cytometry buffer 
followed by centrifugation and the supernatant was discarded. Cells were then 
resuspended in fiow cytometry buffer and kept at 4 °C until use. 
Flow cytometry analysis was performed using a LSR II or LSR Fortessa flow 
cytometry (BD Biosciences). 
2.3.6 Intracellular Ca "^^  mobilisation assay 
Pro-B cells were sorted from the bone marrow and were loaded with the calcium-
sensor dye Indo-I (Invitrogen) at a final concentration of 5 nM in 1 ml of tissue 
culture medium. After incubation for 30 min at 37 °C, the cells were washed twice 
and resuspended with tissue culture medium. Samples were kept on ice until further 
analysis. The acquisition of data was initiated 30 s before the addition of antibody 
against CD79b (Clone HM79b, BD) at a final concentration of 10 ng/ml. lonomycin 
stimulation was used as a positive control to measure a maximum flux. Data were 
collected on LSR Fortessa flow cytometry and analysed with FlowJo software. 
2.3.7 Cell sorting 
2.3.7.1 Flow cytometry sorting 
Cell suspensions were prepared by staining single cell suspensions from the bone 
marrow of mice with appropriate conjugated antibodies in sterile flow cytometry 
buffer. Pro-B cells were sorted on an Aria I or II flow cytometry (BD Biosciences) 
and collected in sterile tissue culture medium for culturing. 
2.3.7.2 Magnetic-activated cell sorting (MACS) 
Pro-B cells from the bone marrow of Ragl'^' and AtplIc™''"' Ragl''' double deficient 
mice were Macs sorted according to manufacturer's specifications using CD 19 
microBeads (Miltenyi Biotec,). Briefly, cell suspensions were prepared from the 
bone marrow of mice followed by red blood cell lysis and determination of cell 
numbers. Cells were then incubated with CD19 microBeads for 15 min at 4 °C in the 
dark followed by centrifugation and separation using Macs separator column. 
Positively selected pro-B cells were then washed and used for further analysis. 
Table 2.2 List of antibodies used in flow cytometry analysis 
Antibody Clone Conjugation Vendor 
Annexin-V Pacific Blue Biolegend 
BP-I 6C3 PE Biolegend 
CD3 145-2CI1 AF 700 eBioscience 
CD4 RM4-5 AF 700 Biolegend 
CD4 GK1.5 Biotin BD 
CD5 53-7.3 APC eBioscience 
CDS 53-7.3 Biotin BD 
CD8a 53-6.7 Biotin BD 
CD8a 53-6.7 PE Cy7 Biolegend 
C D l l b Ml /70 APC AF 750 eBioscience 
C D l l b Ml /70 Biotin BD 
C D l l c HL3 Biotin BD 
CD19 eBiolD3 AF 700 eBioscience 
CD19 1D3 APC BD 
CD19 eBiolD3 Biotin eBioscience 
CD19 1D3 PE BD 
CD21/35 7G6 FITC BD 
CD21/35 7G6 PE BD 
CD23 B3B4 Pacific Blue Biolegend 
CD23 B3B4 PE BD 
CD23 B3B4 PE Cy7 eBioscience 
CD24 91 Biotin SouthemBiotech 
CD24 Ml /69 Pacific Blue Biolegend 
CD25 PC61 APC BD 
CD25 7D4 Biotin BD 
CD25 7D4 FITC BD 
CD43 S7 FITC BD 
CD43 S7 PE BD 
CD44 IM7 APC BD 
CD44 1M7 Pacific Blue Biolegend 
CD45 30-Fl l FITC BD 
CD45R/B220 RA3-6B2 APC BD 
CD45R/B220 RA3-6B2 A700 BD 
CD45R/B220 RA3-6B2 Biotin BD 
CD45R/B220 RA3-6B2 FITC BD 
CD45R/B220 RA3-6B2 PerCP BD 
CD45.1 A20 AF 700 Biolegend 
CD45.1 A20 FITC BD 
CD45.1 A20 PE BD 
CD45.2 104 APC eBioscience 
CD45.2 104 Pacific Blue Biolegend 
CD45.2 104 PerCP Cy5.5 BD 
CD71 C2 Biotin BD 
CD71 C2 PE BD 
CD93 AA4.1 APC BD 
CD93 AA4.1 Biotin eBioscience 
CD95 Jo2 PE Cy7 BD 
CD117(c -Ki t ) ACK2 APC AF 780 eBioscience 
CD127 A7R34 PE eBioscience 
CXCR5 2G8 Biotin BD 
Flt3 A2F10 PE Cy5 eBioscience 
GL-7 GL7 FITC BD 
Gr-1 RB6-8C5 APC Cy7 BD 
Gr-1 RB6-8C5 Biotin BD 
IgD 11-26c Biotin eBioscience 
IgD l l -26c .2a PerCP Cy5.5 Biolegend 
IgD 11-26c FITC eBioscience 
IgM 11/41 APC BD 
IgM 11/41 Biotin BD 
IgM 11/41 PE Cy7 eBioscience 
N K l . l PK136 APC BD 
N K l . l PK136 Biotin BD 
PD-1 J43 PE eBioscience 
pSTAT5 pY694 PE BD 
Sca-1 D7 Pacific Blue Biolegend 
TCRP H57-597 APC Cy7 Biolegend 
TCRP H57-597 Biotin BD 
TCRyS GL3 Biotin BD 
T e r l l 9 TER-119 Biotin BD 
T e r l l 9 TER-119 FITC BD 
T e r l l 9 TER-119 PE Cy7 BD 
7-AAD PerCP Invitrogen 
Table 2.3 List of secondary antibodies used in How cytometry 
analysis 
Secondary antibody 
APC Streptavidin 
Brilliant Violet 605 Streptavidin 
PE Cy7 Streptavidin 
Q-dot 605 Streptavidin 
Vendor 
BD 
Biolegend 
eBioscience 
Invitrogen 
2.4 Generation of bone marrow chimeras 
2.4.1 Mixed bone marrow chimera 
Bone marrow cells with different allotypes of the cell surface marker CD45 were 
harvested from mutant CD45.2, wild-type CD45.2 and wild-type CD45.1 animals as 
detailed above. Extracted cells were counted, and mixed at a 1:1 ratio from either 
wild-type CD45.2 or mutant CD45.2 with wild-type CD45.1. Ragl''' recipient mice 
were irradiated with a single dose of 450 rads before being intravenously injected 
with 200 |il of 2-3 x 10^ bone marrow donor cells for each recipient mouse. In some 
experiments, bone marrow cells from CD45.1 mutant animals were mixed with 
CD45.2 bone marrow cells from Ragl''' animals, and injected into Ragl''' recipients. 
After reconstitution of the haematopoietic system lymphoid tissues were collected 
from the recipient mice and single cell suspensions were prepared as detailed above 
for flow cytometry analysis. 
2.4.2 100% bone marrow chimera 
Bone marrow cells from CD45.1 mutant and CD45.1 wild-type animals were 
extracted as detailed above. CD45.2 wild-type and CD45.2 mutant recipient mice 
were irradiated with double doses of 450 rads before being intravenously injected 
with 200 |il of 2-3 x 1O*" bone marrow donor cells for each recipient mouse. After 
reconstitution of the haematopoietic system lymphoid tissues were collected from the 
recipient mice and single cell suspensions were prepared as detailed below for flow 
cytometry analysis. 
All chimeric recipients received neomycin and polymixin B prophylactic antibiotics 
in the drinking water for 4 weeks after reconstitution. 
2.5 Carboxyfluorescein succinimidyl ester (CFSE) labelling 
Macs-sorted pro-B cells were labelled with the intracellular and membrane 
permeable dye CFSE (Molecular Probes) according to the method described (Quah 
and Parish, 2012). Briefly, purified cells were resuspended to IxloVml in 20 °C 
RPMI 1640 medium supplemented with 10% PCS and a final concentration of 10 
HM of CFSE added to 1 ml aliquots of lymphocytes with immediate vortexing. Cells 
were incubated at 20 °C for 5 min, then washed 3 times with RPMI 1640 
supplemented with 10% FCS. 
2.6 Cell culture 
Flow purified pro-B cells from control and mutant mice were counted by trypan blue 
exclusion. 5 - 6 x 1 0 " pro-B cells were seeded per well onto 96-well flat-bottom 
plates in sterile tissue culture medium and incubated at 37 T and 5% CO2 for up to 7 
days in the presence of 25 ng/ml of IL-7 (R&D Systems). At the end of the 
cultivation period, cells were counted by trypan blue exclusion and stained with 
appropriate antibodies to cell surface markers for flow cytometry analysis. 
In some experiments, Macs purified CD19^ pro-B cells from Ragl'^' and Atpllc"'"''"' 
Ragl'^' double deficient mice were labelled with the membrane permeable dye CFSE 
as described above. 10^ pro-B cells were then seeded per well onto 96-well flat-
bottom plates in sterile tissue culture medium and incubated at 37 °C and 5% CO2 for 
4 days in the absence or presence of various concentrations of IL-7. At the end of the 
cultivation period, cells were stained with appropriate antibodies to cell surface 
markers for flow cytometry analysis and the percentage of proliferating cells in 
response to IL-7 was determined by CFSE dilution. 
2.7 Immunofluorescence microscopy 
Spleen cryo-sections (IO|im) were fixed in acetone and blocked with 5% mouse 
serum, followed by detection of B cell follicles and T cell zones with anti-mouse 
B220-PE (RA3-6B2, BD) and anti-mouse CD3-FITC (145-2C11, BD) antibodies. 
Slides were analysed on an Olympus IX 71 fluorescence microscope. 
2.8 Functional assessment of B cells 
2.8.1 Assessment of antibody responses to T-dependent and -independent 
antigens 
2.8.1.1 Immunisations 
Primary immunisation was done by intraperitoneal injection of 300 (150 jxl to 
each side of the abdomen) PBS containing 50 ng alum-precipitated chicken y 
globul in ( a l u m - C G G ) (Biosearch) and 1 x 10^ heat- and formalin-inactivated 
Bordetella pertussis bacter ia (Lee Laboratories) . Mice were bled at 2 and 4 weeks 
post p r imary immunisa t ion . Booster immunisat ions were 50 |ig alum-precipitated 
C G G coupled to the hapten azo-benzene-arsonate (ABA) and 25 nitrophenyl-
Ficoll (Biosearch) in 300 )il PBS. Mice were bled 6 days post-secondary 
immunisa t ion . Blood samples were diluted at a 1:5 ratio in PBS. Fol lowed by 
cen t r i fuga t ion fo r 4 min at 1340 rpm at 8 °C. Plasma samples were collected, and 
stored at -20 °C for fur ther analysis of the quantif icat ion of the antibody content by 
enzyme- l inked immunoso rben t assay (ELISA). 
2.8.1.2 ELISA 
High prote in-b inding 96-well f la t -bot tom plates were coated with 100 |il/well of 
ant igens of interest (diluted in Coat ing Buffer ) and incubated overnight at 4 °C. Next 
day, unbound ant igen w a s removed by washing plates three t imes with washing 
buffer . B lock ing bu f f e r was then added (150 (il/well) to prevent non-specif ic binding, 
fo l lowed by a 1 hour incubat ion at 37 °C. Blocking buffer was removed and plates 
were washed three t imes with washing buffer . Thawed and appropriately diluted 
p lasma samples (diluted in dilution buffer ) were added (100 nl/well) to each well, 
fo l lowed by a 1-hour incubat ion at 37 "C. Af ter removal of solution and repeat of 
wash ing step, plates were fur ther incubated with 100 |il of alkaline phosphatase 
conjuga ted secondary ant ibodies for 1 hour at 37 °C, fol lowed by a washing step. 150 
^l of substrate solut ion was then added to each well and incubated at 37 °C until 
suff ic ient ye l low colour develops. Plates were read on a Plate Reader (ThermoMax; 
Molecular Devices ) and the absorbance of each well was measured at 405nm and 
650nm. The background absorbance w a s determined by measuring at 650nm, and 
was subtracted f r o m all data points. 
2.8.2 Assessment of HEL-specific GC formation 
2.8.2.1 Conjugation of HEL-SRBCs 
Sterile Sheep Red Blood Cells (SRBCs) were washed three t imes with 50 ml sterile 
P B S or until the supernatant w a s transparent . SRBCs were then washed with 20 ml 
of con juga t ion bu f f e r fo l lowed by incubat ion with conjugat ion buffer with H E L 
( H E L - S R B C ) or wi thout ( M o c k - S R B C ) for 10 minutes on ice on a rocking platform. 
In order to cross- l ink H E L to S R B C s l -Ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (Sigma) was added to the samples and continued rocking for 30 
minutes. SRBCs were then washed three times with PBS, and the number of cells 
was determined. 
Successful conjugation was confirmed by staining cells with APC-conjugated 
HyHel9 antibody (a kind gift of Professor Robert Brink), followed by f low 
cytometry analysis. 
2.8.2.2 Adoptive transfer experiments 
To test HEL-specif ic GC formation, Ambrosius mice were crossed to CD45.1 
allotyped S W h e l transgenic mice, and an adoptive transfer system was used. 
Splenocytes containing lO' congenically CD45.1-labelled HEL-binding B cells from 
donor Alpllc*'" S W h e l transgenic and A t p l S W h e l transgenic mice were 
intravenously injected into non-irradiated CD45.2 wild-type recipient mice in 
combination with 2x10^ Mock-conjugated (control) or HEL-conjugated SRBCs. The 
percentage and total number of wild-type and mutant derived HEL-specific GC B 
cells were determined by f low cytometry analysis. 
2.8.3 Assessment of Tm formation 
Mice were intravenously injected with 2x10^ SRBCs and the frequency and absolute 
number of T f h cells were determined by flow cytometry analysis. 
2.9 Phospholipid translocase (Flippase) activity assay 
Flippase activity assays were performed with mutant and wild-type bone marrow, 
spleen and thymic cells using the fluorescent analogues of PS, l-palmitoyl-2-{12-
[(7-nitro-2-l,3-benzoxadiazol-4yl)amino]dodecanoyl}-OT-glycero-3-phosphoserine 
(ammonium salt) (C12-NBD-PS) and l-palmitoyl-2-{6-[(7-nitro-2-l,3-
benzoxadiazol-4-yl)amino]hexanoyl}-5«-glycero-3-phosphoserine (ammonium salt) 
(C6-NBD-PS) (Avanti Polar Lipids, Inc.). Equal numbers of C D 4 5 . r marked wild-
type cells and CD45.2 ' ' marked mutant cells were mixed and washed with pH 6.0 
Hanks ' Balanced Salt Solution (HBBS) (Life Technologies) supplemented with 5.5 
m M D-glucose and 20 m M HEPES and pre-warmed to 15 °C (and 37 °C in some 
experiments). Cells were then incubated with 5 ^ M NBD-labelled PS in 200 of 
the same solut ion for the indicated t ime points at 15 °C (and 37 °C in some 
exper iments ) . T o s top the f l ipping of N B D - P S and remove the unbound N B D - P S 
f r o m the cell sur face , cel ls were immediate ly placed on ice and incubated with 
H B B S supp lemented wi th 5.5 m M D-glucose , 20 m M HEPES, 1% fatty acid f ree 
bovine se rum a lbumin (BSA) (Sigma-Aldr ich) for 5 min. Af ter 5 min cells were 
cen t r i fuged fo r 4 min at 1500 rpm at 8 °C and washed twice in H B B S supplemented 
with 5.5 m M D-g lucose and 20 m M HEPES. Cells were then transferred to a 96-well 
plate and stained with f luorescent ly labelled antibodies as described before and 
analysed on a L S R II or L S R Fortessa f low cytometry (BD Biosciences). 
The f l ippase activity assay in erythrocytes was performed using the same method 
except that samples f r o m mutant and control animals were kept in the different tubes, 
as red b lood cells do not express CD45. 
The percen tage of C 1 2 -NBD-PS or Ca-NBD-PS uptake in A T P l l C - d e f i c i e n t cells 
relative to wi ld- type cel ls w a s calculated by the formula [geometric MFI of wild-type 
or A m b N B D - P S ( T „ ) / geometr ic MFI of wild-type NBD-PS(T3o)] x 100. 
2.10 Microarray analysis 
For the microarray analysis , 5x10^-1x10 ' 7AAD-B220^IgD-IgM-CD24""CD43"BP-
r pro-B cells were sorted f rom Alpllc*^" and Alp 11 c"'"''"' animals. Sorted cell pellets 
were snap- f rozen and shipped on dry ice to the Miltenyi Biotec Genomic Service 
Depar tment , G e r m a n y for Agilent Whole Genome Microarray Service. 
2.11 Analysis of haematological parameters 
100 Hi of b lood w a s mixed with 100 nl of flow cytometry buffer and run on an 
A D V I A 2 1 2 0 Haemato logy System (Siemens Healthcare Diagnostics) for the 
analysis of b lood parameters . 
2.12 Clinical chemistry 
Mutant mice and their control l i t termates were first culled and then bled by cardiac 
puncture and b lood samples were rested for 0,5 - 1 h at room temperature. Samples 
were then centrifuged for 10 min at 4000 rpm, and sera were collected and frozen at -
20 °C for further analysis. Determination of serum concentrations of alanine 
aminotransferase, aspartate aminotransferase, bilirubin and iron parameters were 
assayed by automated procedures in the Department of Pathology, The Canberra 
Hospital. 
2.13 T u m o u r harvest and histology 
Liver tumours, and surrounding liver tissue were removed and fixed in 10% neutral 
buffered formalin. Liver sections (4 ^m) were cut from paraffin-embedded blocks 
and stained with haematoxylin and eosin (H&E) for histological examination. 
2.14 Determination of erythrocyte lifespan using in vivo CFSE-labell ing 
and lifespan modell ing 
In vivo life span measurements using CFSE, in conjunction with mathematical 
modelling were performed based on the method described (Coupland et al., 2010). 
Mutant mice and their control littermates were intravenously injected with 50 |xl of 
10 mM CFSE in dimethyl sulfoxide mixed with 100|xl PBS. Erythrocyte analysis 
was performed at various time points by taking 5 ixl blood from the tail tip and 
mixing it with 45 nl acid citrate dextrose. Blood loss was controlled via cauterisation 
and lidocaine gel was used on the tail tip to minimize pain. Within 30 min of sample 
collection, 10 nl blood/acid citrate dextrose mixture was added to 990 PBS, and 
the samples were then analysed by flow cytometry. Erythrocytes were identified 
using their characteristic log forward and side scatter parameters. To determine the 
extent of CFSE labelling of erythrocytes at each time point, fluorescence was 
measured on the FITC channel, with the percentage of CFSE-positive erythrocytes 
being followed over time to determine lifespan. 
Erythrocyte lifespans were obtained by curve fitting using the lognormal model as 
previously described (Coupland et al., 2010). Matlab's nonlinear least-squares 
estimator Isqnonlin was used to perform the data fitting. 
2.15 Cation measurement in erythrocytes 
Intra- and extracellular Na"^  and K^ levels were determined using Ultra High Pressure 
Liquid Chromatography (UHPLC; Dionex) linked to a Charged Aerosol Detector 
(CAD; Dionex) based on the method described (Winterberg et al., 2012). 10 nl-
heparinised blood was separated by centrifugation into erythrocyte and plasma 
fractions. The erythrocytes were washed (xl) with a 250 mM MgS04 solution to 
replace extracellular Na"^  and K"^ . The resulting cell pellet and 1 |al of the plasma 
were added to 200 and 100 i^l, respectively, of 40/60 v/v 20 mM ammonium sulphate 
pH 5/acetonitrile, to precipitate proteins. The samples were centrifuged and 10 |il 
aliquots of the resulting supernatant solutions were subjected to the HPLC analysis. 
2.16 Scanning electron microscopy (SEM) analysis of erythrocytes 
Cells attached to coverslips were fixed with 2% v/v glutaraldehyde in 0.1 M sodium 
cacodylate overnight at 4 °C and post-fixed with 1% w/v osmium tetroxide for 1.5 
hours at room temperature. The samples were dehydrated using a graded ethanol 
series, then critical point dried, mounted on aluminium stubs, and sputter-coated with 
gold prior to imaging. Images were taken using a Zeiss Ultraplus FESEM. 
2.17 Osmotic fragility test 
Peripheral blood from wild-type and ATPI IC-deficient mice was diluted to an 
approximate haematocrit of 10% with PBS followed by a further 1 in 10 dilution in 
NaCl solutions of varying osmolarity (0.1%-0.8% w/v NaCl in H2O). After 
incubation for 30 min at room temperature, samples were centrifuged and the 
absorbance of the supernatant solutions measured at 540 nm ( A 5 4 0 ) using a 
microplate reader (ThermoMax; Molecular Devices). Percentage haemolysis of the 
cells in each solution was calculated based on the A 5 4 0 value relative to that obtained 
for cells suspended (and thereby lysed) in H2O. 
2.18 Statistical analysis 
For comparison of only two groups, the two-tailed student t test was used. When 
multiple experimental groups were being compared. One-Way Analysis of Variance 
(ANOVA), followed by pair-wise comparison with a Bonferroni port-test were used. 
For all statistical analysis, differences were taken to be significant when P < 0.05. 
All statistical analysis was performed using GraphPad Prism 5 (GraphPad Software). 
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3.1 Preamble 
The strain named ''Ambrosius" was discovered through ENU mutagenesis by the 
selective reduction of B cells in the peripheral blood of male mice. The causative 
point mutation was mapped to the X-chromosomal Alpllc gene of mutant mice, 
which encodes the putative aminophospholipid transporter ATPl IC that contributes 
to the generation and maintenance of plasma membrane lipid asymmetry. In this 
chapter of the thesis, I characterise the immunological phenotype of Ambrosius mice 
as well as 18NIH30 mice, which were identified during the course of my studies, 
structured around the initially observed B cell phenotype. 
3.2 A T P l l C - d e f i c i e n t mice exhibit severe B cell deficiency 
I first confirmed the B cell deficiency in the peripheral blood oi AlplIc"'"''" mice 
using a large cohort (Figure 3.1 A). Analysis of the peripheral blood of female mice 
demonstrated that homozygous females have also severely reduced B cell frequency 
similar to hemizygous mutant male mice (Figure 3.IB). In contrast, heterozygous 
females had normal percentage of B cells in the peripheral blood (Figure 3.IB). 
These data indicate that loss of A T P l l C in mice results in B cell deficiency 
syndrome. 
3.3 Developmental block at the transition from pro-B to pre-B cell stage 
of B cell development in the bone marrow of ATPl lC-de f i c i en t animals 
B cells develop from the pluripotent HSCs in the bone marrow. Since A T P l l C 
deficiency resulted in loss of B cell population in the peripheral blood, a systematic 
analysis of B cell subsets was performed in the bone marrow of AtplIc"""^" and 
control mice to determine if there is a developmental block during early B cell 
development. While the absolute number of leukocytes was normal (Figure 3.2A), 
the percentage and number of total B cells were decreased m AtplIc"""'' '' mice to 15-
18% of the numbers in wild-type controls (Figure 3.2B, C). The number of 
CD43"'CD24"'"' pro-B cells was 60% of normal, whereas the number of CD43'° 
CD24''' pre-B cells and IgM^lgD' immature B cells were only 6% and 1.8% of 
normal, respectively (Figure 3.2C). IgM^lgD^ mature recirculating B cells in the 
bone marrow were 11% of normal numbers, and these expressed much higher 
densities of IgM compared to wild-type littermates (Figure 3.2B, C), Further analysis 
of slgM-negative and lineage marker-negative bone marrow B cell progenitors by 
CD43, CD24 and BP-1 expression showed normal numbers of pre/pro-B cells 
(Fraction A) in the mutant animals, but progressively reduced numbers of pro-B and 
pre-B cells in Fractions B, C and C (Figure 3.3A, B). These data establish that 
ATP l i e is required for B cells to differentiate normally past the pro-B cell stage. 
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Figure 3.1 Confirmation of B cell deficiency in ATPl lC-def ic i ent mice using more 
biological replicates 
(A) Graph shows B220* cells as a percentage of total lymphocytes in the blood of Alpllc'" 
(WT) or Atp lie"""'''' (Amb) male mice. (B) Graph shows B220 ' cells as a percentage of total 
lymphocytes in the blood of Atpllc (WT), AtplIc""'' (HET) or AtplIc"'"'"""'' (Amb) 
female mice. Each circle represents a single mouse, and data are pooled from at least three 
(or two in panel B) independent experiments with three to ten mice per genotype in each. 
Statistical significance was calculated using the two-tailed Student 's r-test (A) or One-Way 
A N O V A analysis, followed by the Bonferroni post-test, with the P values comparing each 
pair of experimental groups shown on the plots (B). ns, not s i g n i f i c a n t ; F < 0.0001. 
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Figure 3.2 The ATPllC™'' mutation causes a developmental block at the pro- to pre-B 
cell transition stage of B cell development in the bone marrow 
(A) Graph shows the absolute number of leukocytes in the bone marrow from Atpllc" 
(WT) or Atpllc'"''" (Amb) mice. (B) Representative flow cytometric analysis of bone 
marrow cells from Atpllc' " (WT) or AtplIc"'"'''' (Amb) mice. Numbers adjacent to outlined 
areas indicate percentage of B220* B cells (left); percentage of IgMlgD^ mature B cells, 
IgM^IgD" immature (1mm.) B cells, and IgM IgD" pro- and pre-B cells within the B220' 
subset (middle); cells gated on B220'' IgM IgD^ cells, showing the percentage that are 
CD43XD24'" pre-B cells, CD43^CD24'""' pro-B cells and CD43"CD24" pre-pro-B cells 
(right). (C) Graphs show the absolute number of B ceils and indicated B cell subsets in the 
bone marrow from Atpllc " (WT) or Atpllc""'''' (Amb) mice. Each circle represents a 
single mouse, and data are representative of at least five independent experiments with two 
to five mice per genotype in each. Statistical significance was calculated using the two-tailed 
Student's M e s t . F < 0.0001; * * * P < .001; * * P < .01. 
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Figure 3.3 Analysis of B cell subpopulations in the bone marrow 
(A) Representative flow cytometric analysis of B220, CD43, BP-1 and CD24 surface 
expression on lineage-negative bone marrow cells of mice from the indicated genotypes. 
Lineage panel for the analysis contains antibodies against CD4, CDS, CDS, TCRp, TCRyS, 
IgM, Mac-1, C D l Ic, Ter l 19, Ly6c, Gr-1 and N K l . l (B) Graph shows the absolute number 
of Fraction (Fr.) A - C cell populations as shown in (A). Each circle represents a single 
mouse, and data are representative of two independent experiments with two to five mice per 
genotype in each. Statistical significance was calculated using the two-tailed Student 's Mest. 
* , />< 0.0001; * * * / ' < . 0 0 1 ; * P < .05. 
3.4 The ATPllC""''' mutation reduces all B cell subsets except M Z B cells 
in the spleen 
The previous set of results revealed that B cell development in the bone marrow of 
ATPl IC-deficient animals is arrested at the pro-B cell stage. As a next step, the 
effects of ATPl IC mutation on peripheral B cell and B cell subsets were examined. 
Spleens of mutant animals were smaller than those of control mice (Figure 3.4A). In 
line with a smaller spleen, the number of total leukocytes was reduced in mutant 
mice compared to their littermate controls (Figure 3.4B). The number of B cells in 
Alpl Ic"'"''"^ animals was also decreased to 9% of that in wild-type mice (Figure 3.4C, 
D). Consistent with a reduced production of B cells in the bone marrow, immature B 
cells in the spleen were decreased to 1% of the numbers in wild-type mice and FO B 
cells decreased to 5% of the normal number (Figure 3.4C, D). Despite an abnormal 
surface phenotype of higher CD2I and lower CD23 (Figure 3.4C), 
immunofluorescent staining of spleen sections illustrated that the FO B cells were 
located normally (Figure 3.5). By contrast, MZ B cells were present largely in 
normal numbers in AlplIc""'"'' mice (Figure 3.4D), so that they made up 
approximately 40% of all splenic B cells. These data indicate that MZ B cells are 
unique among B cell subsets by either not requiring or being able to compensate for 
A T P l l C deficiency. 
Imm Foil MZ 
Figure 3.4 The ATPl lC'" ' ' mutation reduces all B cell subsets except MZ B cells in the 
spleen 
(A) Spleen size in Atpllc'" (WT) or AtplIc"'"'''' {kmb) mice. Bar, 1 cm. (B) Graph shows 
the absolute number of leukocytes in the spleen from Atpllc " (WT) or Atp 11 c""''" (Amh) 
mice. (C) Representative flow cytometric analysis of B cell subpopulations in the spleen 
from Atpl Ic'" (WT) or Atpl I c""'''" (Amb) mice. Numbers adjacent to outlined areas indicate 
percentage of 8220* B cells and CD3* T cells (left); percentage of B220*-gated cells that are 
CD93* mature B cells and 0093"" immature (Imm) B cells (middle); percentage of the 
CD2l ' "CD23" marginal zone (MZ) and the C D 2 r " ' C D 2 3 * follicular (Foil) B cell subset 
within the B220*CD93" mature B cells (right). (D) Graphs show the absolute number of B 
cells, T cells and indicated B cell subsets in the spleen from Atpllc'" (WT) or Atpllc"'"'''' 
(Amb) mice. Each circle represents a single mouse, and data are representative of at least 
five independent experiments with two to five mice per genotype in each. Statistical 
significance was calculated using the two-tailed Student 's (-test, ns, not significant; P < 
0.0001. 
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Figure 3.5 Normal localisation of the residual B cells in the spleen of ATPllC-def ic ient 
mice. 
Spleen cryosections from Atpllc " (WT) and AtplIc"""'"'' (Amb) mice were stained with 
fluorescently labelled antibodies to detect B cells (B220) and T cells (CD3). 
3.5 Loss of B1 cells in the peritoneal cavity of ATPllC-def ic ient mice 
B1 cells are known as innate-like cells and involved in the early defence against 
pathogens (Berland and Wortis, 2002). Unlike mature recirculating B cells (also 
referred to as "conventional" or "B2" cells), B1 cells are most abundant in the 
peritoneal cavity, and can be identified using specific surface markers (Berland and 
Wortis, 2002). To investigate whether the ATP 11C""* mutation has any effect on the 
development of B1 cells, B1 cells in the peritoneal cavity of Atpllc" and 
Atpllc"'"''"' animals were analysed. There was a slight reduction in the total number 
of leukocytes in the peritoneal cavity oi Atpl Ic"'"''"' mice (Figure 3.6A). Both the B1 
(CD23") and B2 (CD23^) B cell subsets were decreased to less than 10% of normal 
(Figure 3.6B, C). Further analysis of B1 cell subsets based on CDS expression 
revealed that both CDS"' Bla and CDS' Bib cells are equally affected by the 
mutation as the absolute number of both populations was significantly reduced 
(Figure 3.6B, C). These results indicate that in addition to its role in the development 
of conventional B2 cells in the bone marrow and spleen, ATPl IC has a critical role 
in the accumulation of B1 cells in the peritoneal cavity. 
3.6 A cell-autonomous requirement for A T P l l C in B cell revealed by 
mixed bone marrow chimera 
The results presented above showed that ATPllC plays an important role in the 
development of B cells in the bone marrow. In order to test if the effect of the 
ATPl iC""* mutation on B cell numbers is due to a cell intrinsic or extrinsic effect, 
mixed bone marrow chimeras were generated. Recipient RagV'' mice, lacking both 
B and T lymphocytes, were irradiated with one dose of 4S0 rad irradiation, and were 
then reconstituted with an equal mixture of CD4S.1-marked Atpllc*" and CD4S.2 
Atpllc"^'" hon^ marrow cells (Figure 3.7A). As a control, a group of mice were 
reconstituted with a mixture of CD45.1-marked Atpllc*" and CD4S.2 Atpllc*'" 
bone marrow cells (Figure 3.7A). The recipient mice were sacrificed 12-14 weeks 
after the transplantation, and the relative reconstitution of each chimeric mouse by 
Atpllc*'" or Atpllc""""" cms.2* haematopoietic stem cells was gauged by the 
percentage of donor derived B, T and NK cells that were CD4S.2^ in the spleen of 
recipient mice. 
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Figure 3 .6 Effect of the ATPllC"""''mutation on peritoneal B cells. 
(A) Graph shows the absolute number of leukocytes in the peritoneal cavity wash f rom 
AlplIc " ( W T ) or Alpllc""'''' (Amb) mice. (B) Representat ive f low cytometr ic analysis of 
the f requency of B cells and B cell subpopula t ions in the peritoneal cavity ofAtpIlc'" ( W T ) 
and Atpllc"'"^'' ( A m b ) mice . N u m b e r s adjacent to outl ined areas indicate percentage of 
B220" lgM^ B cells ( left) ; percentage of B220*IgM"-gated cells that are C D 2 3 ' B2 cells and 
C D 2 3 " B1 cells (middle) ; percentage of the CD5" B l a and the CD5" B i b B cell subset 
within the C D 2 3 IgM" B1 cells (right). (C) Graphs show the absolute number of B cells a j d 
indicated B cell subsets in the peritoneal cavity wash f rom Alpllc " (WT) or AlpUc""' 
( A m b ) mice . Each circle represents a single mouse, and data are representative of two 
independent exper iments with three to f ive mice per genotype in each. Statistical 
s ign i f icance w a s calculated using the two-tai led Student ' s Mest . \P< 0.0001; *** P < .001; 
* P<.05. 
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Figure 3.7 B cell deficiency in Atpllc mice is due to a cell-autonomous requirement 
for A T P l l C within B cells. 
(A) Bone marrow cells from CDA5.\* Atpllc • " (WT) mice was mixed with equal numbers 
of bone marrow cells from CD45.2^ Atpllc" or Atpllc"'"'''' (Amb) mice and injected 
intravenously into irradiated Ragl animals. (B) 12 weeks after reconstitution the recipient 
mice were analysed by flow cytometry for the percentage of CD45.1' ' versus CD45.2^ CD3* 
T cells, N K l . r NK cells and 8220"^ B cells in the spleen. Data are representative of two 
independent experiments with four to six mice per genotype in each. 
The results showed that there is no significant difference in the ratio of Alpllc*'" 
derived B cells, T cells and NK cells in the spleen of recipient mice (Figure 3.7B). In 
contrast, the requirement for normal A T P l l C in B cells was found to be cell 
autonomous as AlplIc"'"'"'' B cells represented only 1% of B cells in the periphery of 
chimeric recipients (Figure 3.7B). In the same mixed chimeras, Atpllc"'"''"'! cells 
and NK cells nevertheless accumulated in approximately equal proportions to their 
wild-type counterparts, establishing that there is little or no competitive disadvantage 
of mutant cells in T cells, NK cells or their haematopoietic progenitors (Figure 3.7B). 
Taken together, these results illustrate that ATPl IC controls B cell development in a 
cell-intrinsic manner. 
3.7 Identification and phenotypic characterisation of second allele, 
18NIH30 
While analysing the Ambrosius mice, flow cytometric screening of blood from ENU-
mutagenised mouse pedigrees identified another strain with a reduced B cell 
frequency in the peripheral blood of male animals (Figure 3.8A). An Atpllc 
mutation identified by Sanger sequencing in this strain (18NIH30) also disrupts an 
invariant, essential splice donor nucleotide but in the preceding exon 26 splice donor 
sequence (intronic +2T to G: TCTGAAGgrtaga to AACTCTGAAGg^aga). To 
directly compare the phenotype of both strains, a comparative B cell analysis in the 
bone marrow and spleen of both Atpllc mutants and wild-type control was 
performed in the same experiment. Phenotypic comparison of Atpllc"'"''''' and 
Atpllc'^^'"^"'" animals showed that both strains have similarly reduced B cell 
numbers in the bone marrow due to a developmental arrest at the pro-B cells (Figure 
3.8B). Likewise, while the number of total B, immature B and FO B cells was 
severely reduced, MZ B cells remained mostly unaffected in the spleen of 
Atpllc"'"''"' and AtplIc"'^'"^"'" mice (Figure 3.8C). Thus, the discovery of a second 
allele confirms the requirement of A T P l l C at the pro-B cell stage of B cell 
development in the bone marrow. 
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Figure 3.8 Discovery and initial characterisation of second allele, I8NIH30. 
(A) Flow cytometry of B220" B cells in the blood ofAlpllc'" (WT), Atpllc""'"" (Amb) and 
Atpllc"*'^'"^'"' (18N1H30) mice. Numbers adjacent to outlined areas indicate percentage of 
B220^CD3- B cells (top left) or B220 CD3" T cells (bottom right). (B, C) Graphs show the 
absolute number of B cells and B cell subsets in the (B) bone marrow and (C) spleen of 
Atpllc^" (WT), Atpllc""""' (Amb) and AtplIc""""""' (18NIH30) mice. Each circle 
represents a single mouse. 
3.8 Chapter summary and discussion 
This chapter examined the immunological characteristics of two independent mouse 
strains identified through ENU mutagenesis that exhibited severely reduced B cell 
frequency in the peripheral blood caused by splice-site mutations in Atpllc. The 
detailed flow cytometric analysis of mutant animals revealed a developmental block 
of B cell differentiation at the pro-B cell stage, leading to reduced B cell numbers in 
the bone marrow and periphery. In addition to conventional B cells, B1 cells in the 
peritoneal cavity of mutant mice were severely reduced compared to their control 
littermates, but MZ B cells in the spleen of mutant mice remained unaffected by the 
mutation. A cell-autonomous requirement for A T P l l C within B cells was revealed 
through mixed bone marrow chimeras. 
The developmental arrest at the transition from pro- to pre-B cells in A T P l l C 
mutant mice is similar to that observed in some other mouse models including Ragl' 
' ' or Ragl' ' mice and other mice deficient in the expression and signalling through 
the pre-BCR (Mombaerts et a l , 1992, Shinkai et al., 1992) (Kitamura et al., 1991, 
Kitamura et al., 1992, Torres et al., 1996, Gong and Nussenzweig, 1996, Mundt et al., 
2001, Pelanda et al., 2002). Formation and signalling through the pre-BCR is a key 
step in pre-B cell development, because upon successful rearrangement of Ig heavy 
chain it signals the proliferation and differentiation of pre-B cells and initiates light 
chain recombination (Clark et al., 2014). Therefore, it is possible that the ATPl IC""* 
mutation may cripple formation and/or signalling through the pre-BCR, which could 
result in a developmental block in B cell development of ATPl IC mutant animals. 
Mice lacking IL-7, a critical growth factor for the survival and proliferation of pro-B 
cells, or its receptor IL-7R also have a defect in early B cell development (von 
Freeden-Jeffry et al., 1995, Peschon et al., 1994). Although the developmental arrest 
in these mice is already at the pre/pro-B cell stage, it is still possible that ATPl IC 
may have a quantitative or qualitative influence on the expression and/or signalling 
through the 1L-7R. Moreover, one of the critical roles for IL-7 is to control pro-B cell 
survival by regulating important pro- and anti-apoptotic proteins (Corfe and Paige, 
2012). It is also possible that ATPl IC-deficient pro- or/and pre-B cells undergo 
excessive apoptosis due to possibly an impaired signalling through the IL-7R. As 
will be discussed in the next chapter, 1 tried to answer these questions by crossing 
ATPllC-def ic ient mice to mouse strains with transgenic overexpression of IL-7 or 
the anti-apoptotic protein BCL-2. 
In conclusion, A T P l l C deficiency in mice causes a B cell deficiency syndrome due 
to a developmental arrest in B lymphopoiesis in the bone marrow. Although the 
mechanism(s) by which ATPl IC affects B cell development is unclear and will be a 
focus of later chapters in this thesis, the availability of the novel ENU variant mouse 
strains provide excellent model organisms to investigate the role of A T P l l C in B 
cell biology as well as other important biological systems. 
CHAPTER 4: Examination of the 
compromised pathway in ATPl IC-
deficient B cells by crossing Atpl 
with animals carrying transgenes encoding 
the BCR, BCL-2 and IL-7 
Contents of this chapter appeared in: 
Mehmet Yabas, Chads E. Teh, Sandra Frankenreiter, Dennis Lai, Carla M. Roots, 
Belinda Whittle, Daniel T. Andrews, Yafei Zhang, Narei C. Teoh, Jonathan Sprent, 
Lina E Tze, Edyta M. Kucharska, Jennifer Kofler, Geoffrey C. Farell, Stefan Broer, 
Christopher C. Goodnow and Anselm Enders (2011). " A T P l l C is critical for the 
internalization of phosphatidylserine and differentiation B lymphocytes". Nature 
Immunology, 12(5):441-449. 
4.1 Preamble 
In the previous chapter, loss of ATPl IC has been shown to cause a B cell deficiency 
due to a developmental arrest at the transition of pro-B to pre-B cells, but the precise 
mechanism(s) underlying the observed phenotype in AlplIc"'"''"' mice remains 
unknown. Since the transition from pro- to pre-B cells is dependent on signalling 
through the IL-7R and successful rearrangement of Ig heavy chain genes (Clark et al., 
2014), in this chapter I tested if defects in these processes and subsequent apoptosis 
caused the developmental block in AtplIc"'"''"' mice. I explored the possible 
compromised pathway(s) in ATPl IC-deficient B cells by crossing mutant mice with: 
(1) MD4 or S W H E L transgenic mice with Ig heavy and light chain genes already 
rearranged; (2) Vav-Bcl2 transgenic mice to inhibit apoptosis or (3) H2Ea-Il7 
transgenic mice with greatly increased IL-7. In this chapter, B cell development in 
the bone marrow and accumulation of B cell subsets in the spleen of ATPl lC-
deficient mice carrying one of these transgenes will be examined. 
4.2 Partial restoration of B cell deficiency in Atpllc""''"''' mice by a BCR 
transgene 
Once a functionally Ig heavy chain is produced at pro-B cell stage, it leads to the 
assembly of a membrane complex together with the transmembrane proteins Iga, IgP, 
and the SLC molecules X5 and VpreB. This complex is known as pre-BCR and it 
initiates a signalling cascade, which is a crucial check-point in B cell development in 
the bone marrow (Herzog et a l , 2009, Clark et al., 2014). I first wanted to test if a 
failure of pre-BCR signalling is responsible for the defect in Atpllc"'"'"'' B cells and 
if the presence of recombined heavy- and light-chain transgenes corrects B cell 
deficiency in Atpllc'""''"' mice. To do so, I analysed B cell subpopulations in the 
bone marrow and spleen of Atpllc^'" and Atpllc"'"'"'' mice with or without a BCR 
transgene (MD4) that is specific for HEL protein (Goodnow et al., 1988). In MD4 
transgenic mice, the rearranged Ig heavy and light chain transgenes are normally 
activated during the pro-B cell stage, bypassing and suppressing RAG-mediated 
recombination of the endogenous Ig-genes (Goodnow et al., 1988). This lowers the 
number of pro-B cells and pre-B cells to 12% and 2% of normal numbers, 
respectively, replacing them with IgM" IgD" immature B cells that are present in 
normal numbers in the bone marrow (Table 4,1 and Figure 4.1). Whereas the 
ATPl IC""* mutation decreased the number of pro-B cells in non-transgenic mice, it 
increased the number of pro-B cells in Atpllc"'"''"' MD4 transgenic mice to 150% of 
the numbers in control MD4 animals with normal A T P l l C (Table 4.1 and Figure 
4.1). The number of immature B cells in the bone marrow of Alp 11 c"'"'"'' MD4 
animals was nevertheless only partly restored to 11% of the numbers in Atpllc*'" 
MD4 mice, whereas circulating B cells in the bone marrow and total B cells in the 
spleen were partly restored to 37% of those in MD4 transgenic mice with normal 
ATP 11C (Table 4.1 and Figure 4.1). 
Atpllc'""'"'' mice were also crossed with HEL transgenic ( S W H E L ) mice, which carry 
a heavy-chain VDJ knock-in gene combined with a HEL-specific K-light chain 
transgene (Phan et al., 2003). A similar magnitude of rescue occurred in S W H E L mice 
with a rearranged Igh gene targeted in its normal location, but only when combined 
with a rearranged transgenic light chain (Figure 4.2). Collectively, these results 
suggest that bypassing the pre-BCR signalling step partially overcomes the B cell 
deficiency, but does not completely eliminate the need for ATPl IC. 
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Table 4.1 B cells in the spleen and B cell subpopulations in bone 
marrow 
The numbers are expressed as mean values x lO ' ± S.E.M in the bone marrow and xlO ± 
S.E.M in the spleen. B cells (B220" in live lymphocytes gate) in the spleen. Mature B cell 
(IgD^lgM" in B220" gate), Immature B cells (IgD'IgM" in B220* gate), Pre-B cell 
(CD24^'CD43- in IgD'lgM" gate), Pro-B cell (CD24'"'CD43^ in IgO'lgM" gate), Pre/Pro-B 
cell (CD24-CD43" in IgD'lgM" gate) in the bone marrow, n represents number of mice 
analysed for each genotype. 
Transgene 
None 
. *** • 
• • • 
• • 
MD4 
Figure 4.1 Partial correction of B cell phenotype in ATPllC-deficient mice by a BCR 
transgene 
Representative flow cytometric analysis of B cell subpopulations in the bone marrow of (A) 
non-transgenic mice with WT or mutant (Amb) ATPl lC, (B) ATPl lC WT or Amb mice 
expressing rearranged Igh and Igk transgenes from the MD4 strain. Numbers adjacent to 
outlined areas indicate percentage of B220' B cells (left); percentage of IgMlgD^ mature B 
cells, IgM'IgD" immature (1mm.) B cells, and IgM IgD" pro- and pre-B cells within the 
B220" subset (middle); cells gated on B220' IgM IgD" cells, showing the percentage that are 
CD43 CD24'" pre-B cells, CD43"CD24'""' pro-B cells and CD43TD24- pre-pro-B cells 
(right). (C) Graphs show the relative number of pro-B, pre-B, immature B cells in the bone 
marrow and B cells in the spleen of Alp 1 Ic"""'" mulmt mice with the MD4 BCR transgene, 
as a percentage of the mean number in " W T control animals carrying the same 
transgene. Each circle represents one mouse, and data are pooled from multiple experiments 
with one to five mice per genotype in each. Statistical significance was calculated using the 
two-tailed Studem's Mest. * , P < 0.0001; *** P < .001. 
Transgene: None SWHe, He"' SW^ei LC" SWHeiHc-'Lc^ MD4 
Figure 4.2 Limited rescue of B cells in the blood of A T P l l C - d e f i c i e n t animals by 
overexpress ion of transgenic B C R s 
m i Q * B cells ( % of lymphocytes ) in the blood of mice f rom the indicated genotypes. S W H E L 
mice have a rearranged HEL-spec i f i c VDJ exon knocked into the heavy chain locus and a 
rearranged HEL-spec i f i c K l ight-chain t ransgene. The M D 4 mice carry several copies of 
rearranged HEL-spec i f i c heavy and light chain transgenes, co-integrated at one site on 
C h r o m o s o m e 17 several c M distal to H2. Each circle represents one mouse, and data are 
pooled f rom mul t ip le exper iments with one to f ive mice per genotype in each, ns, not 
s ignif icant ; Statistical s igni f icance was calculated using the two-tailed Student ' s Mest . \ P < 
0 .0001. 
4.3 Enforced expression of BCL-2 fails to drive B cell development in 
Atpllc-"""' mice 
BCL-2 is an anti-apoptotic protein that promotes cell survival through the inhibition 
of programmed cell death, apoptosis caused through the cell intrinsic or 
mitochondrial pathway (Vaux et al., 1988, Hockenbery et al., 1990). In order to test 
if diminished mitochondrial apoptosis restores the B cell deficiency in mutant 
animals, Atp 11 c'""'"'' mice with transgenic expression of the gene encoding the pro-
survival protein BCL-2 driven by the promoter of the gene encoding the adaptor 
VAV {Vav-Bcl2 mice) were generated (Ogiivy et al., 1999). Consistent with the 
published report (Ogiivy et al., 1999) Vav-Bcl2 greatly increased the number of 
mature B cells in control siblings with normal ATPl lC (Table 4.1 and Figure 4.3). 
The number of pre-B cells in Atpl Ic'""'"" Vav-Bd2 mice was 29% of the number in 
Atpllc*'" Vav-Bcl2 controls, representing a partial restoration compared to 6% of 
normal numbers in Atpl Ic'""''"' mutants without Vav-Bcl2 (Table 4.1 and Figure 4.3). 
The pre-B cells in AtplIc'""'"" Vav-Bcl2 mice nevertheless failed to increase 
expression of CD24 (Figure 4.3) and CD25 (Figure 4.4), whose expressions are 
increased in pre-B cells. Immature B cells were also partly rescued in Alp lie""'''' 
Vav-Bcl2 animals, although they still represented only 17% of the numbers in 
Atpllc*'" Vav-Bcl2 controls (Table 4.1 and Figure 4.3). Likewise splenic B cells 
remained at 6% of the numbers in Atpllc*'" Vav-Bcl2 controls and 31% of wild-type 
mice (Table 4.1 and Figure 4.3). Collectively, these results indicate that suppression 
of apoptosis by enforced BCL-2 expression is unable to correct the B cell 
developmental abnormalities caused by ATPl IC deficiency. 
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Figure 4.3 E n f o r c e d express ion of B C L - 2 fails to drive B cell deve lopment in Atp 11 c'""'"" 
mice 
Representa t ive f low cytometr ic analysis of B cell subpopulat ions in the bone marrow of (A) 
non- t ransgenic mice wi th wi ld- type ( W T ) or mutant (Amb) A T P l l C , (B) A T P l l C W T or 
A m b mice wi th en fo rced express ion of BCL-2 under the control of the VAV-promote r (Kav-
Bcl2). N u m b e r s ad jacen t to outl ined areas indicate percemage of B220* B cells (left); 
percentage of IgM^IgD" mature B cells, IgM^IgD" immature ( Imm.) B cells, and I g M l g D " 
pro- and p re -B cells wi th in the B220" subset (middle) ; cells gated on B220* IgM lgD" cells, 
showing the percen tage that are € 0 4 3 X 0 2 4 ' " pre-B cells, C043XD24" '=^ pro-B cells and 
C D 4 3 " C D 2 4 - p re -pro-B cells (right). (C) Graphs show the relative number o [ Pro-B, pre-B, 
immature B cells in the bone mar row and B cells in the spleen of Atp 1 Ic"""" mutant mice 
with the B C L - 2 t ransgene , as a percentage of the mean number in Atpllc' W T control 
an imals ca r ry ing the s a m e t ransgene . Each circle represents one mouse, and data are pooled 
f rom mul t ip le exper iments with one to f ive mice per genotype in each. Statistical 
s igni t lcance w a s calcula ted us ing the two-tai led S tudent ' s /-test. \ P < 0.0001; *** P < .001. 
Figure 4.4 Over-expression of BCL-2 fails to upregulate CD25 expression in pre-B cells 
from Atpllc""'"' mice 
Representative flow cytometric profiles of CD25 CD43 ' pro-B cells and CD25*CD43" pre-B 
cells within the IgM'IgD B220'° bone marrow cells from mice of the indicated genotypes. 
Note that the Vav-Bcl2 transgene increases the percentage of CD43" cells in Atpllc"'"'''' 
animals, but these cells show little increase in CD25. The data are representative of two 
independent experiments with two to three mice per genotype in each. 
4.4 A T P l l C deficiency abolishes effects of an / /Ztransgene 
IL-7 is an essential cytokine for early B development in mice and signals through the 
1L-7R (Corfe and Paige, 2012). Analysis of the bone marrow of mice deficient for 
IL-7 or IL-7Ra showed that B cell development is arrested at the uncommitted pre-
pro-B cell stage (von Freeden-Jeffry et al., 1995, Peschon et al., 1994). To 
investigate whether elevated IL-7 rescues the B cell phenotype in AtplIc""'''' 
animals, A T P I I C mutant animals were crossed to H2Ea-Il7 mice with transgenic 
expression of 117 driven by the E a promoter of the gene encoding mouse major 
histocompatibility complex class II (H2Ea-ll7 m\ce) (Mertsching et al., 1996). Due 
to the elevated IL-7, H2Ea-Il7 transgenic mice with a normal Atpllc gene exhibited 
a 5-fold increase in bone marrow pro-B cells and 10-fold increase in pre-B cell 
numbers relative to wild-type mice (Table 4.1 and Figure 4.5), consistent with 
published analysis (Mertsching et al., 1996). By contrast, there was no effect of the 
increased IL-7 on the number of pro-B, pre-B, or immature B cells in Atpllc"'"''''' 
H2Ea-Il7 mice compared to Atpllc"'"''"' mice without the IL-7 transgene (Table 4.1 
and Figure 4.5). Increased IL-7 was therefore unable to rescue development of 
ATPllC-deficient B cells, and instead the mutation abolished the effects of 
transgenic IL-7 on pro-B and pre-B cells in the bone marrow. 
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Figure 4.5 A T P l l C def ic iency abol ishes effects of an / / / t r a n s g e n e 
Representa t ive f low cytometr ic analysis of B cell subpopulat ions in the bone marrow of (A) 
non- t ransgenic mice with wild- type ( W T ) or Mutant (Amb) A T P l l C , (B) A T P l l C W T or 
A m b mice over -express ing IL-7 under the control of the M H C II E a gene promoter (H2Ea-
117). N u m b e r s ad jacen t to outlined areas indicate percentage of B 2 2 0 ' B cells (left); 
percentage of I g M l g D ^ mature B cells, I g M ' i g D " immature ( Imm.) B cells, and IgM IgD" 
pro- and pre-B cells within the B220* subset (middle); cells gated on B220* IgM IgD" cells, 
showing the percentage that are C D 4 3 CD24'" pre-B cells, C D 4 3 T D 2 4 " ' ' ' ' pro-B cells and 
CD43^CD24" pre-pro-B cells (right). (C) Graphs show the relative number of pro-B, pre-B, 
immature B cells in the bone mar row and B cells in the spleen of Atpl Ic""''''mutant mice 
with the 117 t ransgene, as a percentage of the mean number in Atpllc"'^T control animals 
carrying the same t ransgene. Each circle represents one mouse, and data are pooled f rom 
mult iple exper iments with one to f ive mice per genotype in each. Statistical s ignif icance was 
calculated us ing the two-tai led S tudent ' s (-test. * P< .05. 
4.5 Less transition of AtplIc"""''^'' pro-B cells from Ig" to Ig^ cells 
To further characterise the developmental block in bone marrow B cells I performed 
staining for cytoplasmic ^ (c^) heavy chains in surface IgM" B220'° cells, comparing 
Atpllc* or Atpllc""'''"' animals with mice homozygous for null mutations 
eliminating the RAGl recombinase or the CD79a subunit of the pre-BCR and BCR. 
In Atpllc*'" mice, 65% of sIgM" 8220'° cells were en"" and these were CD24'" due to 
normal pre-BCR signalling (Figure 4.6). No sIgM" B220'° cells were in Ragl'^' 
mice (Figure 4.6A), consistent with their inability to recombine the heavy chain 
genes. 15% of sIgM~B220'° cells were in Cd79d'' marrow, and their low 
frequency and lower CD24 expression is consistent with the inability of the pre-BCR 
to assemble and signal (Figure 4.6A, B). Compared to this baseline, the frequency of 
cn"^  cells was even lower in Atpllc"'"''"' mice, representing only 5% of sIgM B220'° 
cells (Figure 4.6). 
Cn'^ cells normally exhibit a heightened proliferative response to IL-7 as a result of 
synergy between IL-7R and pre-BCR signalling (Fleming and Paige, 2001, Marshall 
et al., 1998), so that c^"" cells among sIgM" B220'° cells are preferentially expanded 
in H2Ea-Il7 transgenic mice (Figure 4.6A, B). Like the earlier data on pro-B and pre-
B cell numbers (Table 4.1 and Figure 4.5), this effect of H2Ea-ll7 was also 
completely abolished by the ATP 11C'"'' mutation, so that the low frequency of en'" 
cells in Atpllc"'"'"'' marrow remained unchanged by the 117 transgene (Figure 4.6A, 
B). 
Next I wanted to examine if the proliferative capacity of B cells was diminished by 
ATP l i e deficiency in vivo. Flow cytometric staining for DNA content in bone 
marrow pre/pro-B (CD24Xji-) , pro-B (CD24"Cfxl and pre-B cells (CD24"Cn") 
revealed increased frequencies of mutant pro-B cells and pre-B cells with greater 
than 2n DNA, indicating that a greater proportion of mutant pro-B and pre-B cells 
were in S or G2+M phases of cell cycle (Figure 4.7). 
CD24 was increased on c / cells in Atpllc'""""' bone marrow cells compared to 
Cd79a-'- and R a g r ' ' bone marrow cells, but only to half of the levels on normal cn" 
cells (Figure 4.6A, B). When the need for Ig-gene rearrangement and pre-BCR 
signalling was bypassed in M D 4 transgenic mice, A T P l l C deficiency still greatly 
reduced the frequency of B220'° B cells that expressed the Ig genes and instead there 
was an expanded population o f pro-B cells that had not yet activated Ig transgene 
expression (Table 4.1 and Figure 4.8). Collectively, these resuhs indicate that the 
onset o f H-chain expression and formation and/or signalling through the pre-BCR is 
both diminished in the absence of normal ATPl IC. 
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Figure 4.6 Decreased pro-B cell transit ion from Ig to Ig"^ cells in the bone mar row of 
Atpllc""""' mice 
(A) Representative flow cytometric analysis o f the surface expression of CD24 and 
intracellular expression o f IgM (C^ ) gated on surface IgM B220'' '7AAD B cells in bone 
marrow from non-transgenic or IL-7 transgenic mice with wild-type (WT) or mutant (Amb) 
A T P l l C , or from CrfZPa" 'and Ragl " mxcs. Numbers indicate percent o f gated cells in each 
quadrant.' (B) Percent o f intracellular I g M ' CD24" cells gated as in (A), and mean 
fluorescence intensity (MF I ) o f CD24 staining on these cells. The data are representative of 
three different experiments with one to three mice per genotype in each. 
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Figure 4.7 Cell cycle analysis of B cell precursors in the bone marrow of Atpllc""''"' 
animals 
Representative flow cytometric analysis of the cell cycle of CD24 Cn" pre/pro-B, CD24*Cn" 
pro-B and C D 2 4 ' C n ' pre-B cells from Atpllc'" (WT) and Atpllc"'"'''' (Amb) mice. The 
percentages of cycling cells (GO/1, S and G2/M phase) are indicated. Graph shows % of 
C D 2 4 X ^ " pre/pro-B, C D 2 4 " C n ' pro-B and C D 2 4 X n ' pre-B cells that are in S and G2/M 
phase. Data are representative of two different experiments with two to five mice per 
genotype in each. Statistical significance was calculated using the two-tailed Student's Mest. 
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Figure 4.8 Impaired accumulation of slgM^ B cells in the bone marrow of Atpllc'"" 
mice with a BCR transgene 
Analysis of bone marrow from Alpllc'" (WT) and ^ rp / i c " " ' ' " (Amb) mice expressing the 
rearranged MD4 Igh and Igk transgenes, showing the percentage of B220'°"lgD" cells 
expressing surface IgM and CD24 (top) or CD 19 (bottom). Graphs are combined from three 
different experiments with one to three mice per genotype in each. Statistical significance 
was calculated using the two-tailed Student's (-test. *, P < 0.0001. 
4.6 Chapter summary and discussion 
This chapter examined whether the developmental block in B cell differentiation 
caused by the ATPl IC""* mutation could be rescued by bypassing antigen receptor 
gene rearrangement or by providing pro-survival signals to progenitor B cells in the 
form of growth factor signals through IL-7 or overexpression of the anti-apoptotic 
protein BCL-2. While introduction of a BCR transgene with functionally rearranged 
Ig heavy and light loci in ATPllC-deficient mice partially corrected B cell 
deficiency, overexpression of BCL-2 or IL-7 was incapable of rescuing B cell 
development in AtplIc"""'"'' animals. 
In the BCR transgenic mice, the rearranged Ig heavy and light chain transgenes are 
normally activated during the pro-B cell stage, leading to a redundant pre-BCR 
signalling during B lymphopoiesis (Goodnow et al., 1988). Interestingly, crossing 
ATPlIC-deficient animals to MD4 or S W H E L transgenic mice resulted in a partial 
rescue in B cell numbers in the bone marrow and spleen, and both heavy and light 
chain transgenes were required for the correction. In contrast to the results presented 
here, B cell deficiency in pre-BCR deficient and RAG-1 has been corrected by 
expression of rearranged light or heavy chain transgenes (Spanopoulou et al., 1994, 
Pelanda et al., 1996). These results suggest that B cells developing in the bone 
marrow of ATPl IC-deficient mice may have impaired signalling through the pre-
BCR. Consistent with this notion, further analysis revealed that ATPl IC-deficient 
mice have reduced pre-B cells in the bone marrow, and these cells express lower 
levels of CD24, whose expression is upregulated by the pre-BCR signalling. The 
frequency of Cn'^ cells in mutant mice was lower than that of Cd79d'' mice, which 
are deficient in pre-BCR signalling, as CD79a constitutes an important component 
of the pre-BCR (Torres et al., 1996). These data collectively suggest a role for 
ATPl IC in the expression and/or signalling through the pre-BCR. 
IL-7 plays critical roles in the survival, proliferation and differentiation of pro- and 
pre-B cells (Corfe and Paige, 2012). Given the importance of IL-7 in early B cell 
development, it is likely that impaired signalling through the IL-7R could explain the 
phenotype in mutant mice. In keeping with this notion, there was no phenotypic 
difference between mutant mice and mutant mice with an 117 transgene, suggesting 
that in the absence of A T P l l C developing B cells may have a defect in IL-7R 
signalling. This lack of signalling through the IL-7R could cause increased apoptosis 
of developing B cells in ATPl IC mutant mice. Recently, Malin et al. suggested that 
BCL-2, an important anti-apoptotic survival protein that prevents cells from 
undergoing mitochondrial apoptosis (Youle and Strasser, 2008), could replace the 
survival, but not proliferative function of IL-7R signalling in pro-B cells (Malin et al., 
2010b). The authors showed that transgenic expression of BCL-2 in mice deficient 
for IL-7R resulted in a partial increase in the number of pro-, pre- and total B cell 
numbers in the bone marrow (Malin et al., 2010b). However, no rescue in B cell 
development and numbers of mature B cells was observed in ATPl IC-deficient mice 
with transgenic expression of BCL-2. These results collectively suggest that the 
developmental arrest at the pro-B cell stage of B lymphopoiesis in ATPl IC-deficient 
mice is more fundamental than simply a diminished survival signal or through 
increased apoptosis. 
A synergistic interaction between the IL-7R and pre-BCR signalling has been 
suggested to mediate the transition from pro- to pre-B cells in the bone marrow 
(Fleming and Paige, 2002), suggesting that a defect in one pathway could possibly 
affect another pathway. Therefore, one hypothesis for the developmental arrest in B 
lymphopoiesis of ATPl IC-deficient mice would be that the ATPllC""* mutation 
might influence either IL-7R or pre-BCR signalling, which leads to disruption of 
another pathway. The possible effect(s) of the ATPllC""* mutation on these 
signalling pathways are, therefore, noteworthy and will be examined in more detail 
in the next chapter. 
CHAPTER 5: Analysing the components 
of the IL-7R and pre-BCR signalHng as a 
candidate pathway responsible for the 
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5.1 Preamble 
The IL-7R signalling and expression and signalling through the pre-BCR are two 
crucial processes for pre-B cell development in the bone marrow (Herzog et al., 2009, 
Clark et a l , 2014, Reth and Nielsen, 2014). The findings in the previous chapter 
suggest that ATPl IC might play a role in these two signalling pathways. Therefore, 
in this chapter the effect of the ATPl iC""* mutation on signalling through the IL-7R 
and pre-BCR will be examined. 
5.2 The effect of the ATPllC""''' mutation on IL-7R signalling 
5.2.1 Normal IL-7Ra (CD127) expression in ATPllC-deficient pro-B cells 
Pro- and pre-B cells express the IL-7Ra at the cell surface and internalise the 
receptor after binding to IL-7, which mediates crucial signalling events required for 
normal B cell development in the bone marrow (Corfe and Paige, 2012). I first 
wanted to determine whether the in vivo IL-7 unresponsiveness in AlplIc""''"' pro-B 
cells could be explained by the lack of IL-7R expression. Bone marrow cells were 
stained for surface expression of IL-7Ra by flow cytometry, and pro-B cells from 
Atpllc"'"''"' mice displayed an increased expression of IL-7Ra. A similar increase in 
IL-7Ra expression was also observed on pro-B cells in AtplIc'""'"" mice with an 
H2Ea-n7 transgene compared to wild-type controls (Figure 5.1 A, B). This increased 
expression was similar to IL-7Ra expression on bone marrow cells of pre-BCR 
deficient animals {Cd79a'- and Ragr ' ' ) (Figure 5.IB). The increased IL-
7Ra expression Cd79d^- and Ragl'^' animals could possibly be due to a 
compensatory increase as these mice are defective in the later development stage, 
that is pre-BCR signalling. These data indicate that the absence of an in vivo 
response to the 117 transgene in AtplIc""""" mice is not explained by failure to 
express the receptor, but could be due to a defect in responding to IL-7. 
CD 
E 
" o 60 
1 " 
o 0 
B 
24i 
f 22-
X r 2o\ 
LL 
s 18 
h-
5! 16 
. ,, .. 8 14 0 10^  10^  10* 10® 
CD127 • 12-
Non-Tg 
H2Ea-ll7 
iif 
ID' 
rg 10= 
D 
O 
w r 
• WTAmb 
Amb 
13.9 57.5 
Cd79a-'- Rag1-'-
89.1 
0 10= 10' 
CD127 
Figure 5.1 Increased IL-7Ra expression on pro-B cells from Atpllc"^'" mice 
(A) Expression of CD127 (IL-7Ra) on CD24"''' 'CD19"lgM-B220'° pro-B cells from 
Atpllc'" (WT, shaded area) and Atpllc""''" (Amb, black line) mice. Graph shows the MFI 
of CD127 expression on pro-B cells from multiple animals of each genotype. (B) Panels 
below show representative flow cytometric analysis of CD24 versus CD127 on CD19"IgM" 
B220'°7AAD' cells in bone marrow from non-transgenic or IL-7 transgenic mice with wild-
type (WT) or mutant (Amb) A T P l l C , or from Crf/Pa and RagV mice. The subset of 
CD24""='' pro-B cells is shown in the gate. Data are representative of three different 
experiments with one to three mice per genotype in each. Statistical significance was 
calculated using the two-tailed Student's Mest. ** < .01. 
5.2.2 Pro-B cells from Atpllc""''^'' mice are able to proliferate normally in 
response to high concentration of IL-7 in vitro 
In vitro culture of pro-B cells in the presence of high doses of IL-7 induces a strong 
proliferation, and this can be used to measure signalling through the IL-7R. 
Therefore, I next examined the competence of the mutant pro-B cells to undergo in 
vitro proliferation and to become IgM^ ceils in response to IL-7 signalling. Pro-B 
cells from mutant and wild-type animals were flow sorted and cultured in the 
presence of high concentration of IL-7 (25 ng/ml), and analysed 7 days after cuhure. 
The mutant and wild-type pro-B cells increased in numbers identically over 7 days 
(Figure 5.2A), indicating that pro-B cells isolated from AtplIc""''"' mice exhibited a 
normal proliferative response to IL-7 relative to pro-B cells from Atpllc*'" animals. 
However, when the differentiation of these cells was analysed by measuring the 
fraction that had become small pre-B and slgM^ immature B cells, a much lower 
fraction of the mutant pro-B cells had differentiated compared to control cells 
(Figure 5.2B). These results indicate that the ATPl I C " ' ' mutation does not interfere 
with IL-7R-induced proliferation of pro-B cells, but disrupts their differentiation into 
IgM^ B cells. 
5.2.3 ATPl lC-def ic ient pro-B cells display a defective proliferation response to 
the limiting concentration of IL-7 in vitro 
I next wanted to determine the ability of mutant pro-B cells to proliferate in the 
presence of a wide range of IL-7 concentrations in vitro. Because expression of pre-
BCR on pro-B cells has been suggested to control the ability of cells to respond to 
the limiting concentration of IL-7 (Marshall et al., 1998, Fleming and Paige, 2001), I 
used mice on a RAG-deficient background. This allows me to examine the effect of 
the ATP 11C""* mutation on IL-7R signalling in isolation without any interference 
from possibly also affected pre-BCR signalling. CD 19" pro-B cells from the bone 
marrow oi RagV'' and Atpl Ic"""'" Ragr'' double deficient mice were magnetically 
enriched, labelled with the cell proliferation dye CFSE and cultured in the absence 
and presence of different concentrations of IL-7 for 4 days. At the of culture period, 
cells were analysed by flow cytometry and proliferation was determined by the 
percentage of CFSE diluting cells. 
Consistent with the published data (Marshall et al., 1998, Fleming and Paige, 2001), 
pro-B cells from RagV'' animals showed no response to lower concentration of IL-7, 
and some proliferation when the IL-7 concentration reached 20 picogram/ml (Figure 
5.3). However, nearly all cells proliferated once the IL-7 concentration reached 1 
ng/ml (Figure 5.3). Likewise, the data revealed that pro-B cells isolated from 
Atpllc'""''"' Ragl''' double deficient animals also exhibit no proliferation in response 
to low concentrations of IL-7 (Figure 5.3). The proliferative capacity of the 
Atpllc""'''"' Ragl''' pro-B cells was similar to that observed with the RagV'' pro-B 
cells, but there was a small concentration range where IL-7 was permissive for 
proliferation of the Ragl''' cells but not the double deficient pro-B cells (Figure 5.3). 
Since Ragl''' mice have essentially normal IL-7R signalling, the similar proliferation 
profile of pro-B cells in Ragl''' and AlplIc"'"'"" Ragl''' double deficient animals in 
response to the high concentrations of IL-7 suggests a normal IL-7R signalling in 
ATPllC-deficient pro-B cells. However, it should be noted that this experiment was 
performed only once, and needs to be repeated to test whether the small differences 
in proliferation of ATPl IC-deficient pro-B cells in response to low concentrations of 
IL-7 is reproducible. 
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Figure 5.2 Normal in vitro proliferation of flow-sorted ATPl lC-def ic i ent pro-B cells in 
response to high concentration of IL-7, but defective differentiation into slgM^ cells 
Flow sorted pro-B cells from AtplIc'" and Atp 1 Ic""'''' (kmh) mice were cultured in 
the presence of 25 ng/ml lL-7 for 7 days. (A) Graph shows absolute number of cells after 7 
days culture of sorted pro-B cells in the presence of 25 ng/ml IL-7. (B) Representative flow 
cytometric plots showing the percentage of surface IgM^ cells out of all live B220^ cells 
after 7 day culture of sorted pro-B cells in the presence of 25 ng/ml lL-7. Statistical 
significance was calculated using the two-tailed Student 's (-test. *** P < .001. 
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Figure 5.3 Defective in vitro proliferation of Macs-sorted pro-B cells from Atpllc""''"' 
Ragl' 'doub\e deficient mice in response to low concentrations of IL-7 
Macs sorted CD19" pro-B cells from Ragl" and Atpllc"'""' Ragr'-(Kmh- R a g f ) mice 
were labelled with the cell proliferation dye CFSE and cultured in the absence or presence of 
various concentrations of lL-7 for 4 days. Graph shows the percentage of CFSE diluted cells 
aiter 4 days culture of sorted pro-B cells in the absence or presence of various concentrations 
o f l L - 7 . 
5.2.4 Loss of A T P l l C does not compromise STATS phosphorylation in pro-B 
cells upon IL-7 stimulation in vitro 
The signalling of IL-7/IL-7R is mediated through the JAK-STAT pathway that leads 
to STATS activation (Hofmeister et al., 1999). The results shown above indicate that 
pro-B cells from ATPl IC-deficient animals proliferated normally in response to high 
concentrations of lL-7, suggesting a most likely intact signalling through the IL-7R. 
To further support this, Rag]'^' and AtplIc"""'"'' RagV'- double deficient pro-B cells 
were cultured for 20 minutes in vitro with 0.02 and 10 ng/ml IL-7 and stained 
intracellularly with anti-pSTAT5. 
The data shown in Figure 5.4 indicates that Ragl''' and AtplIc"""'"'' Ragl''' double 
deficient pro-B cells cultured alone or with different concentrations of IL-7 displayed 
equivalent levels of p-STAT5 expression that increased in a dose dependent manner 
in response to IL-7 (Figure 5.4). Therefore, these results indicate that the membrane 
proximal signalling events downstream of 1L-7R is not compromised in A T P l l C -
deficient pro-B cells. 
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Figure 5.4 Normal IL-7-induced STATS phosphorylation in pro-B cells from 
Atpllc""'' ° RagI doubW deHcient mice 
(A) Representative overlay histograms comparing p-STAT5 (pY694) expression on Rag]" 
and Atpllc"'"'''' Rag 1" {Amb; Ragl") double deficient pre/pro-B and pro-B cells cultured in 
the absence or presence of 0,02 and 10 ng/ml of lL-7 for 20 min. Cells were then fixed, 
permeabilised and stained with p-STAT5 intracellularly. (B) Graph shows the fold change in 
MFI of P-STAT5 expression on pro-B cells in the presence of IL-7 over media alone. Data 
are representative of two independent experiments. 
5.3 T h e ef fect of the ATPllC""'" mutation on pre-BCR signalling 
5.3.1 In vivo cross-linking of IgP on pro-B cells from ATPllC-deficient animals 
fails to induce pre-B cell differentiation 
Given that ATPl IC-deficient animals have a developmental block at the pro- to pre-
B transition and show a defective proliferative capacity in response to low 
concentrations of IL-7 similar to the pre-BCR deficient mice, I hypothesised that a 
specific failure in the expression and/or signalling through the pre-BCR could 
explain the B cell deficiency in mutant animals. To test this hypothesis, I took 
advantage of the experimental system in which treatment of Rag2''' mice with an 
antibody against IgP (CD79b) can mimic pre-BCR signalling and induce 
differentiation of RAG2-deficient pro-B cells into pre-B cells in vivo (Nagata et al., 
1997). 
Mixed bone marrow chimeras were set up as shown in Figure 5.5 to test the ability of 
pro-B cells from RagV'' and AlplIc""''"' mice to respond anti-Ig|3 antibody treatment 
under the same experimental conditions (Figure 5.5). Rag]''' recipient mice were 
given one dose of irradiation prior to intravenous injection of bone marrow cells 
mixed at a 1:1 ratio from CD45.2 Ragl''' and CD45.1 AtplIc'""^'" mice (Figure 5.5). 
Five to eight weeks post reconstitution recipient mice were given a single 
intraperitoneal injection of PBS or 200ng antibody against IgP, and B cells in the 
bone marrow were examined by flow cytometry (Figure 5.5). 
Seven days after treatment there was an increase in the number of /?ag7"'"-derived 
total B cells in the bone marrow of recipient mice treated with anti-Ig|3 compared to 
those injected with PBS (Figure 5.6A, B). The antibody treatment also induced 
differentiation of iJa^/'^'-derived pro-B cells into pre-B cells as determined by a 17-
fold increase in the number cells that express the pre-B cell marker CD25 on their 
surface (Figure 5.6A, B). The increase in total B and pre-B cell numbers in anti-IgP 
injected recipient mice cannot be attributed to the different number of leukocytes in 
different recipients, because the number of non-B cells in anti-IgP treated recipients 
was comparable to that in PBS injected recipients (Figure 5.6B). In contrast, anti-IgP 
injection had no impact on mutant-derived pro-B cells in recipient mice as the 
number of mutant derived total B cells and CD25^ pre-B cells were not increased 
upon anti-IgP treatment compared to mutant cells from PBS-treated recipient mice 
(Figure 5.6A, B). 
Pre-B cell differentiation from RAG-deficient pro-B cells after anti-IgP treatment 
could also be confirmed by the expression of different pro- and pre-B cell surface 
markers (Nagata et al., 1997). While antibody treatment induces down-regulation of 
pro-B cell markers such as CD43 and C-Kit, the expression of pre-B cell markers 
such as CD25 and BP-1 are up-regulated, and these phenotypic changes are linked to 
the transition from pro-B cells to pre-B cells (Nagata et al., 1997). Consistent with 
the published data (Nagata et al., 1997), expression of CD25 was up-regulated, and 
expression of CD43 and C-Kit was down-regulated in /?ag/"'"-derived B cells after 
anti-IgP antibody treatment (Figure 5.6A and 5.7). Moreover, antibody treatment 
caused changes in the side and forward scatter profiles of B cells derived from Ragl' 
' ' bone marrow cells (Figure 5.7). However, none of these changes was observed in B 
cells derived from Atp 11 c"""'"'' bone marrow cells after anti-IgP antibody treatment 
(Figure 5.7). These data indicate that pro-B cells from the bone marrow of ATPl IC-
deficient animals fail to respond to IgP cross-linking in vivo. 
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Figure 5.5 Exper imenta l design of mixed bone marrow chimera approach to test 
whether cross- l inking of IgP induces differentiation of A T P l IC-deficient-derived pro-
B cells into pre-B cells 
Bone mar row chimer ic mice were generated by the injection of congenic (CD45.1) bone 
marrow cells f rom Atplie"'"'''' (Amb) animals mixed at a 1:1 ratio with Ragf hone marrow 
cells (CD45 .2 ) into irradiated Ragl" recipients (CD45.2) . 5-8 weeks after reconstitution, the 
recipient mice were intraperitoneally injected with PBS or 200ng ant i - lgp antibody, and B 
cells in the bone mar row of the recipient mice were analysed 7 days post t reatment by f low 
cytometry . 
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Figure 5.6 Defective IgP-mediated pro- to pre-B cell transition in Atpllc"" -derived 
bone marrow cells 
(A) Representative f low cytometric analysis of bone marrow cells from PBS or anti-IgP 
treated-chimeric recipients that were irradiated and reconstituted with a mixture of CD45.2* 
Ragl" and CD45.1'" Atp 1 Ic""''''(Amh) bone marrow cells. Numbers adjacent to outlined 
areas indicate percentage of CD45.2" RagV- and C D 4 5 . r AtplIc""'"'(AmbydtmsA cells 
(left); percentage of B220"CD25" pro-B cells, B220"CD25 ' pre-B cells, and 8 2 2 0 X 0 2 5 " 
non-B cells within the CD45.2" and CD45.1^ donor derived cells (middle and right). (B) 
Graphs show absolute number of CD45.2" RagV- and C D 4 5 . r . ir/7//c ' '"""'(Amb)-derived 
B220" total B cells (lefH), B 2 2 0 X D 2 5 " pre-B cells (middle) and B 2 2 0 X D 2 5 - non-B cells 
(right) in the bone marrow of chimeric recipients that were treated with PBS or ami-lgP 
amibody. Each circle represents a single mouse, and data are pooled from two different 
experiments. Statistical s ignificance was calculated using the two-tailed Studem's Mest. ** 
p<m. 
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Figure 5.7 Anti-IgP treatment fails to upregulate pre-B cell markers in Atpllc""' -
derived bone ma r r ow cells 
Representative flow cytometric analysis o f surface expression of CD43, C-Kit, CD25, 
Forward Scatter (FSC) and Side Scatter (SSC) on CD45.2* Ragl '- and CmS.V AtplIc"""'''' 
(Amb)-derived 7 A A D B220* B cells within the chimeric recipients that were treated with 
PBS or anti-lgP antibody. Data are representative of two independent experiments with two 
to three mice in each. 
5.3.2 In vivo cross-linking of IgP on Atpllc""""" RagV'- double deficient pro-B 
cells fails to induce pre-B cell differentiation 
The in vivo IgP-stimulation-induced pre-B cell differentiation system was also tested 
in Atpllc""'''"' mice on a RAG-deficient background in order to exclude any possible 
effect of pre-B cells that are present in ATPl IC-deficient mice. Ragl''' and 
Atpllc"'"'"'' Ragl''' double deficient animals were injected with anti-IgP antibody, 
and the number of total B and pre-B cells in the bone marrow was determined seven 
days post treatment as detailed above. 
Consistent with the published results (Nagata et al., 1997) and results shown above, 
anti-IgP antibody treatment led to an increase in the number of total B cells and 
CD25^ pre-B cells in Ragl''' mice compared to those injected with PBS (Figure 5.8A, 
B). In contrast, there was no such increase in the number of total B and pre-B cells in 
the bone marrow of anti- IgP antibody treated Atpllc'""''"' Ragl''' mice compared to 
PBS treated Atpllc"'"''"' Ragl''' mice (Figure 5.8A, B). While antibody treatment 
caused changes in the expression of pro- and pre-B cell markers as well as forward 
and side scatter profiles in B cells from Ragl''' mice, no such changes were observed 
in bone marrow cells from Atpllc"'"''"' Ragl''' animals injected with IgP (Figure 5.9). 
5.3.3 In vivo cross-linking of IgP on Atpllc""'''"' Ragl ' double deficient pro-B 
cells fails to induce Ca^^ mobilisation 
Upon activation, signalling through the BCR results in intracellular Ca^* flux 
(Kurosaki et al., 2010). To further test the signalling capacity of the pre-BCR in 
Atpllc"'"'"^ Ragl '- mice, I examined the ability of flow sorted pro-B cells from 
Atpllc""''"" Ragl''' animals to induce Ca^ "" flux after anti-IgP cross-linking. 
Consistent with the published data (Schwickert et al., 2014), treatment with anti-IgP 
antibody led to an increase in Ca^ "" mobilisation in pro-B cells from RAG 1-deficient 
mice (Figure 5.10), indicating that anti-IgP crosslinking in pro-B cells induces pre-
BCR signalling-dependent Ca^ "" release. However, pro-B cells from Atpllc""''"' 
Ragl-'- animals displayed no Ca^^ mobilisation upon anti-IgP treatment, despite a 
comparable baseline intracellular concentration of Ca^^ to RAG-deficient pro-B cells 
and equivalent increase in Ca^^ mobilisation in response to treatment with the Ca ^ 
ionophore ionomycin (Figure 5.10). These data suggest a defective IgP-induced pre-
BCR signalling-driven Ca^ "^  flux in ATPl IC-deficient pro-B cells. 
These data illustrate that the differentiation of pre-B cells mediated by an antibody 
treatment against IgP is impaired in ATPl IC-deficient B cells, suggesting an 
essential role for ATPl IC in the formation and/or signalling through the pre-BCR. 
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Figure 5.8 Defective IgP-mediated pro- to pre-B cell transition in Atpllc"" Ragl ' 
double deficient animals 
(A) Representative flow cytometric analysis of bone marrow cells from PBS or anti-lgP 
antibody treated Ragl " and Atpllc""''''' RagVikmh-, Ragl") mice. Numbers adjacent to 
outlined areas indicate percentage of B220^CD25" pro-B cells, B220"CD25" pre-B cells, and 
B220 CD25" non-B cells within the 7AAD" lymphocytes. (B) Graphs show absolute number 
of B220^ total B cells (left), B220"CD25" pre-B cells (middle) and 8220 CD25" non-B cells 
(right) PBS or anti-lg|3 antibody treated Ragl" and AtplIc'"'"' Ragl" (Kmb\ Ragl") mice. 
Each circle represents a single mouse. Statistical significance was calculated using the two-
tailed Student's Mest. *** P < .001; * P < .05. 
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Figure 5.9 Ant i - lgP treatment fails to upregulate pre-B cell markers in A t p 11 c""''"' 
RagV ' double def ic ient pro-B cells 
Representat ive f low cytometr ic analysis of surface expression of CD25, C-Kit , BP-1, 
Forward Scatter (FSC) and Side Scatter (SSC) on 7 A A D B 2 2 0 ' B cells from the bone 
marrow of P B S or ant i - lgP ant ibody treated R a g l " and A t p l l c " ' 
mice. 
RagV" ( A m b ; R a g l ' ' ) 
Ragl-'- A m b ; Ragl-'-
0 100 200 300 400 SOO 
Time (s) 
200 300 400 SOO 
Figure 5.10 Pro-B cells from A t p l l c " " ' " ' R a g d o u b l e deficient animals fail to induce 
ant i - IgP- induced Ca^^ flux 
Flow cytometry analysis of Ca^" measurements after st imulation with anti-lgP in sorted pro-
B cells f rom R a g l - and A t p l l c " - " ' R a g r ( K m h - , R a g V ) mice. Flow sorted pro-B cells 
were incubated with Indo-1 and analysed on f low cytometry for Ca^^ mobilisation after 
st imulation, l onomyc in ( lono) is used as a posit ive control. Arrows indicate addition of the 
stimuli. Data are representa t ive of three independent experiments with one to two mice in 
each. 
5.4 Microarray analysis in pro-B cells for the characterisation of 
dysregulayed genes that are associated with IL-7R and pre-BCR 
signalling 
I next wanted to compare the pattern of gene expression in Atpllc*'" and AtplIc"'"'"'' 
pro-B cells to identify differentially regulated genes. A microarray gene expression 
analysis was undertaken on flow-sorted 7AAD"B220^IgD IgM"CD24'"'CD43^BP-r 
pro-B cells from control and mutant animals ( -95% pure populations after sorting). 
5.4.1 Dysregulation of IL-7R signalling-related genes in ATPllC-deficient pro-
B cells 
The first set of genes examined were those whose expression is controlled by IL-7R 
signalling. The binding of IL-7 to its receptor leads to activation JAK-STAT5 
pathway, which promotes pro-B cell survival by regulating anti-apoptotic proteins 
BCL-2, BCL-XL and MCL-1 and pro-apoptotic proteins BAX, BAD and BIM (Corfe 
and Paige, 2012). As shown in Table 5.1, the expression of a range of pro- and anti-
apoptotic genes including Mc// , Bax and Bad was reduced in mutant pro-B cells, but 
the expression of Bcl2 and Bcllll remained unaltered compared to pro-B cells from 
control mice (Table 5.1). 
Activation of STATS mediated by IL-7R signalling also promotes Ccnd3 (Mandal et 
al., 2009), whose expression is required for pro- and pre-B cell proliferation (Cooper 
et al., 2006, Powers et al., 2012). Consistent with the data that mutant pro-B cells are 
able to proliferate normally in response to elevated level of IL-7 in vitro, mutant pro-
B cells had normal Ccnd3 expression compared to those from control animals (Table 
5.1). STATS activation also plays an important role in B cell specification and 
commitment by inducing EBFl expression (Kikuchi et al., 2005), which in turn 
promotes PAX5 expression (Figure 1.2A) (O'Riordan and Grosschedl, 1999). The 
mRNA level oiEbfl, but not Pax5, was decreased in ATPl IC-deficient pro-B cells 
compared to those from control animals (Table 5.1). 
Activation of the PI3K-AKT pathway by IL-7 signalling negatively regulates the 
transcription factor FOXOI that directly controls the expression oi Rag 1 and Rag2 
(Amin and Schlissel, 2008, Herzog et al., 2008). Therefore, I also looked at the 
expression of the genes encoding FOXOl , RAGl and RAG2, and found a significant 
reduction in the Foxol transcript in pro-B cells from A T P l l C mutant mice (Table 
5.1). However, the level of Ragl and Rag2 transcripts in mutant pro-B cells was not 
significantly reduced compared to control mice (Table 5.1). 
Expression of a range of genes that are required for signalling through the IL-7R was 
also examined. mRNA levels of genes encoding STAT5A and STAT5B were 
significantly reduced in mutant pro-B cells compared to cells from control animals 
while the expression of Jakl and Jak3 was mostly comparable (Table 5.2). However, 
these data are at odds with results of normal phosphorylation of STATS upon in vitro 
lL-7 stimulation. 
G e n e S y s t e m a t i c W T A m b Fold P 
N a m e P r o - B ce l l s P ro -B cel ls C h a n g e 
( n = 3 ) (n=3) 
Mcll N M _ 0 0 8 5 6 2 8 9 4 ± 3 3 5 1 0 ± 5 0 - 1,75 0 . 0 0 3 0 
Bcl2 N M J 7 7 4 1 0 31 ± 1 34 ± 7 + 1.10 0 . 6 4 6 6 
Bcl2ll N M _ 0 0 9 7 4 3 4 2 5 ± 2 2 372 ± 42 - 1.14 0 . 3 3 0 4 
Bax N M _ 0 0 7 5 2 7 3 6 6 ± 16 2 6 7 ± 19 - 1.37 0 .0161 
Bad N M _ 0 0 7 5 2 2 348 ± 15 241 ± 2 7 - 1.44 0 . 0 2 6 3 
CcndS N M _ 0 0 7 6 3 2 3 1 8 2 ± 119 3 4 7 4 ± 5 1 6 - 1.09 0 . 6 1 0 6 
Ebfl N M _ 0 0 7 8 9 7 7 7 9 ± 17 4 9 2 ± 83 - 1.58 0 . 0 2 7 7 
Pax5 N M _ 0 0 8 7 8 2 41 ± 4 31 ± 8 - 1.32 0 .3313 
Foxol N M _ 0 1 9 7 3 9 711 ± 2 1 4 6 0 ± 50 - 1.55 0 . 0 0 9 6 
Ragl N M _ 0 0 9 0 1 9 535 ± 7 3 323 ± 39 - 1.66 0 . 0 6 1 9 
Rag2 N M _ 0 0 9 0 2 0 4 0 5 ± 4 1 261 ± 4 8 - 1.55 0 .0848 
Table 5.1 Microarray analysis of genes encoding downstream of 
IL-7R signalling 
Table shows the mean ± S.E.M. of relative expression values as estimated by microarray 
analysis for a set of genes encoding downstream of IL-7R signalling in sorted pro-B cells 
from Atpllc' " (WT) and Alp 11 c""'''" (Amb) mice. The data were generated by hybridisation 
of RNA to Agilent microarrays. Statistical significance was calculated using the two-tailed 
Student 's Mest. 
G e n e S y s t e m a t i c W T A m b Fold P 
N a m e P r o - B cel ls P ro -B cel ls C h a n g e 
(n=3) (n=3) 
StatSa N M _ 0 1 1 4 8 8 62 ± 2 47 ± 4 - 1.32 0 . 0 2 4 9 
StatSb N M _ 0 1 1 4 8 9 147 ± 6 106 ± 12 - 1.39 0 .0373 
Jakl N M _ 1 4 6 1 4 5 431 ± 4 6 323 ± 4 8 - 1.33 0 .1790 
Jak3 N M _ 0 0 1 1 9 0 8 3 0 103 ± 7 7 0 ± 11 - 1.47 0 .0650 
Table 5.2 Microarray analysis of genes encoding components of IL-
7R signalling 
Table shows the mean ± S.E.M. of relative expression values as estimated by microarray 
analysis for a set of genes encoding the components of IL-7R signalling in sorted pro-B cells 
from AtplIc'" (WT) and AtplIc"""'(Amb) mice. The data were generated by hybridisation 
of RNA to Agilent microarrays. Statistical significance was calculated using the two-tailed 
Student 's Mest. 
5.4.2 Microarray analysis of pro-B cells reveals dysregulated expression of genes 
related to the pre-BCR signalling 
I also compared the expression of genes involved in the assembly and signalling 
through the pre-BCR. The levels of Syk and Blk, which are downstream of the pre-
BCR signalling, were significantly reduced in pro-B cells from ATPl IC-deficient 
mice despite normal expression of Blnk and Plcg2, which are also downstream of the 
pre-BCR (Table 5.3). Src-family protein tyrosine kinases Blk, Fyn and Lyn were 
shown to play an essential role in B cell development through pre-BCR-mediated 
NFKB activation as triple knock out exhibited a developmental block in early B cell 
development (Saijo et al., 2003). Intriguingly, there was a downward trend of gene 
expression of Blk and Fyn but these were not significant whereas Lyn expression was 
significantly reduced in pro-B cells of ATPllC-deficient mice compared to those in 
control animals (Table 5.3). The analysis of genes encoding the key components of 
the pre-BCR complex illustrated that pro-B cells from mutant animals also exhibit 
significantly reduced expression of these genes including Vprebl, Vprebl, VprebS, 
Iglll, Cd79a and Cd79b (Table 5.4). 
There are a number of genes encoding important transcription factors involved in the 
specification and commitment of B cell lineage including lkaros-1, E2A, and IRF4. 
The transcript levels of genes encoding these transcription factors as well as the 
transmembrane receptor CD93 were significantly reduced in pro-B cells from 
Atpllc"'"'"'' mice compared to those from Atpll*'" animals (Table 5.5). Moreover, 
expression of other B-cell specific genes such as IrfS and Cdl9 showed also a trend 
towards reduced expression in mutant pro-B cells without the differences reaching 
statistically significance (Table 5.5). These data collectively suggest that the 
A T P l l C ' " ' ' mutation causes a reduced gene expression pattern for most known 
genes that are involved in the pre-BCR signalling and B-cell lineage specification 
and commitment. 
In conclusion, the data from the microarray analysis together with results shown 
above suggest that the ATPl lC""* mutation has apparently no direct effect on the 
signalling through the IL-7R. Similar to pre-BCR-deficient RagV'' mice, the inability 
of mutant pro-B cells to proliferate in response to lower levels of IL-7 and the 
presence of few differential changes in the expression of IL-7R signalling-related 
genes in ATPl lC-def ic ien t pro-B cells could possibly be due to a diminished later 
developmental stage (i.e. pre-BCR signalling). Indeed, the defective IgP-mediated 
pre-B cell expansion together with the microarray results suggest that A T P l l C is 
crucial for the expression and/or signalling through the pre-BCR. However, further 
studies are needed to validate the microarray results and also dissect which stage of 
the pre-BCR signalling is specifically affected by the ATPIIC""* mutation. 
Gene Systematic 
Name 
WT 
Pro-B cells 
(«=3) 
Amb 
Pro-B cells 
(n=3) 
Fold 
Change 
P 
Syk NM_011518 1001 ± 5 6 613 ± 7 2 - 1.63 0.0131 
Btk NM_013482 682 ± 3 0 473 ± 66 - 1.44 0.0422 
Blnk NM_008528 7 5 4 6 ± 1 4 1 5624 ± 772 - 1.34 0.0706 
Plcg2 NM_172285 1963 ± 3 4 1508±217 - 1.30 0.1065 
Blk NM_007549 34 ± 4 21 ± 2 - 1.62 0.0576 
Lyn NM_001111096 14 ± 0 . 6 8 ±0 .3 - 1.75 0.0007 
Fyn NM_001122893 32 ± 2 24 ± 4 - 1.33 0.1296 
Table 5.3 Microarray analysis of genes encoding downstream of 
pre-BCR signalling 
Table shows the mean ± S.E.M. of relative expression values as estimated by microarray 
analysis for a set of genes encoding downstream of pre-BCR signalling in sorted pro-B cells 
from Atpllc' " (WT) and Atp 11 c""''" (Amb) mice. The data were generated by hybridisation 
of RNA to Agilent microarrays. Statistical significance was calculated using the two-tailed 
Student 's /-test. 
Gene Systematic WT Amb Fold P 
Name Pro-B cells Pro-B cells Change 
(«=3) («=3) 
Iglll NM_001190325 3117± 108 1856±232 - 1.70 0.0078 
Vprebl NM_016982 13389±512 8703±1093 - 1.54 0.0178 
Vprebl NM^O 16983 2056 ± 2 8 1209 ± 9 6 - 1.70 0.0011 
VprebS NM_009514 10448 ± 2 9 9 6814 ± 9 8 0 - 1.53 0.0238 
Cd79a BC027633 2050 ± 8 1 1260± 152 - 1.63 0.0102 
Cd79b N M 008339 4853 ± 2 7 9 3 1 8 6 ± 3 6 7 - 1.52 0.0223 
Table 5.4 Microarray analysis of genes encoding components of 
pre-BCR signalling 
Table shows the mean ± S.E.M. of relative expression values as estimated by microarray 
analysis for a set of genes encoding the components of pre-BCR signalling in sorted pro-B 
cells f rom Atpllc " (WT) and A t p l i r " " (Amb) mice. The data were generated by 
hybridisation of R N A to Agilent microarrays. Statistical significance was calculated usmg 
the two-tailed Student ' s West. 
G e n e S y s t e m a t i c W T A m b Fold P 
N a m e P r o - B ce l l s P r o - B cel ls C h a n g e 
( « = 3 ) («=3) 
Ikzfl N M _ 0 0 1 0 2 5 5 9 7 194 ± 7 1 2 0 ± 15 - 1.62 0 . 0 1 0 3 
Tcf3 N M _ 0 1 1 5 4 8 833 ± 11 542 ± 65 - 1.54 0 . 0 1 1 4 
lrf4 N M _ 0 1 3 6 7 4 2 8 5 ± 2 9 155 ± 2 2 - 1.84 0 . 0 2 2 4 
IrfS N M _ 0 0 8 3 2 0 971 ± 8 5 782 ± 4 0 - 1 . 2 4 0 .1153 
Cdl9 N M _ 0 0 9 8 4 4 1 9 3 9 ± 175 1263 ± 2 4 6 - 1.54 0 .0885 
Cd93 N M _ 0 1 0 7 4 0 3 6 4 0 ± 155 2 3 0 2 ± 3 3 7 - 1.58 0 . 0 2 2 6 
Table 5.5 Microarray analysis of genes encoding B-cell lineage 
genes 
Table shows the mean ± S.E.M. of relative expression values as estimated by microarray 
analysis for a set of genes encoding B cell lineage transcription factors as well as B cell 
specific proteins in sorted pro-B cells from Atpllc " (WT) and Atp 1 Ic"""'''' (Amb) mice. The 
data were generated by hybridisation of RNA to Agilent microarrays. Statistical significance 
was calculated using the two-tailed Student 's r-test. 
5.4 Chapter summary and discussion 
This chapter examined the role of ATPl IC in the outcome of signalling through the 
1L-7R and pre-BCR that are each essential for the development of pre-B cells 
(Herzog et al., 2009, Clark et al., 2014, Reth and Nielsen, 2014). Pro-B cells from 
ATPl IC-deficient animals expressed elevated levels of IL-7Ra on their surface, 
compared to control cells, and displayed a normal proliferative response to high 
concentrations of IL-7 in vitro. In contrast, the proliferative response of mutant pro-B 
cells in response to limiting concentrations of IL-7 was reduced. This observation 
mirrored the phenotype seen in pre-BCR deficient Rag2''' animals (Marshall et al., 
1998, Fleming and Paige, 2001). Further analysis revealed that ATPl IC-deficient 
pro-B cells failed to differentiate into pre-B cells in response to anti-Igji crosslinking. 
These results suggest that 1L-7R signalling is possibly not affected by the 
ATP l i e " " * mutation, but the problem could be in the formation and/or signalling 
through the pre-BCR. 
Although the results of this chapter suggest that signalling through the IL-7R appears 
to be intact in ATPl IC-deficient pro-B cells, there are some inconsistencies that 
cannot be resolved based on the current data. The microarray analysis demonstrated 
that the expression of some genes encoding downstream of IL-7 signalling was 
reduced in mutant pro-B cells. While this could be a direct effect of A T P l l C 
deficiency on signalling through the IL-7R, it can also occur as a result of the 
developmental defect observed in ATPl IC-deficient mice. Many of the target genes 
identified through the microarray assay remain to be validated by real time PCR as 
well as flow cytometry. Moreover, since IL-7 signals through three different 
pathways, namely JAK-STAT, PI3K-AKT and MAPK-ERK (Corfe and Paige, 2012), 
the results presented above cannot rule out the possibility that IL-7R-mediated 
activation of the PI3K-AKT and MAPK-ERK pathways might also be defective in 
mutant mice. Therefore, in addition to the downstream of JAK-STAT, IL-7R-driven 
activation of these pathways and their downstream molecules also need to be tested 
in mutant pro-B cells. 
Expression and signalling through the pre-BCR is essential for the development of 
pre-B cells as animals deficient for any components of the pre-BCR show a 
developmental arrest at the pro-B cell stage (Herzog et al., 2009, Clark et al., 2014, 
Reth and Nielsen, 2014). Studies using pre-BCR deficient animals reported that 
expression of the pre-BCR could improve the ability of pro-B cells to respond to low 
concentrations of IL-7 in vitro (Marshall et al., 1998, Fleming and Paige, 2001). 
These studies showed that pre-BCR-deficient Rag2''' pro-B cells fail to proliferate in 
response to limiting concentration of IL-7 (picogram) (Marshall et a l , 1998, Fleming 
and Paige, 2001). However, pro-B cells from Ragl''' animals proliferated normally 
when IL-7 is abundant (nanogram) (Marshall et al., 1998, Fleming and Paige, 2001). 
A similar proliferation profile of mutant pro-B cells in response to the different 
concentrations of IL-7 suggests that the ATPl IC"" ' mutation may have an influence 
on the expression and/or signalling through the pre-BCR. The examination of the 
pre-BCR signalling in mutant mice revealed that in vivo IgP-mediated pre-B cell 
differentiation is impaired in the absence of A T P l l C . Consistentiy, microarray 
analysis revealed that ATPl IC-deficient pro-B cells express some of the pre-BCR-
and B cell lineage-related genes at a lower level compared to cells from control 
animals, supporting a critical involvement of ATPl IC in formation and/or signalling 
through the pre-BCR in the bone marrow. 
Because initial studies failed to find a significant Ca "^" flux upon crosslinking of IgP 
in pro-B cells, it was thought that the main difference of pre-BCR and mature BCR 
signalling was the intracellular Ca^"" signalling (Nagata et al., 1997). However, a 
recent study revealed that anti-Ig|5 treatment is able to induce Ca^ "" mobilisation in 
sorted pro-B cells from RAG-deficient mice (Schwickert et al., 2014). Consistent 
with the recent report, Ragl'^' pro-B cells treated with anti-Ig|3 antibody led to an 
intracellular Ca^"" flux. In contrast, antibody-treated mutant pro-B cells were deficient 
in Ca^"" mobilisation, suggesting a functional defect in pre-BCR signalling in 
ATPllC-def ic ient cells. These results suggest that ATPl IC-deficient pro-B cells 
may have reduced signalling through the pre-BCR, most likely caused by a reduced 
expression of key signalling components but possibly also through a more direct 
effect. Therefore, pro-B cells cannot receive important signals through the pre-BCR, 
which then increase the ability to respond to limiting concentrations of IL-7. Further 
studies are needed to explore these possibilities. 
Collectively, these results indicate that the ATPl IC""* mutation may lead to a defect 
in the assembly and/or signalling through the pre-BCR. This notion may also explain 
the results that the small changes in the expression of 1L-7R signalling-related genes 
observed in pro-B cells of ATPl IC-deficient mice could be due to the defective pre-
BCR signalling, as both 1L-7R and pre-BCR pathways are thought to act 
synergistically to control B cell development (Fleming and Paige, 2002). However, 
further studies are required to determine whether mutant pro-B cells express CD79b 
in order for them to respond to antibody treatment, and if so which stages of pre-
BCR formation and/or signalling were disrupted in pro-B cells from AtplIc"'"''"' 
animals. 
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6.1 Preamble 
As discussed in the previous chapters, one of the key defence mechanisms of the 
immune system is the secretion of antibodies by B-lymphocytes. For the effective 
production of antibodies specific to an invading pathogen or in response to 
vaccinations, migration of B-lymphocytes to the GC is essential. GCs are the 
specialized microenvironments within the secondary lymphoid tissues where 
activated B cells undergo clonal expansion, somatic hypermutation and affinity 
maturation for effective humoral immune responses and for the generation of 
memory B-lymphocytes (Jacob et al., 1991, Berek et al., 1991, Liu et al., 1996). TFH 
cells, a recently identified subset of CD4^ T cells, have been shown to provide 
essential help to trigger GC B cell formation (Vinuesa and Cyster, 2011, Crotty, 
2011). During a T-dependent immune response, the differentiation of normal 
numbers of TFH cells is a crucial step as failure of TpH-cell differentiation results in 
impaired GC formation and a lack of high-affinity antibody production (Johnston et 
al., 2009, Nurieva et al., 2009, Yu et al., 2009). In contrast, increased numbers of TFH 
cells results in aberrant production of autoantibodies and the development of 
autoimmune diseases such as systemic lupus erythematosus (Hu et al., 2009, 
Linterman et al., 2009). 
In the previous chapters, it has been shown that ATPl IC-deficiency in mice results 
in loss of FO B cells in the spleen due to a developmental block at the pro- to pre-B 
transition in the bone marrow. However, Atpllc'""'' '' mice have some mature B cells 
that are mainly composed of MZ B cells in the spleen. The aim of this chapter is to 
evaluate the functional capacity of the residual mature B cells in the spleen of 
Atpllc""""' mice. 
6.2 Variably reduced primary and secondary antibody response by 
Atpllc""""" B cells 
To test whether Atpllc"'"''"' B cells are able to produce antibodies against different 
antigens, mutant animals and their control littermates were immunised with formalin 
fixed and heat inactivated Bordetella pertussis (BP) and alum-precipitated chicken y 
globulin (CGG) coupled to the hapten azo-benzene-arsonate (ABA). 2 weeks post 
primary immunisation plasma from the blood of mice was collected, and tested for 
the presence of antibodies against the immunogens by ELISA. The analysis showed 
a variably reduced primary antibody response to both antigens in the mutant animals 
(Figure 6.1 A). Booster immunisation with ABA-CGG 6 weeks later again showed 
variably decreased antibody response to the CGG protein carrier while antibodies to 
the ABA hapten - which depends upon antibody hypermutation and selection in GC 
(Hande et al., 1998) - was almost absent in all mutant animals (Figure 6.IB). 
T cell-independent (Tl) antibody responses were also examined by immunisation 
with the T-cell independent antigen, NP-Ficoll and the production of antigen-specific 
IgM antibodies were monitored. It was found that AlplIc""'"'' mice made a normal 
IgM antibody response to NP-Ficoll (Figure 6.1B). A normal antibody response to 
NP-Ficoll by B cells from AtplIc""'"'' mice can possibly be explained by normal 
numbers of MZ B cells in the spleen of mutant mice as MZ B cells are the major B 
cell subpopulation that are able to respond to TI antigens (Martin et al., 2001). Taken 
together, the results from immunisation experiments indicate that the profound 
decrease in circulating mature B cells in Atpl Ic""'''"' mice causes a variable humoral 
immune deficiency in response to T-dependent antigens. 
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Figure 6.1 Variable humoral immune deficiency in ATPl lC-def ic ient mice 
(A) Primary antibody response in the plasma of Atpllc' " (WT, open circle) and Alp 11 c""''" 
(Amb, black filled circle) animals 14 days after immunisation with inactivated Bordelella 
pertussis (BP) and alum-precipitated chicken y globulin (CGG) coupled to the hapten azo-
benzene-arsonate (ABA). (B) Graphs show antibody response to CGG, the hapten ABA, and 
NP-Ficoll in the plasma of Atpllc'" (WT) and Atpllc""'''' (Amb) animals 6 days after 
booster immunisation. Each circle represents a single mouse. 
6.3 A T P l IC is dispensable for the generation of GC B cells 
The immunisation results presented above demonstrated that while mutant mice still 
have some antibody responses to BP and CGG, the response to ABA is completely 
absent (Figure 6.IB). Since antibody response to the ABA hapten depends on 
antibody hypermutation and selection in GCs (Hande et al., 1998), these results raise 
a possibility of the requirement for A T P l l C in the formation of GC within the 
secondary lymphoid tissues. To test this, a system established by Professor Robert 
Brink, Garvan Institute of Medical Research, Australia, was used (Brink et al., 2008). 
Wild-type and ATPllC-deficient mice were crossed with CD45.1 S W H E L mice, 
which carry a heavy-chain VDJ knock-in gene combined with a HEL-specific K-light 
chain transgene (Phan et al., 2003). In this system, mice transgenic for both the 
heavy and light chain have about 10-25% of B cells specific for HEL. After adoptive 
transfer into wild-type recipient mice and immunisation with SRBCs conjugated to 
HEL, the expansion and formation of GC by the HEL-specific donor B cells can be 
monitored. An important feature of this model is that the HEL specific B cells are 
able to undergo class switch recombination and somatic hypermutation when 
challenged with immunogenic HEL in wild-type host that provides functional T cell 
help (Phan et al., 2003, Phan et al., 2005, Phan et al., 2006, Paus et al., 2006). 
To test if A T P l l C plays any role in GC formation, lO' congenically labelled 
CD45.1^ HEL-binding B cells isolated from the spleen of donor Atpllc*'" S W H E L 
transgenic and AtplIc""''"' S W H E L transgenic mice were intravenously injected into 
CD45.2 wild-type recipient mice in combination whh 2x10^ Mock-conjugated 
(control) or HEL-conjugated SRBCs (Figure 6.2). SRBC immunisation induces GC 
formation and selection, and the percentage and total number of wild-type and 
mutant derived HEL-specific GC B cells were determined by flow cytometry. 
At various time points after injection, spleens from the recipient mice were collected 
and analysed for the formation of HEL-specific GC. Flow cytometric analysis 
revealed a comparable frequency and absolute number of all GC B cells in the spleen 
of wild-type recipients as indicated by staining for B220'^GL-7'^CD95'" cells, 
confirming the ability of SRBCs to induce similar number of GC B cell formation in 
all recipient animals (Figure 6.3A, B). Therefore, any difference in the formation of 
HEL-specific GC B cells cannot be attributed to differences in the total number of 
GC B cells formed in the different wild-type recipients. Surprisingly, accumulation 
of HEL-specific GC B cells was not compromised by the ATPl IC"'"' mutation as the 
percentage and number of CD45.rHEL' ' GC B cells formed by ^/p/yc"'"'"' cells at 
different time points is comparable to that of wild-type control cells (Figure 6.3A, C). 
These results indicate that ATPl IC is not required for the formation and long-term 
survival of HEL-specific GC B cells. 
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Figure 6.2 Exper imenta l approach to test the formation of HEL-speci f ic G C B cells 
CD45.2 wi ld- type recipient mice were intravenously injected with HEL-speci f ic Atpllc" 
( W T ) ox Atpllc'""''" (Kmb) B cells f rom SWHEL-transgenic mice (congenically labelled with 
CD45.1) , and immunised with Mock-conjuga ted or HEL-conjugated SRBCs. At dif ferent 
t ime points a f te r inject ion, splenocytes f rom the recipient mice were analysed for HEL-
specif ic donor derived G C B cells by f low cytometry (Modif ied f rom Brink et al., 2008). 
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Figure 6.3 A T P l l C is not required for the generation of HEL-speci f ic GC B cells 
(A) Representa t ive f low cytometr ic analysis of spleen cells f rom wild-type recipient mice 
given adopt ive t ransfer of HEL-speci f ic Atpllc'" ( W T ) or Atp 1 Ic"""'''' (Amh) B cells f rom 
SWHEL-transgenic mice (congenical ly labelled with CD45.1) , and immunised with Mock-
conjugated or H E L - c o n j u g a t e d SRBCs . The f low cytometric plots show GL-7^CD95 ' G C B 
cells ( left panel) , and HEL"'CD45.1* donor-derived HEL-specif ic GC B ceils (right panel). 
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Figure 6.3 A T P l l C is not required for the generat ion of HEL-speci f ic G C B cells 
(B) Bar graphs show the total number of G C B cells 2.5, 3.5, 4.5, 8.5 and 9 days af ter 
immunisa t ion wi th M o c k - or HEL-conjuga ted SRBCs in wild-type recipient mice that 
received HEL-spec i f i c B cells f rom Alpllc'" SWHET-transgenic (WT-SWHEL) or Alp 1 Ic""'"'' 
SWHEL-transgenic (Amb-SWHEt) mice. (C) Bar graphs show the total number of HEL-
specif ic donor -der ived G C B cells 2.5, 3.5, 4.5, 8.5 and 9 days after immunisat ion with 
M o c k - or H E L - c o n j u g a t e d S R B C s in wild-type recipient mice that received HEL-speci f ic B 
ceils f rom Atpllc' " SWHEL-transgenic (WT-SWHEL) or Atpl IC""'"' SWNEL-transgenic ( A m b -
SWHEL) mice . Each circle represents an individual mouse , and data shown are f rom two 
di f ferent exper iments . 
6.4 A T P l l C is not required for the formation of TF„ cells 
T cell help is required for the generation of GC B cells, and a subset CD4 T cells, 
termed TFH cells has been shown to provide this essential help to trigger GC B cell 
formation (Vinuesa and Cyster, 2011, Crotty, 2011). As shown above, I found that 
while Atpllc"'"mice show defective antibody response to the ABA hapten, the 
formation of antigen specific GC B cells in SWHEL system is intriguingly normal. It 
should be noted that in this system the T cell help is provided by the recipient wild-
type cells. Therefore, one hypothesis could be that AtplIc"'"'"'" mice have a defect in 
the development of TFH cells, thus B cells in the mutant mice cannot receive the 
essential help from T cells to form GCs. Given that the development of normal TFH 
numbers is dependent on the availability of normal B cell numbers, and that mutant 
mice have reduced B cell numbers, mixed bone marrow chimera experiment was 
performed in order to test this possibility. Congenic bone marrow cells from 
Atpllc"'"''"' (CD45.2) and their Atpllc*'" littermates (CD45.2) were collected, 
equally mixed with Atpllc*'" bone marrow cells (CD45.1) and injected into 
irradiated Ragl''' mice (Figure 6.4). The recipient mice were immunised with SRBCs 
10-12 weeks after reconstitution, and spleens of the recipient mice were analysed 6 
and 12 days after immunisation by flow cytometry (Figure 6.4). Since the 
reconstitution of CD4"' T cells in the periphery of chimeric recipients is not affected 
by the ATPllC'""' ' mutation (Figure 3.7B in Chapter 3), the percentage of donor 
derived TFH cells was compared to donor derived CD4"' T cells to test whether the 
mutation has any effect on the TFH differentiation. 
As shown in Figure 6.5A, TFH cells can be identified as CXCR5'"PD-l'" in CD4'' T 
cells 6 and 12 days after immunisation. In control chimeras, the percentage of 
CD45.2 TFH cells derived from wild-type bone marrow was comparable to the 
proportion of CD45.2 cells among non-TFN CD4^ cells on day 6 and day 12 after 
immunisation (Figure 6.5B). Similarly, the percentage oiCDAil AtplIc""'"'' derived 
Tfh cells was comparable to the frequency of CD45.2'" non-TFH CD4 T cells in the 
spleen of recipients mice both 6 and 12 days post immunisation (Figure 6.5B). These 
data therefore suggest that ATPl IC is redundant for the generation and survival of 
TFH cells. 
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Figure 6.4 Experimental approach to test the formation of Atpllc*" (WT) and 
Atpllc""'''"' (Amb) derived T™ cells in the spleen of mixed bone marrow chimeric 
recipients after SRBCs immunisation 
Bone marrow chimeric mice were generated by the injection of congenic (CD45.2) bone 
marrow ceils from Atpllc' ° (WT) and Atp 11 c""''" (Amb) animals mixed at 1:1 ratio with 
Atpllc' ° (WT) bone marrow cells (CD45.1) into irradiated Ragl" recipients. 10-12 weeks 
after reconstitution, the recipient mice were immunised with SRBCs, and spleens of the 
recipient mice were analysed 6 and 12 days post immunisation by flow cytometry. 
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Figure 6.5 A T P l l C is not required for the differentiation of Tfh cells 
(A) Representative flow cytometric analysis of spleen cells from bone marrow chimeric 
recipient mice shows the gating strategy to determine donor derived non-TpH and Tfh cells 
that are accumulated in the recipient mice 6 and 12 days after immunisation with SRBCs. 
(B) Graphs show the percentage of CD45.2" Atpllc " (WT) or AlplIc"""" (Amb) derived 
non-Tra and TFH cells as shown in (A). Each circle represents an individual mouse, and data 
are representative of two independent experiments with three to five mice per genotype in 
each. 
6.5 N o r m a l f o r m a t i o n of G C B a n d TFH cells in •mitAciAtpllc""""'' mice 
Next, intact Atpllc"'"'"" mice and their control littermates were immunised with 
SRBCs, and the formation of GC B and TFH cells 7 and 14 days post immunisation 
was determined. Interestingly, the frequency of GC B cells formed in AlplIc""'"''' 
mice was higher than their control littermates at both 7 and 14 days after SRBCs-
immunisation (Figure 6.6A, upper left panel). However, the absolute number of GC 
B cells formed in Atpl Ic"'"'"'' mice was significantly reduced (Figure 6.6A, upper 
right panel), but this is most likely a reflection of the reduced number of total B cells 
in the spleen of Alpl Ic""^^" mice (Figure 3.4C, D in Chapter 3). 
TFH formation in intact AlplIc"'"^'" animals after SRBCs immunisation was also 
tested. The differentiation of TFH cells in immunised Atpl Ic"'"''"' mice appeared to be 
slightly lower both 7 and 14 days after SRBCs-immunisation (Figure 6.6B, bottom 
left panel). Similar to the number of GC B cells, AtplIc"'"'"" mice had significantly 
reduced TFH numbers (Figure 6.6B, bottom right panel), but again this most likely 
reflects the reduced number of total lymphocytes in Atpl mice (Figure 3.4B in 
Chapter 3). 
Collectively, these results together with the results from S W H E L and mixed bone 
marrow chimera experiments indicate that ATP 11C is not required for the generation 
of GC B or TFH cells in vivo despite its requirement for B cells to differentiate 
normally past the pro-B cell stage in the bone marrow. 
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Figure 6.6 Normal GC B and T f h formation in intact ATPl lC-def ic ient mice 
(A) Graphs show the percentage and absolute number of GC B cells formed in Atpllc'" 
(WT) and Atpllc""''"'' (Amb) mice 7 and 14 days after SRBC immunisation. (B) Graphs 
show the percentage and absolute number of Tfh cells occurred in Atpllc'" (WT) and 
Atpllc""'''" (Amb) mice 7 and 14 days after SRBC immunisation. Day 0 values represent 
unimmunised mice. Each circle represents an individual mouse. Statistical significance was 
calculated using the two-tailed Student 's Mest. *** P < .001; ** P < .01; * P < .05. 
6.6 Chapter summary and discussion 
In this chapter, the functional capacity of B cells that are present in AtplIc"'"'"'' mice 
was examined. Immunisation experiments revealed that AtplIc""''"' mice showed a 
variable reduced primary and secondary antibody response to T-dependent antigens, 
but normal T-independent antibody response. The normal T-independent immune 
response by ATPl IC-deficient mice could be explained by the presence of normal 
number of MZ B cells in the spleen of these mice, as MZ B cells and B1 cells both 
respond to T-independent antigens in vivo (Fagarasan and Honjo, 2000). 
Analysis of secondary immune response interestingly revealed that A T P l l C -
deficient mice show no response to the ABA hapten, which depends on antibody 
hypermutation and selection in GCs (Hande et al., 1998), suggesting a possible role 
for ATPl IC in the formation of GC B cells within the secondary lymphoid tissues. 
To further explore the role of A T P l l C in GC B cell function, I used the S W H E L 
system to analyse antigen-specific GC formation (Brink et al., 2008). These studies 
revealed that the ATPl IC""* mutation does not affect the generation and survival of 
GC B cells in the spleen. These data indicate that A T P l l C is dispensable for the 
formation of GC B cells. 
In the S W H E L system, wild-type recipient mice that provide T cell help were used to 
test the ability of ATPl IC-deficient S W H E L transgenic B cells to form GC B cells 
(Brink et al., 2008). Thus, one hypothesis would be the involvement of A T P l l C in 
TFH formation in intact mutant mice. However, this was not the case as following 
immunisation T cells from ATPl IC mutant mice were able to differentiate into TFH 
cells, which identified that ATPl IC is not required for TFH cell differentiation. 
Despite normal GC B and TFH cell formation in the presence of ATPl IC deficiency, 
AtplIc""'''^ mice showed a defective immune response to the ABA hapten. Since B 
cells found in mutant mice are primarily MZ B cells, one possibility is that 
Atpllc"'"''"' mice have a limited receptor repertoire that could limit the ability of 
mutarn B cells to recognise a diverse range of protein antigens. Thus, it would be 
interesting to determine the diversity of BCRs within mature B cells from ATPl IC-
deficient mice. 
Activated B cells within the GCs undergo affinity maturation and somatic 
hypermutation in order to produce antibodies with increased affinity for antigen 
(Goodnow et al., 2010). Thus, another possibility to explain the defective response to 
ABA despite normal GC formation is the involvement of ATP 11C in these latter 
processes. Consistent with this notion, it has been suggested that affinity maturation 
and B cell memory can be generated independent of GC formation in the case of 
lymphotoxin-alpha-deficiency (Matsumoto et al., 1996). Therefore, it is possible that 
although ATPllC-def ic ient mice have a normal GC B cell formation, they may not 
be able to undergo somatic hypermutation or isotype switching in response to GC 
centre triggers. The future experiments will also be needed to explore this possibility. 
It should also be noted that the immunisation screen used in this study was designed 
to test Thl and Th2 function in the ENU-mutagenised mice. In addition to TFH cells, 
polarisation of Th cell differentiation into the Thl and Th2 cells also contributes to 
the quality of the immune responses. Having seen a variably reduced antibody 
production to T-dependent antigens would suggest a potential impact of ATPL IC on 
the differentiation and functional properties of naive T cells into effector Thl or Th2 
cells, which will be noteworthy for future studies. 
Collectively, the results presented in this chapter suggest that ATPl IC is dispensable 
for the activation of mature B cells through the BCR, despite a critical involvement 
in the formation and/or efficient signalling of the pre-BCR during early B cell 
development. 
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7.1 Preamble 
The previous chapters immunologically characterised two ENU-induced mouse 
strains with point mutations in Alpllc, which encodes the putative 
aminophospholipid translocase A T P l l C . Since A T P l l C is thought to serve as a 
flippase that contributes to the generation and maintenance of the plasma membrane 
lipid asymmetry through translocation of phospholipids between the two leaflets of 
the bilayer, some important mechanistic questions remain unanswered: does 
ATPl IC function as a flippase in the biological membranes? And if so, how does a 
possible defective flippase activity in B cells from ATPl IC-deficient animals cause 
B cell deficiency? These are important questions because the results will not only 
illustrate for the first time whether A T P l l C is a flippase, but also provide 
mechanistic insight into the B cell phenotype observed in mutant animals. Therefore, 
this part of the thesis will examine the functional consequences of the ATPl lC ' " ' ' 
and ATPl mutations on PS internalisation across the plasma membrane of 
cells of the immune system. 
7.2 Aminophosphol ipid translocation (Flippase) activity assay 
As discussed in Chapter 1, phospholipids in the plasma membrane of most 
eukaryotic cells are asymmetrically distributed between the two leaflets of the 
plasma membrane with PS and PE being predominantly confined to the cytosolic 
leaflet (Sebastian et al., 2012, van der Mark et al., 2013). In 1984, Seigneuret and 
Devaux were the first to show the energy-driven translocation of spin-labelled PS 
and PE from the external leaflet of erythrocyte membranes to the cytosolic leaflet, 
indicating that the lipid asymmetry is generated by aminophospholipid translocase or 
flippase activity (Seigneuret and Devaux, 1984). Since then fluorescent and spin-
labelled phospholipid analogues have been extensively used to quantitatively 
measure the movement of phospholipids between the two leaflets of the plasma 
membranes. Short-chain fluorescent phospholipid analogues such as NBD-PS have 
been most commonly used to test the translocation activity in different cell types as 
they are selectively transported to the cytosolic leaflet of plasma membranes by 
aminophospholipid translocases. In order to test flippase activity in different 
haematopoietic lineages from ATPl IC-deficient animals I also used fluorescently 
labelled PS analogues. 
7.3 A d e v e l o p m e n t a l s tage-spec i f i c defect in C , 2 - N B D - P S internal isat ion 
in p r o - B s tage o f B cell d e v e l o p m e n t in the bone m a r r o w oi Atp 11 c""'"^'' 
mice 
A T P l l C is believed to function as a fiippase that transports phospholipid from the 
outer leaflet of the plasma membrane to the inner leaflet (Sebastian et al., 2012, van 
der Mark et al., 2013). As revealed in Chapter 3, mutations in the AtplIc gene led to 
a developmental arrest at the pro-B cell stage of differentiation. Therefore, I focused 
on this population of B lineage precursors as well as other haematopoietic lineages 
for aminophospholipid fiippase activity. To test whether pro-B cells from mutant 
animals exhibit an impaired PS translocation, congenically marked bone marrow 
cells f rom AtplIc""''"' CD45.2 and Atpllc*'" CD45.1 control animals were mixed at 
a 1:1 ratio and incubated for various amounts of time with the fluorescent PS 
analogue, C12-NBD-PS (Figure 7.1). Any dye remaining in the exoplasmic leaflet 
was then extracted by incubation with excess fatty acid free BSA. The mutant and 
control cell subsets were distinguished by antibody staining, and analysed by flow 
cytometry (Figure 7.1). 
I found that C12-NBD-PS fluorescence in Atpl Ic"'"''"' and Atpllc*'" B cell subsets 
increased rapidly as a result of transmembrane movement of the analogue, and 
approached saturation by 12 minutes at 37°C (Figure 7.2). The rate of C12-NBD-PS 
translocation was homogeneously less in mutant pro-B cells compared to those from 
control mice (Figure 7.2). Interestingly, the flippase defect appeared specific for the 
pro-B cell stage, as other B cell subsets in the bone marrow of Atpl Ic""''"' animals 
including pre/pro-B, immature B and mature B cells exhibited a normal fiippase 
activity (Figure 7.2). It would also be interesting to compare the flippase activity in 
mutant pre-B cells. However, because pre-B cells are present in very low number in 
ATPI lC-def ic ien t mice, it was not possible to analyse sufficient pre-B cells in the 
flippase assay to make a reliable comparison between wild-type and A T P l l C -
deficent pre-B cells. 
I also analysed other haematopoietic lineages including N K l . l ^ NK cells, TCR|3" T 
cells, M a c - r O r - r myeloid cells and T e r l l 9 " red cells in the bone marrow, and 
found that all cell types from Atpllc""""' animals show a normal flippase activity 
compared to those in control animals (Figure 7.3). Similarly, analysis of different B 
cell subsets including immature, FO and MZ B cells and other leukocyte lineages in 
the spleen revealed that all cell types from AtplIc'""''''' animals also show a normal 
C12-NBD-PS internalisation compared to those from control animals (Figure 7.4A, 
B). 
Because ATPl IC-deficient animals may have increased number of apoptotic cells 
and these cells may have reduced flippase activity, I next examined whether the 
defective flippase activity in mutant pro-B cells can be overcome by the introduction 
of a transgene that encodes the pro-survival protein BCL-2 that prevents cells from 
apoptosis. I found that the decreased C12-NBD-PS flippase activity in AtplIc"'"''"' 
pro-B cells could not be corrected by enforced expression of BCL-2 (Figure 7.5). 
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Figure 7.1 Aminophosphol ipid translocase (Flippase) activity assay 
Cells from the bone marrow, spleen and thymus of CD45.2 AtplIc""'"' and CD45.1 
Alpllc'" control animals were mixed at a 1:1 ratio and incubated for various amounts of 
time with the fluorescent PS analogue (Cn-NBD-PS). Any dye remaining in the exoplasmic 
leaflet was then extracted with fatty acid free bovine serum albumin (BSA) and washed 
away. Different cell subsets were distinguished by antibody staining, and analysed on a flow 
cytometer. 
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Figure 7.2 A lineage- and developmental stage-specific defect in Cu-NBD-PS 
internalisation in pro-B cells from ATPl lC-def ic ient mice 
Representative Co-NBD-PS fluorescence profiles after 1, 3, 6 and 12 min incubation in 
pre/pro-B, pro-B, B220'°IgM^ B, and B220'"IgM'' B cells in the bone marrow from 
/^rpZ/c™'"' (Amb, black lines), compared to the corresponding CD45.I-marked oiAtpllc'" 
(WT, shaded grey) cells in the same tube. Data are representative of at least three 
independent experiments with one mouse per genotype in each. 
NK1.r 
1 
min 
3 
min 
12 
min 
TCRp* Mac-r Gr-r Ten 19* 
WT A 
Amb 1 i 1 
i 1 1 i 
1 I i 1 
I i i i 
C„-NBD-PS 
Figure 7.3 The A T P l l C " ' ' mutat ion does not affect C12-NBD-PS translocation into NK , 
T, myeloid cells and erythrocytes in the bone marrow 
Representative C12-NBD-PS fluorescence profiles after 1, 3, 6 and 12 min incubation in 
N K l . r N K cells, TCRp'" T cells Mac-l'Gr-T Myeloid cells and Terl 19" red cells in the 
bone marrow from Atpllc""'''' (kmh, black lines), compared to the corresponding CD45.1-
marked of Atpllc' " (WT, shaded grey) cells in the same tube. Data are representative of at 
least two independent experiments with one mouse per genotype in each. 
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Figure 7.4 The ATPllC"""' mutat ion does not affect C n - N B D - P S translocation into B, 
NK, T and myeloid cells in the spleen 
(A) Representa t ive C12-NBD-PS fluorescence profi les after 1, 3, 6 and 12 min incubation in 
Immature B, Foll icular B and Marginal Zone B cells in the spleen f rom Atp 1!c"'"''" (Amb, 
black lines), compared to the corresponding C D 4 5 . I - m a r k e d of Atpllc^" (WT, shaded grey) 
cells in the same tube. Data are representat ive of three independent experiments . (B) 
Representa t ive C12-NBD-PS fluorescence profi les af ter 1, 3, 6 and 12 min incubation in 
N K l . r N K cells, TCRp* T cells and M a c - r C r - T Myeloid cells in the spleen f rom 
AtplIc""''" (Amb, black lines), compared to the corresponding CD45 . I -marked of Atpllc'" 
(WT, shaded grey) cells in the same tube. Data are representat ive of at least two independent 
exper iments with one mouse per genotype in each. 
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Figure 7.5 Overexpression of BCL-2 does not correct the impaired flippase activity in 
pro-B cells from A T P l l C - d e f i c i e n t animals 
Representative C12 -NBD-PS fluorescence profiles after 1 min incubation in pro-B cells from 
Atpllc""'"" (Amb) or AtplIc^ " (WT) mice lacking or carrying the Vav-Bcl2 transgene (black 
lines), compared to the corresponding CD45.1-marked Atpllc'" pro-B cells (shaded grey) in 
the same tube. Data are representative of two independent experiments with one mouse per 
genotype in each. 
7.4 A d e v e l o p m e n t a l s tage - spec i f i c de fec t in C 1 2 - N B D - P S trans locat ion in 
D N a n d D P s tages of T cell d e v e l o p m e n t in the t h y m u s of Atp 11 c"'"''^'' mice 
While peripheral T ceil numbers are normal in ATPl IC-deficient animals, I wanted 
to test whether developing thymocytes have a normal flippase activity. Thymocytes 
from Atpllc"'"'"" CD45.2 and Atpllc^'" CD45.1 control animals was mixed, 
incubated with C12-NBD-PS for various amounts of time at 37°C, and analysed on 
the flow cytometry. Interestingly, C D 4 X D 8 " double negative (DN) and CD4''CD8^ 
double positive (DP) thymocytes from AtplIc"'"''"' animals were found to have a 
reduced flippase activity (Figure 7.6). Similar to pro-B cells, the flippase deficit was 
stage-specific for DN and DP stages as flippase activity was normal in CD4'^ or 
CD8"^ single positive (SP) thymocytes and in mature T cells in bone marrow or 
spleen (Figure 7.3, Figure 7.4B and Figure 7.6). However, the reduction in flippase 
activity does not cause an obvious defect in DP cell differentiation into SP cells (data 
shown in Chapter 8). 
Taken together, these data show that ATPl IC is critical for phospholipid flipping in 
a developmental stage-dependent way and that pro-B cells are peculiarly sensitive to 
reduced flippase activity. 
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Figure 7.6 A lineage- and developmental stage-specific defect in C12-NBD-PS 
internalisation in DN and DP stages of T cell development in the thymus of A T P l l C -
deficient mice 
Representative Cu-NBD-PS fluorescence profiles after 1, 3, 6 and 12 min in CD4 and CDS 
double negative (DN) or double positive (DP), and CD4 or CDS Single Positive (SP) cells in 
the thymus from Atpllc"'"^'' (Amb, black lines), compared to the corresponding CD45.1-
marked of Atpllc " (WT, shaded grey) cells in the same tube. Data are representative of 
three independent experiments with one mouse per genotype in each. 
7.5 Optimization of the flippase activity assay: Utilization of a more 
suitable PS analogue 
The measurements of PS internalisation by different type of haematopoietic lineages 
shown so far were performed using C12-NBD-PS (16:0-12:0 NBD-PS) at 37 °C. The 
results revealed relatively modest differences of flippase activity between control and 
ATPl IC-deficient pro-B cells as well as DN and DP thymocytes. Because it was 
shown that Cs-NBD-PS (16:0-6:0 NBD-PS), which is different from the C12-NBD-
PS by the length of the sn-2 chain to which the NBD fluorescence marker is attached 
(Figure 1.1 A), is a more sensitive PS analogue to measure flippase activity (Hanada 
and Pagano, 1995), I wanted to compare the two different analogues. 
As a comparison, I isolated and incubated bone marrow cells from wild-type mice 
with C12-NBD-PS and Ce-NBD-PS for various time points at 15 °C, followed by 
back-extraction of fluorescent lipid remaining with fatty acid free BSA. Incubating 
cells with the analogues at 15 °C insured that the PS internalisation detected was due 
only to the flippase activity rather than non-specific endocytosis of PS micelles (van 
Genderen and van Meer, 1995). Translocation of the Ce-NBD-PS analogue increased 
more than 10-fold compared to that of the C12-NBD-PS analogue at indicated time 
points (Figure 7.7B). Because these data confirm that Ce-NBD-PS is far a more 
suitable PS analogue to measure flippase activity, I repeated the PS internalisation 
assay for all haematopoietic cells from wild-type and ATPIIC mutant mice using 
C6-NBD-PS. 
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7.6 Haematopoiet ic lineages froni Atpllc""''"' animals exhibit a defective 
Ce-NBD-PS flippase activity 
Having established the most suitable analogue, the flippase activity assays in 
different haematopoietic lineages in the bone marrow, spleen and thymus were 
repeated using Ca-NBD-PS at 15 °C. Analysis of different B cell subpopulations 
revealed that all B cell subsets including pre/pro-B, pro-B, pre-B, B200'°IgM^ and 
B220'"IgM^ B cells from the bone marrow of AtplIc"'"''"' animals showed a 
significantly reduced rate of Ce-NBD-PS intemalisation compared to those from 
Atpllc*'" animals (Figure 7.8). The lower intemalisation of Ca-NBD-PS could not be 
corrected over time as ATPllC-deficient cells had decreased Ce-NBD-PS uptake 
even after 30 min incubation (Figure 7.8). Measurement of Ce-NBD-PS 
intemalisation into B cell subsets in the spleen demonstrated that the rate of C^-
NBD-PS uptake was also notably reduced in splenic B cell subsets from Atpllc"'"^"' 
animals compared to those from control animals (Figure 7.9). 
To determine whether the defective flippase activity is specific for B cell subsets, I 
measured the uptake of Ca-NBD-PS into different leukocyte subsets including NK 
cells, T cells and myeloid cells in the bone marrow and spleen, and into different T 
cell subsets in the thymus. I found that NKl.!"" NK cells, TCRp"" T cells, and Mac-
[""Gr-l"" myeloid cells in the bone marrow and spleen of AtplIc'""''"' animals also 
exhibit a lower rate of Ce-NBD-PS uptake compared to those from control animals 
(Figure 7.10 and Figure 7.11). Moreover, analysis of different T cell subsets in the 
thymus demonstrated that DN, DP, CD4 SP and CDS SP thymocytes from ATPIIC-
deficient animals showed a significantly reduced Ce-NBD-PS uptake compared to 
the corresponding thymocytes in wild-type mice (Figure 7.12). 
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Figure 7.8 T h e ATPllC"""' mutat ion decreases Cs -NBD-PS translocation into all B cell 
subsets in the bone m a r r o w 
(A) Representa t ive C6-NBD-PS fluorescence profi les after 0, 1, 3, 5, 10, 20 and 30 min 
incubat ion in B cell subsets f rom the bone marrow of Atpl Ic""'''" (Amb, black lines), 
compared to the co r respond ing CD45 .1 -marked of Atplie ° (WT, shaded grey) cells in the 
same tube. (B) Graphs represent mean ± S.E.M of the percentage of Cs-NBD-PS uptake 
relat ive to W T at 30 min. Data are pooled f rom two independent exper iments with one 
mouse per geno type in each. 
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Figure 7.9 The ATPl lC""" mutation decreases Ce-NBD-PS translocation into all B cell 
subsets in the spleen 
(A) Representative Cs-NBD-PS fluorescence profiles after 0, 1, 3, 5, 10, 20 and 30 min 
incubation B cell subsets f rom the spleen oi Atp!Ic"""'(hmh, black lines), compared to the 
corresponding CD45.1-marked of Atpllc'" shaded grey) cells in the same tube. (B) 
Graphs represent mean ± S.E.M of the percentage of C,-NBD-PS uptake relative to WT at 
30 min. Data are pooled from three independent experiments with one mouse per genotype 
in each. 
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Figure 7.10 The A T P l l C ™ * mutation decreases Cs-NBD-PS translocation into different 
lineages in the bone marrow 
(A) Representative Cs-NBD-PS fluorescence profiles after 0, 1, 3, 5, 10, 20 and 30 min 
incubation in N K l . T NK cells, TCRp ' T cells and Mac-l^Gr-l"" Myeloid cells from the 
bone marrow oi Atpllc"'"'''' (Amb, black lines), compared to the corresponding CD45.1-
marked of Atpllc'" (WT, shaded grey) cells in the same tube. (B) Graphs represent mean ± 
S.E.M of the percentage of Ce-NBD-PS uptake relative to WT at 30 min. Data are pooled 
from two independent experiments with one mouse per genotype in each. 
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Figure 7.11 The ATPllC""* mutation decreases Ct-NBD-PS translocation into different 
lineages in the spleen 
(A) Representative C^-NBD-PS fluorescence profiles after 0, 1, 3, 5, 10, 20 and 30 mm 
incubation in N K l . r NK cells, TCRp- T cells and M a c - f G r - r Myeloid cells from the 
spleen of AtplIc""''" (Amh, black lines), compared to the corresponding CD45.1-marked of 
Atpllc- " (WT, shaded grey) cells in the same tube. (B) Graphs represent mean ± S.E.M of 
the percentage of Ce-NBD-PS uptake relative to WT. Data are pooled from three 
independent experiments with one mouse per genotype in each. 
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Figure 7.12 The A T P l l C " " ' muta t ion decreases C6-NBD-PS translocation into all T cell 
subsets in the t h y m u s 
(A) Representative Cs-NBD-PS fluorescence profiles after 0, 1 , 3 , 5, 10, 20 and 30 min 
incubation in CD4 and CDS double negative (DN) or double positive (DP), and CD4 or CDS 
Single Positive (SP) cells from the thymus of AtplIc""''" (Amb, black lines), compared to 
the corresponding CD45.1-marked of Alpl Ic" shaded grey) cells in the same tube. 
(B) Graphs represent mean ± S.E.M of the percentage of Ct-NBD-PS uptake relative to WT 
at 30 min. Data are pooled from three independent experiments with one mouse per 
genotype in each. 
7.7 The defective Cs-NBD-PS flippase activity in ATPl lC-def i c i ent 
leukocyte subsets is confirmed using cells from the second allele, 
A t p l l c ' " ^ ' 
I also tested different leukocyte subsets from Atpl Ic'^'^'"^"'" mice for Cs-NBD-PS 
transport activity as described above. I found that the rate of translocation of €5-
NBD-PS from the outer leaflet of the plasma membrane to the inner leaflet in B cell 
subsets, NK cells, T cells and myeloid cells in the bone marrow and spleen, and in T 
cells in the thymus of Atpl is significantly reduced compared to cells from 
wild-type controls (Figure 7.13, Figure 7.14, Figure 7.15, Figure 7.16 and Figure 
7.17). These results show that the defective Ce-NBD-PS translocation activity is also 
present in cells from Atpllc'^"""^""' animals. 
Taken together, the data obtained with the more sensitive PS analogue Ce-NBD-PS 
indicate that ATPl IC is a flippase that selectively mediates the inward transport of 
PS, and that all immune cells from mutant animals are defective in the intemalisation 
ofC6-NBD-PS. 
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Figure 7.13 The A T P I I C " ' ' ' " ^ ' ' muta t ion decreases Ct-NBD-PS translocation into all B 
cell subsets in the bone m a r r o w 
(A) Representative Ce-NBD-PS fluorescence profiles after 0, 1, 3, 5, 10, 20 and 30 min 
incubation in B cell subsets from the bone marrow ofAtpllc ' (18NIH30, black lines). 
compared to the corresponding CD45.1-marked of Atpllc " (WT, shaded grey) cells in the 
same tube, (B) Graphs represent mean ± S.E.M of the percentage of Cs-NBD-PS uptake 
relative to W T at 30 min. Data are pooled from two independent experiments with one 
mouse per genotype in each. 
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Figure 7.14 The ATPllC"^™'" mutation decreases C^-NBD-PS translocation into all B 
cell subsets in the spleen 
(A) Representative C^-NBD-PS fluorescence profiles after 0, I, 3, 5, 10, 20 and 30 min 
incubation B cell subsets from the spleen of AtplIc""'"""' (18NIH30, black lines), 
compared to the corresponding CD45.1-marked oiAtpllc'" (WT, shaded grey) cells m the 
same tube. (B) Graphs represent mean ± S.E.M of the percentage of Ce-NBD-PS uptake 
relative to WT at 30 min. Data are pooled from two independent experiments w,th one 
mouse per genotype in each. 
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Figure 7 .15 T h e A T P l l C " ' ™ ^ " mutation decreases Cs-NBD-PS translocation into 
different l ineages in the bone m a r r o w 
(A) Representa t ive Ce -NBD-PS fluorescence profiles after 0, 1 , 3 , 5, 10, 20 and 30 min 
incubation in N K l . l " N K cells, T C R P ' T cells and M a c - r O r - l " Myeloid cells f rom the 
bone mar row oi Atpllc'"""""' ( I 8 N I H 3 0 , black lines), compared to the corresponding 
CD45 .1 -marked of Atpllc'" (WT, shaded grey) cells in the same tube. (B) Graphs represent 
mean ± S .E.M of the percentage of C6-NBD-PS uptake relative to WT at 30 min. Data are 
pooled f rom t w o independent exper iments with one mouse per genotype in each. 
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Figure 7.16 The ATPl lC"""^" mutation decreases Ce-NBD-PS translocation into 
different lineages in the spleen 
(A) Representative Ce-NBD-PS fluorescence profiles after 0, 1, 3, 5, 10, 20 and 30 min 
incubation in N K l . l " NK cells, T C R r T cells and M a c - r G r - l ' Myeloid cells from the 
spleen oi Atpllc""''"''" (18NIH30, black lines), compared to the corresponding CD45.1-
marked ofAtpllc " (WT, shaded grey) cells in the same tube. (B) Graphs represent mean ± 
S.E.M of the percentage of C^-NBD-PS uptake relative to WT at 30 min. Data are pooled 
from two independent experiments with one mouse per genotype m each. 
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Figure 7.17 The A T P l l C ' " " " " mutation decreases Cj-NBD-PS translocation into all T 
cell subsets in the thymus 
(A) Representative C6-NBD-PS fluorescence profiles after 0, 1 , 3 , 5, 10, 20 and 30 min 
incubation in CD4 and CDS double negative (DN) or double positive (DP), and CD4 or CDS 
Single Positive (SP) cells from the thymus of AtplIc"'"""" (18N1H30, black lines), 
compared to the corresponding CD45.1-marked of Atpllc " (WT, shaded grey) cells in the 
same tube. (B) Graphs represent mean ± S.E.M of the percentage of Cs-NBD-PS uptake 
relative to W T at 30 min. Data are pooled from two independent experiments with one 
mouse per genotype in each. 
7.8 Pro-B cells show the highest rate of Cs-NBD-PS internalisation 
compared to the other B cell subsets in the bone marrow 
While flippase assay performed using C12-NBD-PS revealed a stage specific defect 
in PS internalisation into the mutant pro-B cells, the experiments performed with a 
more sensitive PS analogue Ca-NBD-PS demonstrated a broader PS translocation 
defect into the different haematopoietic lineages from ATPl IC-deficient animals. 
These results raise the question why pro-B cells are particularly sensitive to reduced 
flippase activity as I only observed a cellular defect at the pro-B stage. One possible 
explanation is an increased need for PS internalisation at this stage. To examine this, 
I tested the rate of Ce-NBD-PS internalisation in different B cell subpopulations in 
the bone marrow of wild-type animals. I found that pro-B cells show the highest rate 
of PS internalisation compared to the other subsets including pre/pro-B, pre-B, 
B200'°IgM^ and B220'"IgM^ B cells in the bone marrow (Figure 7.18). While the 
rate of Ca-NBD-PS internalisation in mature B cells and pre/pro-B cells at 30 
minutes was 92% and 84% of that in pro-B cells, respectively, it was reduced to 67% 
in B200'°IgM^ B cells, and to 53% in pre-B cells (Figure 7.18). These results 
illustrate that different B cell subsets in the bone marrow have different PS 
translocation activity with pro-B cells showing the highest and pre-B cells showing 
the lowest flippase activity. 
7.9 Pro-B cells from Atpllc""'''^'' animals display normal steady-state PS 
concentration in the outer plasma membrane leaflet 
The reduced flippase activity in AlplIc"'"''"' animals raises the possibility that 
ATPl IC mutations lead to a steady-state increase in the concentration of PS in the 
exoplasmic plasma membrane leaflet of pro-B cells. To test this hypothesis, bone 
marrow cells were stained with the PS-binding protein Annexin-V and the 
membrane-impermeable DNA dye, 7AAD and analysed on a flow cytometry. There 
was no increased Annexin-V fluorescence on viable 7AAD- pro-B or pre-B cells 
from Atpllc"""'" animals, but the percentage of apoptotic cells staining with both 
Annexin-V and 7AAD was increased among pre-B cells from Atpllc"'"'"' mice 
(Figure 7.19). This increase in apoptotic pre-B cells was suppressed by enforced 
expression of BCL-2 (Figure 7.19). 
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Figure 7.18 The highest rate of PS internalisation into pro-B cells compared to other B 
cell subsets in the bone marrow 
(A) Representative Ce-NBD-PS fluorescence profiles after 1 min incubation in pre/pro-B, 
pro-B, pre-B, B220'' 'IgM^ and B220'"IgM* B cells from the bone marrow of wild-type 
animals. (B) Graph represents mean ± S.D of the percentage of Cs-NBD-PS uptake in 
different B cell subsets relative to pro-B cells at 30 min. Data are pooled from three 
independent experiments with one mouse in each. 
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Figure 7.19 Normal surface expression of PS on the exoplasmic leaflet of pro-B cells 
from A T P l l C - d e f i c i e n t animals 
Percentage of pro-B or pre-B cells that are apoptotic as measured by positive staining for 
Annexin-V and 7AAD, from Alpllc" (WT) and AtplIc""'''' (Amb) mice lacking or 
carrying the Vav-Bcl2 transgene. Data are from two experiments (non-transgenic) or one 
experiment (Vav-Bcl2) with two to five mice per genotype in each. Statistical significance 
was calculated using the two-tailed Student 's (-test. *** P < .001. 
7.10 Blocking the "eat me" signal fails to rescue the B cell phenotype in 
Aipllc'"""' mice 
Despite normal steady-state PS concentration on B cells from Atpllc'""'"^ mice, one 
hypothesis could still be that PS transiently accumulates on the extracellular leaflet 
of the plasma membrane due to the impaired flippase function of ATPl IC, triggering 
phagocytosis and destruction by bone marrow macrophages or stromal cells. One 
way of testing this hypothesis is to block the "eat me" signal on the mutant bone 
marrow B cells with Diannexin, a homodimer of Annexin-V, which has been 
suggested to have a higher affinity for PS on the outer leaflet of the plasma 
membrane as well as an increased in vivo half-life compared to Annexin-V (Teoh et 
al., 2007). If the PS accumulation on pre-B cells is responsible for their destruction 
in ATPl IC-deficient mice and PS accumulation could be adequately saturated by 
Diannexin, it is expected that treatment would lead to a clear accumulation of pre-B 
cells within 1-2 days as pre-B cells are rapidly dividing cells. 
To examine this hypothesis AtplIc"'"'"'' animals and their control littermates were 
intravenously injected with Diannexin at a concentration that has been shown to be 
effective in preventing recognition of PS exposing cells by macrophages in hepatic 
ischemia-reperfusion injury studies (Teoh et al., 2007), and sacrificed 20h after 
treatment. Another group of mice was treated again with Diannexin 20h after the first 
injection. The mice of this group were sacrificed 24h after the second Diannexin 
injection and B cells from the bone marrow and spleen of both groups were analysed 
on a flow cytometry. Control mice received PBS instead of Diannexin. 
Enumeration of B cell subsets in the bone marrow showed no difference in the 
number of pro-B, pre-B and total B cell numbers in AtplIc'"""'" animals treated with 
Diamiexin compared to PBS-injected Atpllc""""" animals (Figure 7.20A; left panels). 
Similarly, there was no difference in the number of total B cell numbers in the spleen 
of Diannexin-administered Atpllc"""" animals compared to PBS-injected mutant 
mice (Figure 7.20B; left panel). Likewise, two consecutive daily Diannexin 
treatments did not cause a significant increase in the number of different B cell 
subsets in the bone marrow, and number of total B cells in the spleen oi Atpl Ic'"""' 
mice (Figure 7.20A, B; right panels). Collectively, these results suggest that loss of B 
Ml 
cell numbers in the bone marrow and spleen of Aipllc"'"'"' animals is likely 
independent of possible PS accumulation on the surface of pre-B cells due to the 
defective flippase activity. 
A 
0.6-, 
f 
0.4' 
1 
m 0.2 
o 
0.0 
Group 1 
O 
O 
WT Amb WT Amb 
2.0-
o X 1.5-
s 1.0-m 
i 0.5-D_ 
0.0-
8l 
• e 
S 6-
1 4-o 
CM 2-s 
0-
0.6n 
04' 
9 0.2' p 
0 . 0 -
Group 2 
o 
WT Amb WT Amb 
PBS Diannexin 
injected injected 
PBS Diannexin 
injected injected 
WT Amb WT Amb 
2.0i 
€ 
1.5 
s 1.0 
m 
0.5 
Q. 
0.0 
oO 
WT Amb WT Amb 
PBS Diannexin 
injected injected 
WT Amb WT Amb 
€ 
S 2-
CD 
0-
PBS Diannexin 
injected injected 
WT Amb WT Amb 
PBS Diannexin 
B injected injected injected 
lO 
20i 
o 
E 15' 
O 
E 15 0 
i2 0 o 
S 10 s ID-
O) 
5 5 
o 
n. • • V 
5 
o 
S' 
n-
PBS Diannexin 
WT Amb WT Amb WT Amb WT Amb 
PBS Diannexin 
injected injected 
PBS Diannexin 
injected injected 
Figure 7 .20 Blocking the "eat me" signal by administering Diannexin does not correct 
B cell p h e n o t y p e in the bone m a r r o w and spleen of A T P l l C - d e f i c i e n t mice 
Atpllc " ( W T ) and Atp 1 Ic""'''" (Amh) animals were intravenously injected with Diannexin 
and sacr i f iced 20h af ter t rea tment (Group I). The second group of mice was given another 
Diannexin t rea tment 20h af ter the first t reatment. The mice were sacrificed 24h after the 
second t rea tment (Group 2). B cells f rom the bone marrow and spleen of both groups were 
analyzed on a f low cytometry . Control mice received PBS instead of Diannexin (A) Graphs 
show n u m b e r of pro-B, p re -B and total B cells in the bone marrow of Alpllc^ (WT) and 
Atpllc""""' ( A m b ) mice that were injected with either PBS or Diannexin. (B) Graphs show 
number of total B cells in the spleen of Atpllc " (WT) and Atpllc''"" (Amb) mice that 
were injected with ei ther P B S or Diannexin . Each circle represents one mouse, and data are 
representat ive of t w o independent exper iments with two to three mice per genotype m each. 
7.11 Chapter summary and discussion 
The results presented in the previous chapters revealed that ENU-induced point 
mutations in the gene encoding the putative aminophospholipid translocase ATPl IC 
resulted in a B cell deficiency syndrome in mice. A T P l l C is believed to mediate the 
inward movement of PS, and to lesser extent PE, between the two leaflets of the 
plasma membrane (Sebastian et a!., 2012, van der Mark et al., 2013), but there is no 
direct evidence for the aminophospholipid translocase activity of A T P l l C that has 
been reported. In this chapter, therefore, the effect of two allelic mutations of the 
Atpllc gene, namely ATPl iC '" ' ' and ATPl was studied in relation to the 
aminophospholipid translocation activity. Using the fluorescently labelled PS 
analogue (C12-NBD-PS), initial experiments revealed that pro-B cells from the bone 
marrow of Atpllc"'"''"' show a reduced rate of PS internalisation compared to those 
from control animals, and this defect was specific for only pro-B cells. 
A multiple lines of evidence suggest that a more sensitive analogue (C6-NBD-PS) 
was available (Hanada and Pagano, 1995), that differed from the original C12-NBD-
PS ligand by the length of the sn-2 chain to which the NBD fluorescence marker is 
attached. The shorter sn-2 chain increases the critical micelle concentration of the 
phospholipid analogue. While C12-NBD-PS can form micelles in aqueous solutions, 
the C6-NBD-PS analogue can also exist in its monomeric form. This allows the C(,-
NBD-PS to penetrate more easily into a lipid bilayer, and also allows it to back 
extract with the fatty acid free BSA because of the equilibrium between the 
monomeric Ce-NBD-PS in solution and in the outer leaflet of the cell membrane. 
The utilisation of the more sensitive C6-NBD-PS analogue revealed that all 
lymphocyte subsets including B cell subsets, T cells, NK cells as well as myeloid 
cells in the bone marrow, spleen and thymus of Atpllc"'"''"' animals have a 
significantly reduced rate of PS internalisation compared to corresponding cells from 
control animals. Notably, the defective flippase activity was confirmed using cells 
from mice carrying an independent ATPl IC mutant allele {AtplIc'^^'"^""). 
Why are pro-B cells particularly sensitive to the impaired flippase activity despite 
that all cells of the immune system in mutant mice exhibit slower rate of PS 
internalisation? Comparison of PS flippase activity in different B cell subsets in the 
bone marrow of wild-type mice revealed that pro-B cells display the highest rate of 
PS internalisation. This finding is interesting because it could indicate that pro-B 
cells have an increased dependence on PS internalisation, and this could explain the 
stage specific defect observed in B cell development in the bone marrow of 
ATPl IC-deficient animals. However, the variable internalisation rate did not 
correlate with gene expression of Atpllc in different B cell subpopulations in the 
bone marrow as it is comparably expressed in pre/pro-, pro-, pre- and immature B 
cells in the bone marrow (Figure 1.9B in Chapter 1) (Heng and Painter, 2008). 
Therefore, it is plausible that the cellular defect at the pro-B cell stage of B cell 
development in the bone marrow of ATPl IC-deficient animals could be explained 
by the defective flippase activity in pro-B cells as they exhibit the highest rate of PS 
translocation activity compared to the other B cell subsets. 
Exposure of PS on the surface of cells is critical for the recognition and clearance of 
apoptotic cells by macrophages (Fadok et al., 1992). An alternative explanation for 
the stage specific defect in B lymphopoiesis could be that the impaired flippase 
activity causes a temporary increased PS concentration on the cell surface this could 
result in rapid PS-mediated phagocytosis of B cells in ATPl IC-deficient mice. 
However, there was no increase in surface expression of PS on pro-B and pre-B cells 
from Atpllc"'"''"' animals. Moreover, blocking the "eat me" signal by administering 
an Annexin-V homodimer, Diannexin, did not rescue the reduced B cell numbers in 
the bone marrow and spleen of ATPl IC-deficient mice. It should be noted that 
because of the lack of a positive control to show that the Diannexin treatment did 
block the "eat me" signal in developing B cells, I cannot rule out this possibility and 
further experiments are needed to test this crucial hypothesis. A definitive 
experiment will be to cross ATPl IC mutant mice with animals that are defective in 
the engulfment of PS-exposing apoptotic cells by macrophages (i.e. mice lacking the 
membrane tyrosine kinase c-mer or the PS receptor Tim4 (Cohen et al., 2002, 
Miyanishi et al., 2007)), and determine whether this genetic ablation rescues the B 
cell deficiency in ATPl IC-deficient mice. 
Collectively, these results demonstrate for the first time that the mutations in the 
gene encoding ATPl IC resulted in the diminished flippase activity, and suggest that 
A T P l l C is a flippase that selectively transports PS from the outer leaflet o f the 
plasma membrane to the inner leaflet. This was confirmed recently by a study where 
A T P l l C was shown to act as a flippase in human cells (Segawa et al., 2014). 
Segawa et al. also determined the substrate specificity of A T P l l C as cells lacking 
A T P l l C failed to flip PS and PE, but not PC, from the exoplasmic to the 
cytoplasmic leaflet o f the bilayer cells (Segawa et a l , 2014). Furthermore, the (3-
subunit of the heterodimeric complex, CDC50, was also required for proper flippase 
activity (Segawa et al., 2014). Therefore, the results of this chapter together with the 
findings o f Segawa et al. suggest that A T P l l C functions as a flippase in the 
biological membranes. 
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8.1 Preamble 
As shown in Chapter 3, the ATPl IC""* and ATPl i c " ^ ™ " mutations in mice led to 
a defect in the accumulation of B cells in the bone marrow and periphery. Consistent 
with the predicted biochemical function of A T P l l C , the previous chapter revealed 
that B cells from the bone marrow and spleen of AtplIc"'"'"'' and AtplIc'^^'"^"'" mice 
display an impaired flippase activity as measured by decreased uptake of the 
fluorescent PS analogue C6-NBD-PS into the plasma membrane compared to B cells 
from AtplIc*'" animals. Interestingly, the defective flippase activity was not specific 
for B cells and was also detected in other blood lineages including T cells, NK cells 
and myeloid cells from Atpl Ic'""'"'" and AtplIc'^^'"^"'" mice. These results raise a 
possible involvement of A T P l l C in the development and homeostasis of multiple 
cell lineages. Therefore, in this chapter I investigated the effect of the ATPl lC""* 
mutation on the accumulation of haematopoietic progenitor cells in the bone marrow 
and other non-B cell lineages in the thymus and periphery. 
8.2 A T P l l C is dispensable for the generation of blood cell progenitors 
and lineages in the bone marrow 
Given that all the cells of the immune system originate from the pluripotent HSCs of 
the bone marrow, I first tested the effect of the ATPl IC""* mutation on the number 
of progenitors in the bone marrow. Analysis of haematopoietic progenitors including 
CD12rLin"C-Kit ' 'Sca-rFl t3" haematopoietic stem and progenitor cells, CD127"Lin" 
C-Kit^Sca-rFl t3^ MPPs, and CD127^Lin-CD93 "Sca-l'"'Flt3"'C-Kit""^'' CLPs which 
are the earliest lymphoid progenitors revealed normal or slightly elevated numbers of 
these populations in the bone marrow oi AtplIc"'"'''''' met compared to their wild-
type littermates (Figure 8.1). 
1 next performed a more detailed enumeration of different lineages in the bone 
marrow, and showed that AtplIc"'"'" have normal number of M a c - l ^ G r - r 
myeloid and N K l . l " NK, slightly lower Te r l l 9" erythroid and slightly higher 
number of CD3" T cells (Figure 8.2). These data indicate that A T P l l C is not 
required for blood cell progenitors and their development into different mature 
lymphoid and myeloid lineages except B cells. 
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Figure 8.1 Analysis of major blood cell progenitors in the bone marrow 
(A) Representative flow cytometric analysis of haematopoietic stem and progenitor cells 
(HSPC) multipotent progenitors (MPP), and common lymphoid progenitors (CLP) in the 
bone marrow ofAtpllc" (WT) and Alpllc'-" (Amb) mice. (B) Graph shows^absolute 
number of the cell populations gated as in (A), from AtpUc " (WT) and Atpllc""' (Amb) 
mice analysed in two different experiments. Each circle represents a single mouse. Lmeage 
panel for the analysis includes antibodies against CD4, CDS, CDS, TCRp, TCRyS, IgM, IgD, 
B220, CD19, Mac-I, C D l l c , Ter l l9 , Ly6c, Gr-1 and NKl . l . Statistical significance was 
calculated using the two-tailed Student's (-test. * P < .05. 
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Figure 8.2 Analysis of major blood cell lineages in the bone marrow 
(A) Representative flow cytometric analysis of the frequency of Myeloid cells (Mac-T"' ' 'Gr-
1 med Mac- l ' "Gr- r= ' ' and Mac-l '"Gr-l '" respectively), Erythrocytes (Terl l9") , NK cells 
(NKl . l^ ) and T cells (CD3^) in the bone marrow of Alpllc'" (WT) and AtpJlc''°'''°{Amb) 
mice. (B) Graph shows absolute number of the indicated cell populations from Atp 11c" 
(WT) and AtplIc""''"' (Amh) mice analysed in two different experiments. Each circle 
represents a single mouse. Statistical significance was calculated using the two-tailed 
Student's Mes t . " P < .0001; * * * / ' < .001. 
8.3 Normal deve lopment of a p and yb T cells in the thymus of/i/p/Zc""'* " 
mice 
T cell development takes place in the thymus, and follows a well defined cell 
differentiation process characterised on the basis of expression of cell surface 
markers (Shortman and Wu, 1996, Zuiiiga-Pfiucker, 2004). T cells can be 
differentiated into two different T-cell lineages including alpha-beta (aP) T cells and 
gamma-delta (yS) T cells. T a p cells can further be differentiated into different 
subsets including CD4 SP and CDS SP cells. While CD4 and CDS T cells orchestrate 
different types of cell-mediated immune responses, yb T cells play critical roles in 
the immune regulation, primary immune responses and tumour surveillance (Hayday 
and Pennington, 2007). 
As shown in Chapter 7, T cells from the thymus and spleen of AlplIc""''"' animals 
exhibited a lower rate of PS internalisation compared to those in AtpUc*'" animals. 
In order to test whether ATPl IC has any role in T cell development and survival, I 
first isolated thymocytes from Atp 1 Ic'""''"' amma\s and their control littermates, and 
stained with surface markers to dissect the different stages of T cell development by 
flow cytometry. I found that the development of T cells in the thymus oiAlplIc"""'"'' 
mice was normal as the frequency and number of CD4^ SP, CDS'" SP, DN and DP T 
cells was equivalent to that observed \n Atp lie*'" mice (Figure 8.3 A-C). 
A small percentage of thymocytes that successfully rearrange genes encoding a 
TCRy and TCR8 chain expresses a mature TCRyS receptor and becomes TyS cells. I 
found that the number of y8 T cells in the thymus of AtplIc'""'"" mice was 
comparable to Atpllc*'" controls (Figure S.3D, E). Collectively, these resuhs suggest 
that ATPl IC is not required for the development of a P and y8 T cell lineages in the 
thymus. 
8.4 Normal distribution of a P and yS T cells in the periphery of 
Atpllc''""'"'mKt 
Having shown that the ATPl mutation has no effect on the development of T 
cells in the thymus, I next sought to determine whether ATPIIC influences the 
1S7 
survival of T cells in the periphery. Alp lie*'" and Alp 1 Ic"'"'"'' animals were sacrificed, 
and the numbers of a p and yb T cells in the spleen and lymph node were enumerated 
using flow cytometry. As shown in Figure 8.4A A T P l l C has no effect on the 
number of T cells with comparable numbers of a p and yb T cells being present in the 
spleen and lymph node oiAlplIc"'"'"'' mice. 
I also analysed the ratio of CD4 and CDS T cells in the periphery oiAtplIc"'"'''" mice, 
and found an elevated percentage of CD4'' T cells in the spleen oi Atpl Ic"'"'"''m\CQ 
compared to their wild-type littermates (Figure 8.4B and C). Collectively, these 
results indicate that A T P l l C deficiency in mice has apparently no impact on the 
development and survival of T cells in the peripheral circulation despite an impaired 
flippase activity, but seems to have an effect on the CD4/8 ratio in the spleen, which 
requires further examination. 
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Figure 8.3 Normal T cell development in the thymus of Alp lie""'''' mice 
(A) Representative f low cytometric analysis of thymic cells from Atpllc" (WT) and 
AlpHc""''''' (Amb) mice. Numbers adjacent to outlined areas indicate percentage of 
CD4^CD8" CD4 Single Positive (SP) cells; CD4 C D 8 ' CDS Single Positive (SP) cells; 
CD4^CD8^ Double Positive (DP) cells; CD4 CDS Double Negative (DN) cells. (B, C) 
Graphs show absolute number of (B) total thymocytes and (C) T cell subpopulations in the 
thymus. Each circle represents a single mouse, and data are representative of two 
independent experiments of three to five mice per genotype in each. (D) Representative flow 
cytometric analysis of 76 T cells from the thymus of Atpllc'" (WT) and Atpl Ic""""'(Amb) 
mice. Cells were pre-gated on CD3^ T cells. Numbers adjacem to outlined area indicates 
percentage of TCRyd^TCRp- yb T cells. (E) Graph shows absolute number of 76 T cells in 
the thymus. Each circle represents a single mouse. 
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Figure 8.4 Normal distribution of a p and yb T cells in the periphery of Atpllc"'"'"'' mice 
(A) Graphs show absolute number of a p and 76 T cells in the spleen and lymph node. Each 
circle represents a single mouse. (B) Representative flow cytometric analysis of CD4 and 
CDS T cells f rom the spleen oiAtpllc " (WT) and AtplIc-"'"" (\mh) mice. Cells were pre-
gated on CDS'" T cells. Numbers adjacent to outlined areas indicate percentage of CD4"CD8" 
CD4 T cells and CD4 CD8" CDS T cells. (C) Graph shows the ratio of CD4 and CDS T cells 
gated as in (B), from the spleen of Atpllc " (WT) and Atpl I c""'"'(Amh) mice analysed in 
at least four different experiments. Each circle represents a single mouse. Statistical 
significance was calculated using the two-tailed Student 's /-test." P < .0001. 
8.5 N o r m a l N K and N K T cell populations in the spleen of Atplie""""" mice 
NK cells play an important role in the innate immune response with the capacity to 
kill virus infected cells, and contribute to anti-viral and anti-tumour immunity 
(Yokoyama et al., 2004). Natural Killer T (NKT) cells, on the other hand, arise from 
DP cells in the thymus and display a restricted TCR repertoire and play a crucial role 
in immune surveillance in the liver and spleen (Bendelac et al., 2007). Most of NKT 
cells express NK cell marker NKl .1 and an invariant T-cell receptor a chain that is 
paired with a limited repertoire of Vp chains (Bendelac et a l , 2007). Similar to other 
blood lineages, NK cells in the bone marrow and spleen of AlplIc"'"'"'' mice also 
demonstrated reduced Ce-NBD-PS internalisation (Chapter 7). To determine 
whether the A T P l l C ' " ' ' mutation has any effect on the differentiation and 
accumulation of NK cells as well as NKT cells, NKl.l^CDS" NK cells and 
NKl.r '^ ' 'CD3'"" ' NKT cells in the spleen oiAtpllc*'" and Alp 1 Ic""'"'' mice were 
ascertained by flow cytometry. 
As shown in Figure 8.5, accumulation of NKTl'^CDS" and NKl . r ' ' 'CD3" ' ' ' ' cells 
mostly occurred at normal or slightly increased percentages in the spleen of 
AtpIIc"'"^"' animals compared to wild-type controls. The absolute number of both 
NK and NKT cells were severely reduced compared to their wild-type littermates 
(Figure 8.5B and C), however this is most likely due to a reduction in total leukocyte 
numbers in the spleen of mutant mice (Figure 3.4A in Chapter 3). These data thus 
indicate that ATP 11C has likely no effect on NK and NKT cell development or 
peripheral homeostasis. However, it should be noted that NKl . l and CD3 are not 
ideal markers to detect NKT cells, and CD Id alpha-galactosylceramide tetramer 
together with CD3 must be used to identify the precise NKT cell population. 
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Figure 8.5 Normal frequency of NK and NKT cells in the spleen of Alpllc"""' mice 
(A) Representative flow cytometric analysis of spleen cells from Alpllc'" (WT) and 
AtplIc"""'''' (Amb) mice. Numbers adjacent to outlined areas indicate percentage of 
N K l . r C D 3 " NK cells and N K l . l ' C D 3 ' NKT cells. (B, C) Graphs show percentage and 
absolute number of (B) NK and (C) NKT cells in the spleen of Atpllc' " (WT) and 
Atpllc"'"'''' (Amb) mice analysed in two different experiments. Each circle represents a 
single mouse. Statistical significance was calculated using the two-tailed Student's (-test. 
*** P < . 0 0 1 ; ** .01. 
8.6 ATPl lC-de f i c i en t environment inHuences the ability of wild-type 
HSCs to differentiate into B cell lineage 
Having seen that ATPl IC does not have a discemable impact on the accumulation of 
other haematopoietic lineages, I next wanted to test if wild-type HSCs can normally 
give rise to cells of the immune system in ATPl IC-deficient recipient. To do so, I 
generated non-competitive bone marrow chimeras, in which 100% Atpllc*'" and 
100% Atpllc"'"''"' bone marrow cells were adoptively transferred alone to both 
Atpllc*^" and AtplIc"'"''"' recipients that were irradiated with two doses of 450 rad 
(Figure 8.6A). The recipient mice were bled 9 weeks after transfer and leukocytes 
were analysed by flow cytometry for the donor-derived (CD45.1^) cells in the 
peripheral blood (Figure 8.6B). 
The degree of chimerism was close to 100% regardless of the genotype of the donor 
or recipient animals as evident from the percentage of CD45.1"^ donor-derived 
myeloid cells in the blood of each chimeric recipient (Figure 8.7A). Similarly, the 
percentage of donor-derived lymphocytes was close to 100% in all groups except 
that Atpllc"'"'''^ bone marrow cells showed an approximately 85% reconstitution in 
Atpllc*"' recipients (Figure 8.7A). Consistent with the findings that ATPl lC 
controls B cell development in a cell intrinsic-fashion (Figure 3.7 in Chapter 3), bone 
marrow cells from AlplIc"'"'"'' animals could not give rise to B cells either in wild-
type or in ATPl IC mutant recipients (Figure 8.78). 
In the control recipients, on the other hand, the wild-type donor CD45 . r bone 
marrow cells were able to efficiently differentiate into B cells in wild-type recipients 
as the percentage of B cells was found to be approximately 70% of total lymphocytes 
(Figure 8.7B). Remarkably, CD45.1'' wild-type derived B cells represented only 9% 
of total lymphocytes in the blood of Atpl Ic""'"'' recipients (Figure 8.7B). In the same 
chimeras, AtplIc*'" T cells nevertheless accumulated in approximately comparable 
proportion to other groups of recipients (Figure 8.7B). These results surprisingly 
suggest that the ATPl i C " " mutation may also affect some cell extrinsic factors that 
support B cell development in the bone marrow and/or B cell survival in the 
periphery. 
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Figure 8.6 Experimental design of noncompetitive bone marrow chimeras, and gating 
strategy for the analysis of donor-derived cells in the peripheral blood of chimeric 
recipients 
(A) Congenically CD45.1-labelled bone marrow cells from Atpllc^" (WT) and AlpIIc""'"' 
(Amb) animals intravenously injected into irradiated CD45.2 Alpllc'" (WT) or AtplIc""'''' 
(Amb) recipients. The recipient mice were bled 9 weeks after transfer and analysed by flow 
cytometry. (B) Gating strategy for flow cytometric analysis of blood samples from the 100% 
bone marrow chimeric recipients. Donor derived cells in the irradiated hosts can be 
identified by CD45.1 congenic label. 
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Figure 8.7 Impaired B cell accumulation in the blood of ATPl lC-def ic ient animals that 
were irradiated and reconstituted with wild-type bone marrow cells 
(A) Graphs show the percentage of CD45.1'" donor-derived myeloid cells and lymphocytes 
(gated as in Figure 8.6B) in the blood of chimeric recipients 9 weeks after transfer. (B) 
Graphs show the percentage of CD19" B cells and CD3" T cells within the donor-derived 
C D 4 5 . r lymphocytes in the blood of chimeric recipients 9 weeks after transfer. Each circle 
represents a single mouse. 
8.7 Analys is of an A T P l IC-deficient mouse that was irradiated and 
reconstituted with wild-type bone marrow cells 
It was unexpected that AlplIc""""" mice reconstituted witii Atpllc*'" bone marrow 
ceils sliow defective B cell accumulation in tlie periplieral blood (9% compared to 
70% in the control chimeras). Unfortunately, there was only one AtplIc"'"''"' mouse 
reconstituted with 100% wild-type bone marrow cells available for the detailed 
analysis of B cell subsets. Therefore, this mouse was compared to intact Atpllc*'" 
and Atpllc"'"''"' animals. Firstly, B cell development in the bone marrow of the 
chimeric mouse was analysed to determine if the apparent loss of B cells in the 
peripheral blood is caused by a block in the early stages of development. Analysis of 
the B cell development in the bone marrow of the Alp]Ic"'"'"''' mouse reconstituted 
with wild-type cells showed that the frequency of total B cells in the bone marrow is 
largely normal compared to that in control mouse (Figure 8.8). 
Detailed analysis of B cells subsets revealed that IgD^IgM^ mature circulating B 
cells represent approximately 80% of total B cells in the bone marrow of the 
Atpllc""''"' mouse transplanted with wild-type bone marrow cells (Figure 8.8). 
However, the percentage of IgD'IgM^ immature B cells in the AtplIc""'''"' mouse 
transplanted with control bone marrow cells was considerably reduced compared to 
intact Atpllc^'" animal (Figure 8.8). Similarly, IgDTgM' bone marrow B cell 
progenitors represented only 12% of total B cells in the AtplIc""'''"^ mouse 
transplanted with control bone marrow cells compared to 57% and 82% in intact 
Atpllc*'" and Atp 11 c'""'''" animals, respectively (Figure 8.8). When these cells were 
sorted by CD24 and CD43 expression, there was a partial defect at the pro-B cell 
stage as the percentage of pre-B cells represented 35% of total progenitors compared 
to 70% in control animal (Figure 8.8). Collectively, these results suggest that there is 
a defect in early B cell development in the bone marrow of the ATPl IC-deficient 
host that received transplants of wild-type haematopoietic cells, but that mature B 
cells can develop and survive. 
Next, B cell and B cell subsets in the spleen of Atpl Ic''", Alpl Ic""""" and chimeric 
Atpl 1 mice were analysed. In the AtplIc'""''' mouse that was irradiated and 
reconstituted with wild-type bone marrow cells, the percentage of total B and 
immature B cells was increased compared to the intact Alpl Ic""'"'' mouse, but it was 
still lower than in the control animal (Figure 8.9). Interestingly, B cells within the 
mature B cells were phenotypically indistinguishable from those in the 
intact Atpllc"'"''"' mouse with approximately 50% MZ B cells (Figure 8.9). The loss 
of repopulating activity of wild-type bone marrow cells in the Atpllc"'"''"^ mouse was 
specific for B cells, because bone marrow cells from wild-type mice gave rise to 
normal percentages in all major haematopoietic lineages including NK cells and T 
cells in the spleen (Figure 8.10) and T cells in the thymus (Figure 8.11) on 
transplantation into an irradiated Atpllc"'"'''" mouse. 
Taken together, the results from the non-competitive bone marrow chimera 
experiments suggest that A T P l l C may also affect some other cell extrinsic factors 
that are required for the development of pre-B cells in the bone marrow and 
accumulation of FO B cells in the spleen. However, these results are preliminary and 
needed to be confirmed and extended by future experiments. 
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Figure 8.8 A partial developmental arrest at the pro-B cell stage of B-cell development 
in ATPl lC-def i e i ent mouse that was irradiated and transplanted with wild-type bone 
marrow cells 
Representative flow cytometric analysis of bone marrow cells from Atpllc" (WT) and 
Atpllc""''''' (Amb) animals or an Atpllc""'''' (Amb) mouse that was irradiated and 
reconstituted with Atpllc'" (WT) bone marrow cells. Numbers adjacent to outlined areas 
indicate percentage of B220* B cells (left); percentage of IgM'igD* mature B cells, 
IgM^IgD" immature B cells, and IgM IgD" precursor B cells within the QUO* subset 
(middle); cells gated on B220'' IgM IgD" cells, showing the percentage that are CD43" 
€ 0 2 4 " ' pre-B cells, CD43^CD24"'='' pro-B cells and CD43"CD24- pre-pro-B cells (right). 
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Figure 8.9 Impa ired differentiation of wild-type bone marrow cells into mature B cells 
in the spleen of irradiated ATPl lC-def ic ient host 
Representative flow cytometric analysis of splenocytes from Atpllc " (WT) and Atpllc"' " 
(Amb) animals or an Atpllc""'''' (Amb) mouse that was irradiated and reconstituted with 
Atpllc'" (WT) bone marrow cells. Numbers adjacent to outlined areas indicate percentage 
of B220'"-gated cells that are CD93" mature B cells and CDQS"" immature B cells (left); 
percentage of the CD2l ' "CD23" marginal zone and the CD2 r " 'CD23 " follicular B cell 
subset within the B220"CD93" mature B cells (right). 
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Figure 8 .10 N o r m a l di f ferent iat ion of wi ld-type bone marrow cells into N K and T cell 
l ineages in the spleen of irradiated A T P l l C - d e f i c i e n t host ^^^^ 
Representa t ive f low cy tomet r ic analysis of splenocytes f rom Atpllc^" ( W T ) and AtplIc""'''" 
(Amb) animals or an Atpllc"'"''' ( A m b ) mouse that was irradiated and reconsti tuted with 
AlplIc'" ( W T ) bone mar row cells. N u m b e r s adjacent to outlined areas indicate percentage 
of N K 1. r N K cells and C D 19" B cells (left); percentage of CD4" and CD8" T cells (right). 
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Figure 8.11 Normal differentiation of wild-type bone marrow cells into T cells in the 
thymus of irradiated ATPl lC-def ic ient host 
Representative flow cytometric analysis of thymocytes from Atpllc " (WT) and Atpllc""' 
(Amb) animals or an Alpllc"''"' (Amb) mouse that was irradiated and reconstituted with 
Atpllc' " (WT) bone marrow cells. Numbers adjacent to outlined areas indicate percentage 
of CD4^ single positive, CD8^ single positive, CD4"CD8- double positive and CD4 CD8 
double negative T cells. 
8.8 Deve lopment of liver tumours in Atpllc"'"''^'' mice 
During the analysis of the blood samples, pronounced yellow coloured plasma from 
Atpllc"'"''"' animals were noticed (Figure 8.12A). It was found that the yellow 
coloured plasma is due to a 30-fold increase in unconjugated and conjugated 
bilirubin (Figure 8.12B). Measurements of liver injury, as measured by the plasma 
markers alanine aminotransferase and aspartate aminotransferase these were 
comparable between Atpl Ic"""^^" and control animals that are 8-14 weeks of age, but 
slightly increased with the age (25-30 weeks) in mutant mice (Figure 8.12C). 
Necropsy, however, revealed gross or microscopic liver pathology consistent with 
hepatocellular carcinoma (HCC) in 10 out of 10 Atpllc"'"''"' animals analysed at 6 
months of age and not in normal controls. Liver tumours were well to poorly 
differentiated HCCs containing areas of haemorrhage, necrosis and hypervascularity. 
Tumour development in these mice was likely to have been preceded by the 
formation of foci of altered hepatocytes (Figure 8.13). Several such foci were present 
in liver tissue surrounding the tumours, exhibiting a striking number of mitotic 
figures, many of which were multipolar with condensed and asymmetric chromatin 
aggregation (Figure 8.13). Other dysplastic features in Atpllc"'"''"' animals include 
nuclear anisocytosis, hyperchromasia, pleomorphism and increased nuclear to 
cytoplasmic ratio (Figure 8.13). By contrast, no such abnormalities were seen in the 
liver of control littermates. Interestingly, preliminary results seem to indicate that the 
development of liver tumours in mutant mice is accelerated by an immune 
stimulation, but further experiments are needed to confirm this, and also test if this is 
a liver intrinsic defect or related to the abnormalities in the haematopoietic system. 
These experiments are of considerable interest, but go beyond the scope of my thesis. 
8.9 Chapter summary and discussion 
As shown in Chapter 7, all cells of the haematopoietic system in A T P l l C mutant 
animals showed an in vitro defective flippase activity. These data prompted me to 
investigate a possible involvement of A T P l l C in the differentiation and/or survival 
of haematopoietic progenitors as well as different blood lineages. I found the number 
of haematopoietic progenitors in the bone marrow of mutant animals was 
comparable to those of control mice, indicating that A T P l l C had no impact on the 
development of haematopoietic progenitors. A T P l l C deficiency had also no 
discernible effect on the accumulation of T cells, NK cells and myeloid cells in the 
primary and secondary lymphoid tissues despite the fact that the aminophospholipid 
translocase activity was impaired in all these cells as a result of the A T P l l C 
deficiency. The results suggest that ATPl IC is redundant for the development and 
homeostasis of all other subsets, except B cells, of the immune system. 
Despite the expression of ATPl IC in a wide range of leukocytes it only appears to 
be required for B lymphopoiesis. This can possibly be explained by the expression of 
other P4-type ATPases (14 in mice, 13 in humans) (Sebastian et al., 2012). This 
notion is supported by the prominent expression of other flippases in specific cell 
types for example high expression of ATP8A2 in CD4 memory T cells as well as 
NKT cells, ATP8B1 expression in Langerhans DCs, ATPl OA expression in DP T 
cells (Heng and Painter, 2008). Thus, it would be interesting to test the specific roles 
of other flippases in the development, homeostasis and function of cells within the 
immune system by generating knock out mouse models for all P4-type ATPases. 
Despite normal T cell development in the thymus of ATPl IC-deficient mice, the 
accumulation of mature T cells in the bone marrow was intriguingly increased. 
Moreover, the ratio of CD4 vs. CDS T cells was also increased in the spleen of 
mutant mice compared to their control littermates. These results suggest that 
ATPl IC is not required for thymic development of T cells, but might play a role in 
the accumulation, localisation and/or function of mature T cells in the periphery. 
It was surprisingly discovered that wild-type bone marrow cells failed to give rise to 
B cells in lethally irradiated ATPl IC-deficient host. This phenotype was also 
observed with two independent A T P l l C mutant alleles (Siggs et al., 2011b). 
Preliminary data revealed that the wild-type HSCs transplanted into an A T P l l C 
mutant host displayed a partial arrest at the pro- to pre-B cell stage of B cell 
development. Moreover, the phenotype of splenic B cells in the mutant host that was 
transplanted with wild-type HSCs was also similar to that seen in intact mutant 
animals. These results interestingly indicate that A T P l l C deficiency may also affect 
some cell-extrinsic factors that need further examination to be fully delineated. 
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Figure 8.12 Elevated bilirubin level in the plasma of Atpllc"" ' mice 
(A) Yellow coloured plasma from Alpllc""''" mice. (B) Graph shows unconjugated and 
conjugated bilirubin in the plasma of Atpllc " (WT) and AtplIc""'"'(^mb) mice. The data 
are representative of at least three independent experiments with four to eight mice per group 
in each. Each circle represents a single mouse. (C) Graphs show alanine aminotransferase 
(ALT) and aspartate aminotransferase (AST) in the plasma of Atpllc" (WT) and 
Atpllc'"'''" (hmh) mice that were 8-14 weeks (left) or 25-30 weeks old (right). Each circle 
represents a single mouse and results are shown from two independent experiments. 
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Figure 8.13 Development of hepatocellular carcinoma in Atplld"" mice 
(A) Typical dysplastic focus on hematoxylin and eosin (H&E) stained liver section from 
Atpllc"'"'''' mice at 6 months (X400 magnification). (B) Multiple mitotic figures seen in a 
representative H & E stained liver tumour section from a Atpllc"'"'''' mutant mouse (X200 
magnification). (C) Abnormal mitotic figures with condensed, asymmetric chromatin at 
higher magnificat ion (X400 magnification). (D) Representative H&E stained section of 
Atpllc"'"''''mutant hepatocellular carcinoma (HCCs) at 6 months(X200 magnification). 
This chapter also identified that AtplIc"""'"'' mice develop HCC at 6 month of age. 
The increased expression of Atpllc in the liver (Figure 1.10 in Chapter 1) (Wu et al., 
2009) supports the conclusion that A T P l l C might play a critical role in normal 
hepatocyte physiology. Consistently, A T P l l C has been shown to be critical for the 
prevention of intrahepatic cholestasis and parturition (Siggs et al., 201 lb). Therefore, 
the development of HCC in mutant mice is of great interest as only a few 
experimental models are available to study spontaneous development of HCC in 
mice, but a detailed investigation of this phenotype is beyond the scope of this thesis. 
CHAPTER 9: ATPl IC-deficient mice 
exhibit altered erythrocyte shape, anaemia 
and reduced erythrocyte hfespan 
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Anseim Enders (2014). "Mice deficient in the putative phospholipid flippase 
ATPl IC exhibit altered erythrocyte shape, anemia and reduced erythrocyte lifespan". 
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Contributions from others: 
• Ms. Jennifer Kofler and Ms. Ayla Lorenzo provided technical help for the 
data in Figure 9.1, Figure 9.2, Figure 9.3, Table 9.1 and Table 9.2. 
• Dr. Lucy A. Coupland designed and performed the experiment for the data in 
Figure 9.6A, and Dr. Deborah Cromer generated Figure 9.6B using the data 
in Figure 9.6A. 
• Ms. Cathy Gillespie and Dr. Lucy A. Coupland generated the images in 
Figure 9.7A. 
• Ms. Anne Prins performed H&E staining of the blood smears in Figure 9.7B. 
• Dr. Markus Winterberg and Prof Kiaran Kirk designed, and Dr. Markus 
Winterberg performed the experiment for the data in Figure 9.10. 
• Prof Narci C. Teoh provided help in the analysis of samples for the data in 
Figure 9.11. 
• Dr. Lucy A. Coupland injected mice with CFSE and collected blood samples 
for the data in Figure 9.148, but staining and flow cytometry analysis 
performed by myself. 
• Prof. Stefan Broer contributed to the establishment of flippase assay. 
9.1 Preamble 
Erythrocytes or red blood cells (RBCs) are the most common type of blood cells. 
Their function is to transport oxygen from the lung to other tissues. Mammalian 
erythrocytes are unique amongst eukaryotic cells in that they lack nuclei, 
cytoplasmic structures and organelles. Thus, the structural and functional properties 
of erythrocytes are closely associated with their plasma membranes (Mohandas and 
Gallagher, 2008). Like other eukaryotic cells, the erythrocyte membrane consists of a 
lipid bilayer with an asymmetrical distribution of specific phospholipids between the 
two leaflets of the bilayer (Daleke, 2008). While PC and SM are predominantly 
concentrated in the outer monolayer, PS and PE are mainly confined to the 
cytoplasmic leaflet of the erythrocyte membrane (Daleke, 2008). The generation and 
maintenance of this asymmetric structure is essential for erythrocyte survival and 
function (Daleke, 2008, Mohandas and Gallagher, 2008). In particular, localisation 
of PS to the cytoplasmic leaflet of erythrocytes is crucial, as PS exposure on the 
surface of erythrocytes plays an essential role in the modulation of the mechanic 
stability of the membrane through an interaction with the skeletal protein spectrin 
(An et al., 2004, Manno et al., 2002). PS exposure on the surface of erythrocytes acts 
as an "eat-me" signal to phagocytes and also can lead to adherence of erythrocytes to 
the vascular endothelium and activation of surface-dependent plasma blood clotting 
factors (Daleke, 2008), as well as contributing to the anaemia observed in a wide 
variety of blood disorders, including sickle cell anaemia and thalassemia (Wood et 
al., 1996, Kuypers et al., 1998, de Jong et al., 2001, Kean et a l , 2002, Yasin et al., 
2003). 
As already mentioned in the previous chapters, members of the P4-type ATPase 
family are specialized to serve as 'flippases' that selectively translocate PS, and to a 
lesser extent PE, into the cytoplasmic leaflet of cell membranes (Daleke, 2007, 
Sebastian et al., 2012), and this activity was shown for the first time in human 
erythrocytes (Seigneuret and Devaux, 1984, Daleke and Huestis, 1985). Although 
there have been a large number of studies related to the asymmetric distribution of 
phospholipids in the erythrocyte membrane (Daleke, 2003), the role of specific lipid 
transporters in erythrocyte biology is not well understood. Therefore, in this chapter I 
aimed at determining the possible role of ATPl IC in erythrocyte biology. 
9.2 A T P l IC-def ic ient mice exhibit anaemia 
In order to test whether ATPl IC-deficiency has any effect on the development and 
survival of erythrocytes, an erythrocyte count in the blood of mutant mice and their 
control littermates was performed. 1 found that there were approximately 25% fewer 
total erythrocytes in the blood of Alp 1 Ic"'"^'" (Figure 9.1). However, mutant animals 
had normal reticulocyte numbers (Figure 9.1). 
Separate analysis of peripheral blood of female and male mice demonstrated that 
ATPllC-deficient female mice have also reduced number of erythrocytes similar to 
hemizygous mutant male mice (Figure 9.2). In contrast, Alp]Ic"'"'"'* heterozygous 
female mice had a normal erythrocyte count in the peripheral blood (Figure 9.2). 
These results reveal that A T P l l C deficiency in mice causes anaemia, and suggest 
that A T P l l C plays a significant role in the development and/or survival of 
erythrocytes. 
In order to extend these findings different haematologic parameters were analysed in 
the blood of mutant mice and their control littermates. I confirmed the reduction in 
the number of erythrocytes in the blood of mutant mice compared to wild-type 
among all age groups (Figure 9.3). In line with the lower number of erythrocytes, 
ATPl IC-deficient mice also exhibited a significant decrease in their haemoglobin 
and haematocrit (Figure 9.3). While the relative proportion of reticulocytes was 
significantly increased in the blood of A T P l l C mutant animals (Table 9.1) the 
absolute number of reticulocytes was not significantly increased (Figure 9.3). I also 
analysed mean corpuscular haemoglobin (MCH) and mean corpuscular volume 
(MCV) which are the average mass of haemoglobin per erythrocyte and the average 
erythrocyte cell size, respectively. Interestingly, mutant mice had higher MCH in 
older age groups, and higher MCV among all age groups (Figure 9.3), Together these 
changes resulted in a reduced corpuscular haemoglobin concentration mean (CHCM) 
of erythrocytes from ATPl IC-deficient mice (Table 9.2). 
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Figure 9.1 Reduced number of erythrocytes in the blood of Atplie"'"'"" mice 
Graphs show number of erythrocytes (left) and reticulocytes (right) in the blood of Atpllc'" 
(WT) and Atpllc""'"" (Amb) mice. Each circle represents a single mouse, and data are 
representative of two independent experiments. 
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Figure 9.2 Anaemia in mice with a point mutation in/l//)//c ^ ^^^^ 
(A, B) Graphs show the number of erythrocytes in the blood of (A) Alpllc' and Alpllc""' 
male, and (B) Atpllc , Alpllc" and Atpllc""""-' female mice. Bar graphs represent 
mean ± S.E.M. with four to seven mice per genotype. Statistical significance was calculated 
using the two-tailed Student's Mest (A) or One-Way ANOVA analysis, followed by the 
Bonferroni post-test, with the P values comparing each pair of experimental groups shown 
on the plots (B). ns, not significant; P < 0 . 0 0 1 ; < 0.0001. 
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Figure 9.3 The deve lopment of anaemia in A T P l l C - d e f i c i e n t mice 
Graphs show the number of erythrocytes, haemoglobin, haematocrit, the number of 
reticulocytes, mean corpuscular haemoglobin (MCH) and mean corpuscular volume (MCV) 
in the blood of Atpllc" (WT, open circle) and Alpllc"""" (Amb, black filled circle) 
animals of the indicated age groups. The symbols represent mean ± S.E.M. Data are 
representative of two independent experiments with four to eight mice per genotype in each. 
Statistical significance was calculated using One-Way ANOVA analysis, followed by the 
Bonferroni post-test, with the P values comparing each age pair of groups shown on the plots. 
# / ' < 0.0001; * * * P < 0.001; ** F < 0.01 ; * P < 0.05. 
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Tab le 9.1 Reticulocyte analysis in the blood 
Analysis of different hematologic parameters on reticulocytes from the blood of Atpllc^ 
(WT) and Atpllc""''" (Amb) animals for each age group using an ADVIA 2120 
Haematology System. The numbers are expressed as mean ± S.E.M. MCV, mean 
corpuscular volume; CHCM, corpuscular haemoglobin concentration mean; RDW, red cell 
distribution width; HDW, haemoglobin distribution width. The reticulocyte index was 
calculated by multiplying the percentage of reticulocytes with the haematocrit of each mouse 
divided by the average haematocrit of control mice of the same age. Statistical significance 
was calculated using One-Way ANOVA analysis, followed by the Bonferroni post-test, with 
the P values comparing each age pair of groups shown on the plots. ^ P < 0.01; P < 0.001; 
' ' , P < 0.0001. 
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Table 9.2 Erythrocyte analysis in the blood 
Analysis of different hematologic parameters in the blood o f / i / p Z / c (WT) and Atpllc""'''' 
(Amb) animals for each age group using an ADVIA 2120 Haematology System. The 
numbers are expressed as mean ± S.E.M. MCHC, mean corpuscular haemoglobin 
concentration; CH, cellular haemoglobin; CHCM, corpuscular haemoglobin concentration 
mean; RDW, red cell distribution width; HDW, haemoglobin distribution width. Statistical 
significance was calculated using One-Way ANOVA analysis, followed by the Bonferroni 
post-test, with the P values comparing each age pair of groups shown on the plots. \ P < 
0.05; ^ P < 0 . 0 1 ; P < 0.001; ^ P < 0.0001. 
9.3 Normal erythropoiesis in ATPllC-deficient mice 
The data presented above suggest a critical involvement of A T P l l C in the 
development and/or survival of erythrocytes. In order to assess if A T P l l C is 
required for erythropoiesis, 1 examined the early stages of erythroid development in 
the bone marrow and spleen. Stepwise analysis of different stages of erythroblast 
differentiation based on surface marker CD44 and forward scatter profile (Chen et al., 
2009) demonstrated that ATPllC-def ic ient mice have essentially normal 
erythropoiesis in the bone marrow and spleen (Figure 9.4). The normal 
erythropoiesis in the bone marrow and spleen of ATPl IC-deficient mice was also 
confirmed using CD71 and Terl 19 co-staining (Socolovsky et al., 2001) (Figure 9.5). 
Collectively, these results indicate that animals deficient for ATPl IC have no defect 
in the early stages of erythropoiesis. 
9.4 Erythrocytes from ATPllC-deficient mice have reduced lifespan 
As the production of erythrocytes appeared normal in ATPl IC-deficient animals, the 
life span of erythrocytes was investigated using a method developed by Dr. Lucy 
Coupland from the John Curtin School of Medical Research (Coupland et al., 2010). 
She injected ATPl IC mutant and control mice with the fluorescent dye CFSE, which 
efficiently labels the erythrocytes, followed by collection of blood from the tail of 
CFSE-injected mice at different time points and flow cytometric analysis. 
Interestingly, it was found that erythrocytes from ATPl IC-deficient animals exhibit 
a reduced survival compared to cells from their control littermates as determined by 
percentage of CFSE-labelled erythrocytes in the blood (Figure 9.6A). Using a 
mathematical modelling developed by Dr. Deborah Cromer from the University of 
New South Wales (Coupland et al., 2010), the average survival of erythrocytes was 
determined. The analysis revealed that erythrocytes from A T P l l C mutant animals 
showed an average lifespan of 25.2 ± 3.5 days, compared to 38.7 ± 3.6 days in the 
control littermates (presented as means ± S.E.M) (Figure 9.6B). These data clearly 
indicate that ATPl IC plays an important role in the survival of erythrocytes. 
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Figure 9.4 Normal erythropoiesis in the bone marrow and spleen of ATPllC-deficient 
animals 
(A, B) Representative flow cytometric dot plots of CD44 and Forward Scatter (FSC) profiles 
in the (A) bone marrow and (B) spleen of Atpllc " (WT) and AtplIc""''"' (Amb) animals. 
The plots are pre-gated on CDVl"" and Terl 19^ erythrocytes. Bar graphs represent mean ± 
S.E.M of the percentage of cells in the outlined areas in the flow cytometric plots. Data are 
representative of two independent experiments with one to four mice per genotype in each. 
Statistical significance was calculated using the two-tailed Student's Mest. ns, not 
significant; *** P < .001; ** P < .01; * P < .05. 
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Figure 9.5 Normal erythropoiesis in the bone marrow and spleen of ATPllC-deficient 
animals 
(A, B) Representative flow cytometric dot plots of CD71 and Terl 19 profile in the (A) bone 
marrow and (B) spleen of Alpllc" (WT) and AtplIc""''" (Amb) animals. Bar graphs 
represent mean ± S.E.M of the percentage of cells in the outlined areas in the flow 
cytometric plots. Data are representative of three independent experiments with four to six 
mice per genotype in each. Statistical significance was calculated using the two-tailed 
Student's Mest. ns, not significant; * * * P < . 0 0 1 ; ** P < .01; */> < .05. 
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Figure 9.6 A shortened erythrocyte life span in the periphery of ATPllC-deficient 
animals 
(A) Graph shows the percentage of CFSE-labelled erythrocytes in the blood of Atpllc'" 
(WT, open circle) and Atp 1 Ic""'''" (Amh, black filled circle) mice after in vivo labelling. (B) 
Graph shows the average erythrocyte life span calculated by lognormal modelling from the 
data presented in (A). The symbols and bar graph represent mean ± S.E.M. Statistical 
significance was calculated using the two-tailed Student's Mest. ** P<.0\-* P< .05. 
9.5 ATPllC-deficient erythrocytes form stomatocytes 
The composition and asymmetric distribution of phospholipids in the cell membrane 
is essential for maintaining the normal biconcave shape of erythrocytes (Manno et al., 
2002). To examine the morphology of erythrocytes, Ms. Cathy Gillespie and Dr. 
Lucy Coupland from the John Curtin School of Medical Research performed 
scanning electron microscopy analysis of erythrocytes from the blood of A T P l l C 
mutant and littermate control mice. As expected red cells from the blood of control 
animals showed the typical biconcave disc shape (Figure 9.7A, top pictures). 
Interestingly, distinct changes were observed in erythrocytes from ATPl IC-deficient 
mice with the majority of mutant erythrocytes showing stomatocyte-like morphology 
(Figure 9.7A, bottom pictures). Peripheral blood smears confirmed the formation of a 
stomatocyte-like morphology in erythrocytes from ATPl IC-deficient mice (Figure 
9.7B). 
Furthermore, flow cytometry analysis revealed that erythrocytes in the blood and 
spleen from ATPl IC-deficient animals were significantly larger than erythrocytes 
from control animals as determined by an increase in their forward scatter profile 
(Figure 9.8A). This increased size was consistent with higher MCV in mutant mice 
(Figure 9.3), and it was first apparent in mature erythrocytes in the bone marrow, and 
orthrochromic erythroblasts and reticulocytes in the spleen (Figure 9.8B). 
The effect of the mutation on osmotic fragility was also assessed by incubating 
erythrocytes from ATPllC-deficient mice and control littermates in solutions of varying 
osmolarity, and measuring the extent of haemolysis. Erythrocytes from ATPl lC-
deficient mice displayed a normal haemolysis profile, suggesting that their surface-to-
volume ratio and cell hydration is comparable to that in erythrocytes from wild-type 
mice (Figure 9.9). 
9.6 No effect of the ATPllC""'* mutation on Na^ and K"^  homeostasis 
Stomatocytosis observed in ATPl IC-deficient mice may be associated with ahered 
cation transport across the erythrocyte membrane, and a consequent perturbation of 
erythrocyte Na"" and K"" homeostasis (Bruce, 2009). In some cases the cation 
transport abnormality is enhanced upon reduction of the temperature to which the 
cells are exposed (Stewart, 2004). Comparisons of Na"" and K^ levels in erythrocytes 
from Alpllc"'"'"'' mice with those in erythrocytes from control mice, using ion 
chromatography, revealed there to be no difference between the two groups (Figure 
9.1 OA). Measurement of the plasma K'' concentration in blood samples that had been 
incubated for 30 min, 1.5 and 3.5 hours at room temperature (in order to enhance any 
temperature-dependent K"" leak that might be present) revealed the plasma K"" 
concentration of ATPllC-deficient mice to be comparable to that in wild-type mice 
(Figure 9.1 OB). Thus, ATPl lC deficiency apparently has no significant effect on 
erythrocyte Na^ and K^ homeostasis. 
Hereditary stomatocytosis in humans can cause iron overload (Bruce, 2009). Serum 
iron and transferrin in 8-10 and 18-20 week old ATPl IC-deficient mice and their 
wild-type littermates were measured. Serum iron and transferrin levels were 
comparable between ATPl lC mutant and wild-type animals and between both age 
groups (Figure 9.11) thus excluding iron overload as a feature of the stomatocytosis 
seen in these mice. 
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Figure 9.7 A T P l l C - d e f i c i e n t erythrocytes have an abnormal shape 
(A) Scanning electron microscopic analysis of erythrocytes from tlie blood of Alpllc" 
(WT) and AtplIc"""'"'' (Amb) animals. (B) Peripheral blood smears from Atpllc' " (WT) and 
Atpl Ic"""'''' (Amb) animals. 
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Figure 9.8 Larger mature erythrocytes from Atpllc""'"' animals 
(A) Representative overlay histograms of forward scatter (FSC) profile in Ter l l9^ 
erythrocytes from the bone marrow, spleen and blood of Atpllc' ° (WT, shaded grey) and 
Alpllc"""'''' (Amb, black line) animals. Data are representative of three independent 
experiments with four to six mice per genotype in each. (B) Representative overlay 
histograms of forward scatter (FSC) profile in different stages of eiythroid development 
(gated as in Figure 9.4) in the bone marrow (top panel) and spleen (bottom panel) of 
Atpllc'" (WT, shaded grey) and Atpllc"""' (Amb, black line) animals. Data are 
representative of at least five independent experiments with one to four mice per genotype in 
each. 
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Figure 9.9 Erythrocytes from ATPl lC-def ic ient mice show normal osmotic fragility 
Osmotic fragility of eiytlnrocytes from Atpllc " (WT, open circle) and AtplIc""''"" (Amb, 
black filled circle) mice. The symbols represent mean ± S.E.M of the percentage of 
haemolysis. Data are representative of three independent experiments with four to five mice 
per genotype in each. 
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Figure 9.10 Normal intra-erythrocytic and plasma content of cations in A T P l l C -
deficient mice 
(A) Ratio of intra-erythrocytic N a ' and K" of AtpJ Ic" {'^T) and Atpl Ic""''"" (Amb) animals 
analysed by HPLC within 30 min of blood collection (0.5 h) and after resting at room 
temperature for 1.5 and 3.5 hours. Bar graph represents mean ± S.E.M of the ratio of intra-
erythrocytic Na"" and K^ content. (B) HPLC measurement of K^ in the plasma of Alp 11c'" 
(WT) and Atpllc""'''' (Amb) animals within 30 min of blood collection (0.5 h) and after 
resting at room temperature for 1.5 and 3.5 h. Bar graph represents mean ± S.E.M of the 
plasma K"" content. Data are representative of two independent experiments with four to five 
mice per genotype in each. 
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Figure 9.11 Normal iron and transferrin levels in the serum of ATPllC-deficient 
animals 
Graphs show the analysis of iron (A, B) and transferrin (C, D) in the serum from young (8-
10 weeks) (A, C) and older (18-20 weeks) (B, D) Alpllc" (WT, open circle) and 
AtplIc""'''" (Amb, black filled circle) animals. Each symbol represents a single sample in 
which sera from three different mice were pooled. 
9.7 Lower flippase activity in erythroblasts from ATPllC-deficient mice 
To test if developing erythroblasts or mature erythrocytes have reduced flippase 
activity, 1 performed an in vitro flippase activity assay using the Ce-NBD-PS. I first 
tested flippase activity in the different erythroid stages (Proerythroblasts, Basophilic 
erythroblasts, Polychromatic erythroblasts, Orthochromatic erythroblasts and 
reticulocytes and mature red blood cells; gates as regions I, II, III, IV and V respectively 
in Figure 9.4), in the bone marrow and spleen, separated on the basis of their CD44 
and forward scatter profiles (Chen et al., 2009). Erythroid precursors (R I - R III) 
from wild-type mice took up Ce-NBD-PS rapidly whereas orthochromatic 
erythroblasts and reticulocytes as well as mature erythrocytes (R IV and R V 
respectively) showed a significantly reduced overall Ce-NBD-PS uptake (Figure 9.12 
and Figure 9.13A, B), indicating that flippase activity decreases with erythrocyte 
maturity. At all stages, Ca-NBD-PS uptake approached equilibrium by 30 min 
(Figure 9.12 and Figure 9.13A, B). In comparison, the uptake of Ca-NBD-PS by 
A T P I I C mutant erythroid precursors (R I - R III) was significantly slower (Figure 
9.12 and Figure 9.13A, B). The difference in Ce-NBD-PS internalisation between 
wild-type and ATPI IC-deficient cells was less marked in the more mature forms (R 
IV - R V) (Figure 9.12 and Figure 9.13A, B). Similarly, there was a very low uptake 
of Ce-NBD-PS in erythrocytes from peripheral blood of wild-type and A T P l l C -
deficient mice with only a minimal reduction in mutant erythrocytes (Figure 9.13C). 
9.8 Increased PS exposure on the surface of ATPllC-deficient 
erythrocytes 
The appearance of PS in the exoplasmic leaflet of erythrocyte membranes serves as 
an "eat-me" signal for the recognition and clearance of erythrocytes by phagocytes 
(McEvoy et al., 1986, Connor et al., 1994). To test if the defective flippase activity in 
mutant animals results in increased surface accumulation of PS, erythrocytes from 
the peripheral blood were stained with Annexin-V, which binds to PS in the 
exoplasmic leaflet (Koopman et al., 1994). The percentage of Annexin-V^ 
erythrocytes in the blood of ATPllC-deficient mice was 17-fold higher than in 
control littermates in which there were virtually no Annexin-V^ erythrocytes (4.28 ± 
0.50 % vs. 0.25 ± 0.05 %, P < 0.0001) (Figure 9.14A). I next determined the extent 
of Annexin-V binding as a function of erythrocyte age using in vivo CFSE-labelling. 
At all ages tested (newly generated to 40 days of age) there was virtually no 
Annexin-V binding by wild-type erythrocytes (Figure 9,14B). However, as ATPl IC-
deficient erythrocytes aged, there was a gradual increase in the number of Annexin-
V binding from 4.3% of newly formed erythrocytes (CFSE") to more than 20% of 
erythrocytes aged > 39 days (CPSE^) (Figure 9.14B). In agreement with the 
accumulation of PS on aged erythrocytes I also found a greater than a two-fold 
increase in the frequency of Annexin-V^ erythrocytes in the spleen of mutant mice 
compared to their control littermates (31 ± 2 % vs. 14 ± 1 %, P < 0.0001) (Figure 
9.14C). In contrast, no difference in Annexin-V staining was observed on 
erythroblasts in the bone marrow of wild-type and ATPl IC-deficient mice (Figure 
9.14D). 
Taken together, these data suggest that ATPl IC-deficient erythrocytes accumulate 
PS on their surface in the peripheral circulation due possibly to a defect in PS 
intemalisation. Alternatively, it could also be due to reduced removal of PS-
expressing RBCs because of overload of the system. 
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Figure 9.12 The ATPl lC™' mutation decreases Ct-NBD-PS translocation into 
erythroblasts 
(A, B) Representative overlay histograms of Cs-NBD-PS fluorescence profiles after 0, 1, 3, 5, 
10, 20 and 30 min incubation in Proerythroblasts, Basophilic erythroblasts, Polychromatic 
erythroblasts, Orthochromatic erythroblasts and reticulocytes and mature red blood cells 
(Regions I, II, III, IV and V, respectively, gated as in Figure 9.4) in the bone marrow (A) and 
spleen (B) of Alpllc'" (WT, shaded grey) and AtplIc""'''' (Amb, black line) animals. Data 
are representative of at least five independent experiments with one mouse per genotype in 
each. 
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Figure 9.13 T h e A T P l l C " ' " ' muta t ion decreases C6-NBD-PS translocat ion into 
e ry th rob las t s in vitro 
(A, B) Graphs show Ce-NBD-PS uptake after 0, 1 , 3 , 5, 10, 20 and 30 min incubation in 
Proerythroblasts, Basophilic erythroblasts. Polychromatic erythroblasts, Orthochromatic 
erythroblasts and reticulocytes and mature red blood cells (regions I, II, 111, IV and V 
respectively, gated as in Figure 9.4) in the bone marrow (A) and spleen (B) from Atpllc'" 
(WT, open circle) and Atp!Ic""'''" (Amh, black filled circle) mice. Graphs represent mean ± 
S.E.M. of the percentage of Cs-NBD-PS uptake relative to wild-type region 11 at 30 min. 
Data are pooled from five independent experiments with one mouse per genotype in each. 
(C) Graph shows Ce-NBD-PS uptake after 0, 1 , 3 , 5, 10, 20 and 30 min incubation in 
Terl 19"" erythrocytes in the blood from Atpllc'" (WT, open circle) and Atpllc""''"'' (Amb, 
black filled circle) mice. Graph represents mean ± S.E.M. of the percentage of Cj-NBD-PS 
uptake relative to wild-type erythrocytes at 30 min. Data are pooled from four independent 
experiments with one mouse per genotype in each. 
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Figure 9.14 Mature erythrocytes from ATPl lC-de f i c i en t mice demonstrate increased 
PS exposure on their surface 
(A) Representative overlay histogram of Annexin-V staining in Terl 19^ erytiirocytes in tlie 
blood of Alpllc' " (WT, shaded grey) and Alp 11 c""''" (Amh, black line) animals. Bar graphs 
represent mean ± S.E.M. of the percentage of Annexin-V* cells in Terl 19* erythrocytes. 
Data are representative of at least three independent experiments with four to six mice per 
genotype in each. (B) Graph shows mean ± S.E.M. of the percentage of Annexin-V* cells 
among circulating CFSE" or CFSE* erythrocytes in the blood of Atpllc'" (WT) and 
Atpllc""''' (Amb) mice after in vivo labelling. (C) Representative overlay histogram of 
Annexin-V staining in Terl 19*" erythrocytes in the spleen of Atpllc' " (WT, shaded grey) 
and Atpllc""''''' (Amb, black line) animals. Bar graphs represent mean ± S.E.M. of the 
percentage of Annexin-V* cells in Terl 19*" erythrocytes. Data are representative of at least 
three independent experiments with four to six mice per genotype in each. (D) 
Representative overlay histogram of Annexin-V staining in Terl 19* erythrocytes in the bone 
marrow of Atpllc" (WT, shaded grey) and Atpllc"""'''' (Amb, black line) animals. 
Statistical significance was calculated using the two-tailed Student 's M e s t . P < 0.0001. 
9.9 Chapter summary and discussion 
The first description of a phospholipid transiocase activity was the characterisation 
of the erythrocyte membrane aminophospholipid transiocase (Seigneuret and Devaux, 
1984, Daleke and Huestis, 1985). Despite the extensive research over the ensuing 30 
years to characterise this enzyme activity and its influence on membrane asymmetry 
and erythrocyte shape, the protein(s) responsible for this activity is still mostly 
unknown (Daleke, 2008). The data presented in this chapter revealed a significant 
role for the P4-type ATPase ATPl IC in erythrocyte biology, and identified ATPl IC 
as the main aminophospholipid transiocase in developing erythrocytes. 
The findings of this chapter demonstrated that erythrocytes in ATPl IC-deficient 
mice have 1) reduced numbers in circulation, 2) increased exposure of PS in the 
outer leaflet, particularly for older erythrocytes, 3) a decreased lifetime in circulation, 
4) a large percentage of stomatocytic cells, and 5) a significandy reduced NBD-PS 
transiocase activity during development. Interestingly, erythrocytes from A T P l l C 
mutant mice had normal development and maturation in the bone marrow and spleen. 
Previously ATP8A1 has been suggested to be expressed in erythrocyte membranes 
(Soupene and Kuypers, 2006), however Atp8al''' erythrocytes display none of the 
phenotypic changes seen in ATPl IC-deficient mice (Levano et al., 2012). Therefore, 
this study identifies the first enzyme responsible for the flippase activity in 
erythrocytes. 
In line with the role of ATPl IC as a flippase (Sebastian et al., 2012, van der Mark et 
al., 2013, Segawa et al., 2014) and the expression of Atpllc in adult erythroblasts 
(Figure 9.15) (Kingsley et al., 2013), in vitro uptake of a PS analogue by mutant 
erythroblasts was severely reduced compared to erythroblasts from wild-type control 
mice. Moreover, mature erythrocytes from mutant mice showed increased PS-
exposure. These data suggest that a defective translocation activity results in the 
accumulation of PS on the surface, and removal of PS-expressing erythrocytes from 
the circulation by phagocytes will eventually result in anaemia. Interestingly, PS-
exposing erythrocytes in ATPl IC-deficient mice continued to circulate, which 
suggests that overload of the phagocytic capacity of the reticuloendothelial 
macrophages or other extrinsic factors may also be involved. Future studies are 
required to identify any cell extrinsic factors that influence the survival of ATP 1IC-
deficient erythrocytes and also their relative importance compared to the cell-
intrinsic flippase defect. 
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Figure ^ A S A t p U c expression in different erythroblast stages 
Normalised expression for all probes associated with Atpllc in primitive, foetal definitive, 
and adult definitive erythroid cells. Proerythroblast (P), Basophilic Erythroblast (B), 
Polyorthochromatic Erythroblast (O), and Reticulocyte (R). Data from the Erythron 
Database (http://www.cbil.upenn.edu/ErythronDB), and methods of isolation and expression 
measurement are described on the paper (Kingsley et al., 2013). 
CHAPTER 10: General Discussion 
10.1 Unveil ing complexit ies in the immune system through identification 
of novel genes by ENU mutagenesis 
Phenotype-driven ENU mutagenesis screens in mice provide a powerful tool to shed 
light into understanding important biological processes including the immune system. 
Identification of the function of novel genes through ENU mutagenesis contributes to 
the understanding of the immune system and the molecular basis that controls 
lymphocyte differentiation, development of effector responses, immune tolerance 
and homeostasis. The mouse strains generated not only in our laboratory (Jun et al., 
2003, Papathanasiou et al., 2003, Vinuesa et al., 2005, Siggs et al., 2007, Wu et al., 
2008, Randall et al., 2009, Enders et al., 2012, Bergmann et al., 2013, Teh et al., 
2013, Enders et al., 2014) but also in other laboratories around the world (Arnold et 
al., 2012) provide a good example of how ENU mutagenesis screens in a non-biased 
manner can help uncover important "checkpoints" in the immune system that are 
crucial for the development and/or function of lymphocyte subsets. 
The Amhrosius strain was discovered in the mutagenesis program at the John Curtin 
School of Medical Research because of a selective reduction in B cell frequency in 
the peripheral blood. The observed block in B cell development in the bone marrow 
of Ambrosius mice helped to identify for the first time a role for a previously 
uncharaeterised aminophospholipid translocase in the immune system. 
It has been known for a long time that every eukaryotic cell is surrounded by a 
plasma membrane that is made of a lipid bilayer with an asymmetric distribution of 
the specific lipids between the two leaflets of the plasma membrane (Sebastian et al., 
2012, van der Mark et al., 2013). A growing body of work suggests that specific lipid 
transporters found in the cellular membranes are crucial for the establishment and 
maintenance of the dynamic lipid asymmetry. Energy-dependent transporters known 
as flippases and fioppases are responsible for the transport of phospholipids from the 
outer to the inner leaflet of the plasma membrane and vice versa, respectively 
(Sebastian et al., 2012, van der Mark et a l , 2013). Beside their role in the 
intemalisation of specific lipids such as PS and PE, flippases are also involved in 
vesicle-mediated protein transport (Sebastian et al., 2012). 
Several tlippases are highly expressed in cells of the immune system, which suggests 
a possible involvement of these enzymes in the development and/or function of 
immune cells (Heng and Painter, 2008). However, until the start of this project 
specific roles for flippases in the immune system remained completely unknown. 
Thus, the discovery of the Ambrosius strain and the results presented in this thesis 
have provided a novel entry point to understand the role of phospholipid flipping in 
the control of B cell development within the immune system. Moreover, in addition 
to its contribution to the immune system, this study also revealed the importance of 
lipid asymmetry in the survival of erythrocytes, and provides the leading candidate 
for the flippase activity in erythrocytes, which was shown about 30 years ago 
(Seigneuret and Devaux, 1984, Daleke and Huestis, 1985). 
10.2 Insights into the role of A T P l IC in B cell development 
The development of B cells in the foetal liver and bone marrow is a complex process, 
and is critical for long-term health. Although studies over the last few decades have 
identified key signals that are needed for normal B cell development (Herzog et al., 
2009, Clark et al., 2014, Reth and Nielsen, 2014), there is still much to uncover. In 
this thesis, the phospholipid transporter ATPl IC has been shown, for the first time, 
to play a critical role in B lymphopoiesis. B cell development in the bone marrow of 
ATPl IC-deficient animals is arrested at the pro-B cell stage of B lymphopoiesis. 
Since the transition from pro- to pre-B cell stage is dependent on two main receptor-
signalling pathways, namely IL-7R and pre-BCR signalling (Herzog et al., 2009, 
Clark et al., 2014, Reth and Nielsen, 2014), the focus of the mechanistic studies in 
this thesis was on these two signalling pathways. 
IL-7 is an important cytokine for the development of B cells in the bone marrow and 
signals through its receptor, IL-7R (Corfe and Paige, 2012). The importance of lL-7 
in early B lymphopoiesis has been shown by studies where genetic ablation of IL-7 
or IL-7R resulted in a developmental arrest at the pre/pro-B cells stage of B cell 
development (Peschon et al., 1994, von Freeden-Jeffry et al., 1995, Miller et al., 
2002). The findings presented here that A T P l l C diminishes effects of an 117 
transgene in vivo suggest that ATPl IC might have a role in IL-7R signalling during 
B cell development in the bone marrow. Consistently, as shown in Chapter 3, 
ATPllC-def ic ient animals possess normal numbers of MZ B cells in the spleen, 
which resembles the phenotype seen in mice deficient for IL-7 or IL-7R (Carvalho et 
al., 2001, Hessiein et al., 2006). However, there are some crucial distinctions 
between ATP 11C- and IL-7-deficient animals. In IIT'' or ll7ra'' mice with complete 
absence of IL-7R signalling (Kikuchi et al., 2005), B cells fail to develop into the 
pro-B cell stage. In contrast, B cells in Atpllc mutant mice develop into pro-B cells 
similar to ll7ra' Vav-Bcl2 mice (Malin et al., 2010b). Furthermore, the presence of 
residual B lymphopoiesis in IIT'' or Il7r^' mice can be completely abrogated by the 
introduction of Flt3 deficiency (Sitnicka et al., 2003, Jensen et al., 2008), but Siggs et 
al. revealed that mice double deficient for ATPl IC and Flt3 exhibit a similar B cell 
phenotype to those with a single deficiency in A T P l l C (Siggs et al., 2011a). 
Moreover, high doses of IL-7 were able to induce normal proliferation of sorted pro-
B cells from ATPl IC-deficient animals. These observations suggest that A T P l l C 
most likely has no direct influence on signalling through the IL-7R, but it may have a 
more indirect effect. 
IL-7R signalling has been shown to upregulate the expression of EBFl in B cells 
(Kikuchi et al., 2005), and this marks a key step in the commitment to the B cell 
lineage (Lin and Grosschedl, 1995). The findings that ectopic expression of EBFl 
alone was sufficient to rescue B cell deficiency in mice deficient for IL-7, IL-7Ra, 
PU.l , Ikaros or E2A (Seet et al., 2004, Dias et al., 2005, Kikuchi et al., 2005, Medina 
et al., 2004, Reynaud et al., 2008) suggest a vital involvement of EBFl in early B 
cell development in the bone marrow. Thus, another possibility for the phenotype 
observed in A T P l l C mutant mice could be that the mutation may indirectly affect 
EBFl expression through the IL-7R signalling. Consistent with this hypothesis, the 
microarray analysis presented in this thesis revealed that mRNA expression of Ebfl 
in pro-B cells from mutant mice was reduced. In keeping with this notion, Siggs et al. 
demonstrated that EBFl expression was impaired in pre/pro-B cells from ATPl IC-
deficient animals (Siggs et al., 2011a). In contrast, both mRNA and protein 
expression of the SLC component 1.5, which is a target of EBFl (Lin and Grosschedl, 
1995), has been found to be comparable between ATPl IC mutant and control mice 
pre/pro-B cells (Siggs et al., 201 la). By contrast, I found here that mRNA expression 
oflglll, which encodes X5, is significantly reduced in mutant pro-B cells compared 
to cells from control animals. The reduced expression of Iglll in pro-B cells but 
normal expression in pre/pro-B cells is consistent with the pro-B cell stage specific 
defect in A T P I I C mutant animals. It would be interesting to test if ectopic 
expression of EBFI can rescue B cell deficiency in ATPl IC-deficient mice. 
The bone marrow contains two distinct niches based on the availability of IL-7, 
namely IL-V'" and IL-7'° (Tokoyoda et al., 2004), and migration of B cell progenitors 
through the different niches is important in order for them to access IL-7 and 
undergo their normal proliferation and differentiation (Clark et al., 2014). Given the 
fact that IL-7 signalling appears normal in ATPI IC mutant mice, a possibility to 
explain the in vivo unresponsiveness to IL-7 in these mice could be that there is a 
role of ATPl IC in the determination and/or entry to the specific niches within the 
bone marrow. This hypothesis is currently speculative, and requires further 
examination to reveal how impaired flippase activity and a loss of lipid asymmetry 
by ATPl IC-deficiency affects the movement of pro-B cells between the different 
niches. 
Downstream of the IL-7R the signals bifurcate with the activation of not only 
JAK/STAT5 but also the PI3K/AKT/F0X0 and MAPK-ERK pathways (Hofmeister 
et al., 1999). AUhough I was able to analyse the JAK/STAT portion of the pathway 
of IL-7R signalling in AtplIc"'"''"' pro-B cells there was insufficient time to analyse 
the activation of the PI3K/AKT/F0X0 and MAPK-ERK pathways. Therefore, one 
of the clear aims for future research in this area is to focus on whether or not there is 
normal activation of the PI3K/AKT/FOXO and MAPK-ERK pathways in 
Atpl Ic""''"" pro-B cells upon IL-7 stimulation. 
A synergistic cross talk between the IL-7R and pre-BCR signalling has been 
suggested to control early B cell development in the bone marrow (Fleming and 
Paige, 2002, Clark et al., 2014). The proper expression of pre-BCR is critical for the 
selection of a population within pro-B cells that can respond to the limiting 
concentration of IL-7 and that eventually differentiates into pre-B cells (Fleming and 
Paige, 2002). While pro-B cells from RagT' animals, which lack a pre-BCR, have a 
normal proliferative capacity in response to high concentration of IL-7 compared to 
wild-type pro-B cells, their proliferation was reduced when IL-7 level was limiting 
(Marshall et a!., 1998, Fleming and Paige, 2001). These studies suggest an important 
checkpoint in early B cell development in which pre-BCR expression controls the 
ability of pro-B cells to respond to low concentration of IL-7 (Fleming and Paige, 
2002). Interestingly, pro-B cells from A T P l l C mutant mice exhibited an in vitro 
proliferative capacity comparable to /?ag2'^"-deficient pro-B cells. These results 
suggest that the lack of in vivo response to elevated IL-7 in ATPI IC-deficient mice 
may be due to a lack of pre-BCR signalling. In keeping with this notion, A T P l l C -
deficient mice had a developmental arrest at the pro-B cell stage, which is similar to 
that observed in animals deficient for pre-BCR signalling (Kitamura et al., 1991, 
Kitamura et al., 1992, Torres et al., 1996, Gong and Nussenzweig, 1996, Mundt et al., 
2001, Pelanda et al., 2002). Further support for impaired pre-BCR signalling in 
ATPl lC-def ic ient pro-B cells comes from experiments where pre-BCR signalling 
was mimicked by treating cells with an antibody against IgP, which is a key 
component of the pre-BCR. Similarly, Ig(3-stimulation induced Ca '^^  mobilisation 
was also compromised in mutant pro-B cells. In addition, ATPI IC-deficient pro-B 
cells exhibited reduced transcript expression of most of the genes encoding the key 
molecules that are involved in the expression and signalling through the pre-BCR. 
These results collectively indicate a critical involvement of A T P l l C in the 
expression and/or signalling of the pre-BCR. 
The observation that transgenic expression of BCL-2 in ATPI IC mutant mice failed 
to activate the pre-B cell transition is similar to what was observed in mice deficient 
in Ig(3 (Gong et al., 1996). Thus, one possibility to explain the failure of mutant pro-
B cells to respond in vivo and in vitro to anti-IgP-stimulation could simply be due to 
reduced IgP expression on the surface of pro-B cells in mutant mice. Reduced IgP 
expression would also explain why transgenic expression of functional heavy and 
light chains failed to correct B cell development fully in ATPI IC mutant mice. In 
support of this hypothesis, I observed that mRNA expression of Cd79h in mutant 
pro-B cells was reduced compared to cells from control animals. In agreement with 
published results (Nagata et al., 1997), I found that the expression of IgP on pro-B 
cells is too low to be quantitatively detected by flow cytometry. It needs to be tested 
by further experiments, for example western blotting, if protein expression of Igp is 
reduced in ATPl IC-deficient pro-B cells. Moreover, future experiments are also 
needed to validate the microarray results. 
How can A T P l l C deficiency disrupt the pre-BCR signalling besides a possibly 
reduced expression of IgP? As mentioned earlier, one of the fundamental differences 
between the pre-BCR and mature BCR signalling is the way that activation cascade 
is initiated. While an antigen is absolutely required for signalling through the mature 
BCR, activation of the pre-BCR signalling remains controversial (Herzog et al., 2009, 
Clark et al., 2014, Reth and Nielsen, 2014). Although different stimuli such as 
Heparin and Galectin 1 have been shown to be required for the activation of pre-
BCR signalling (Bradl and Jack, 2001, Gauthier et al., 2002), autoaggregation of pre-
BCRs has also been suggested to be critical for the activation (Ohnishi and Melchers, 
2003). In the case of latter hypothesis, it is possible that normal lipid asymmetry in 
the plasma membrane of pro-B cells is required for aggregation and initiation of 
signalling through the pre-BCRs. Thus, the possibility that loss of ATPl IC activity 
may disrupt the asymmetric lipid distribution, leading to impaired autoaggregation of 
pre-BCRs for their activation cannot be disregarded. Another possibility is that 
expression of pre-BCR leads to a lipid raft-dependent Ca'"" flux, which activates 
scramblase activity. This could result in a transient PS exposure in these cells, and a 
consequent requirement of flippases for the reestablishment of the asymmetric 
phospholipid distribution in the plasma membrane. It is plausible that in the absence 
of ATPl IC activity, cells cannot reestablish the lipid asymmetry, which may lead to 
rapid uptake of PS-expressing B cells in mutant mice by macrophages. This 
possibility could be tested by genetic ablation of PS receptor Tim 4 (Miyanishi et al., 
2007) or the membrane tyrosine kinase c-mer (Cohen et al., 2002) in A T P l l C 
mutant mice, followed by the analysis of resulting B cell phenotype in double 
deficient animals. 
Both the in vivo and in vitro defects could all reflect some critical qualitative element 
of IL-7 signalling, or could be secondary since there is a complex feed-forward loop 
between IL-7 signalling, B cell transcription factors, and pre-BCR signalling (Malin 
et al., 2010a, Ye and Graf, 2007, Mandel and Grosschedl, 2010, Nutt and Kee, 2007). 
The elevated expression of the IL-7R on the surface of mutant pro-B cells may 
reflect less signalling through the IL-7 receptor, because binding of IL-7 to the IL-7R 
normally leads to rapid endocytosis of the receptor via ciathrin-coated pits and this 
internalization is necessary for efficient signal transduction (Henriques et al., 2010). 
A further reduction of IL-7R expression is achieved through a feedback loop where 
IL-7R signalling normally diminishes IL-7R mRNA transcription (Alves et a l , 2008, 
Park et al., 2004). The biophysics of antigen receptor or IL-7R signalling is not well 
understood, but several independent observations provide possible connections with 
PS concentrations in the cytoplasmic membrane leaflet and in lipid rafts. PS is most 
concentrated on the inner leaflet of the plasma membrane at endocytic cups and early 
endosomes (Leventis and Grinstein, 2010) and in lipid rafts associated with the T cell 
receptor (Zech et al., 2009), where it serves as a binding site and regulatory factor for 
proteins with cationic or C2-domains, such as Src, Ras, Rho and PKC family 
proteins (Leventis and Grinstein, 2010), and for binding the cationic stretch 
preceding ITAMs in CD3 subunits (Xu et al., 2008, Aivazian and Stern, 2000). The 
efficiency of IL-7R signalling has also recently been linked to its association with 
lipid rafts (Cho et al., 2010, Rose et al., 2010). PS has also been found to be 
externalised and co-capped with the BCR during BCR or pre-BCR signalling (Dillon 
et al., 2000). Thus, it will be important in future studies to test the consequences of 
Atpllc mutation for accumulation of PS and signal-transducing proteins at 
subcellular patches where IL-7, pre-BCR or BCR signalling has been initiated. 
As mentioned above, PS in the cytoplasmic leaflet of the plasma membrane provides 
docking sites for important intracellular signalling molecules including Src, Ras, Rho 
and PKC family proteins (Leventis and Grinstein, 2010). Among those, activation of 
endogenous Ras has been suggested to play a critical role in pre-BCR signalling as 
constitutive activation of Ras in RAG-deficient animals rescued the developmental 
arrest at the pro-B cells stage and led to accumulation of B cells in the bone marrow 
and periphery (Shaw et al., 1999). Therefore, one possibility to explain the defect in 
the differentiation of pre-B cells in mutant mice could be that PS is important for the 
localisation, recruitment and/or activation of Ras in the cytoplasmic leaflet of the 
plasma membrane. Accordingly, in the presence of an impaired flippase activity in 
ATPl IC mutant mice, Ras cannot be activated, which leads to a block at the pro-B 
cells stage of B lymphopoiesis. Further studies including testing if the constitutive 
expression of Ras in ATPl IC-deficient mice can rescue B cell deficiency are 
warranted to explore this important possibility. 
With respect to the biochemical function of ATP I I C , the simplest interpretation of 
the data is that A T P l l C is an essential aminophospholipid flippase in the plasma 
membrane of pro-B cells. Other members of this protein family have been shown to 
be PS flippases in biochemical reconstitution and yeast genetic studies (Tang et al., 
1996, van der Velden et al., 2010, Paulusma and Elferink, 2010, Muthusamy et al., 
2009). The finding that A T P l l C functions as a flippase has been confirmed by a 
recent paper, which showed that A T P l l C functions as a flippase in human cells 
(Segawa et al., 2014). In addition to the PS flippase activity this paper has also 
reported some activity of ATPI IC for PE, but not for PC (Segawa et a l , 2014). The 
observation that PS flippase activity was slower but by not completely abolished in 
A T P l l C mutant cells implies that other aminophospholipid flippases also act in B 
cells, consistent with the relatively ubiquitous mRNA expression of many other P4 
ATPase family members (Heng and Painter, 2008). However, analysis of yeast 
mutants in P4 ATPases have underscored the potential for effects on protein or 
organelle trafficking and cell metabolism that could indirectly affect PS flippase 
activity (Muthusamy et al., 2009, Gall et al., 2002, Hua et al., 2002, Alder-Baerens et 
al., 2006). This possibility has so far not been tested, and further studies are required 
to determine if ATPI IC has also some of these indirect effects. 
Why are B cells profoundly compromised by the Atpllc mutation while T cells and 
most other tissues appear normal? Microarray profiling of Atpllc mRNA shows that 
it is equally expressed in B and T lymphocytes (Figure 1.9 in Chapter 1) (Heng and 
Painter, 2008) and most other tissues with highest expression in liver (Figure 1.10 in 
Chapter 1) (Wu et al., 2009). In agreement with the broad expression profile, PS 
flippase activity was reduced in all cells of the immune system, yet the mutation 
selectively compromised differentiation of pro-B cells. One explanation for the pro-
B cell specific defect would be that these cells rely more on flippase activity in 
comparison to other cells. Indeed, pro-B cells from wild-type mice exhibited the 
highest flippase activity. Therefore, the absence of A T P l l C thereby impaired 
flippase activity may explain the developmental arrest at the pro-B cell stage. 
Consistent with this notion, viable pro- and pre-B cells were shown to express PS on 
their surface (Dillon et al., 2000, Dillon et al., 2001), thus pro-B and pre-B cells may 
exhibit an increased need for flippase activity. Alternatively, post-translational 
regulatory changes in phospholipid flippase, floppase and scramblase activity, and 
unique membrane events required in bone marrow pro-B and pre-B ceils, may 
explain the stage- and lineage-specific dependence upon ATPl IC. 
10.3 Insights into the role of ATPl IC in erythrocyte biology 
In the course of their journey through the blood capillaries erythrocytes undergo 
dramatic, transient changes in shape. The asymmetric distribution of phospholipids 
in the erythrocyte membrane plays a role in erythrocyte deformability and is essential 
for the development, survival and function of red blood cells (Daleke, 2008, 
Mohandas and Gallagher, 2008). Similar to other cells, members of the P4-type 
ATPase family contribute to the generation and maintenance of membrane lipid 
assymetry in erythrocytes by mediating the inward movement of PS and PE (Daleke, 
2008, Sebastian et al., 2012), but their functions in red cell biology remains to be 
fully eluciated (van der Mark et al., 2013). Several P4-type ATPases are expressed 
during erythropoiesis with ATP8AI , ATPl IB and ATP 11C being particularly 
prominent in primitive, fetal and adult erythroblasts (Kingsley et al., 2013). The high 
expression of several flippases suggests a potential role for them in erythrocyte 
biology. So far only ATP8A1, a homologue of which has a PS flippase activity in 
yeast (Soupene et al., 2008), has been shown to be expressed in erythroblasts and to 
be present in the plasma membrane of mature erythrocytes (Soupene and Kuypers, 
2006). However, erythrocytes from AtpSal''' animals exhibit no increased PS 
exposure on their surface, and this is explained by the compensatory expression of 
ATP8A2 in erythrocytes ixom AtpSal''' animals (Levano et al., 2012). 
The results o f this thesis demonstrated that erythrocytes from ATPl IC-deficient 
animals have an apparently normal development in the bone marrow but show 
stomatocytic morphology in the peripheral blood as well as having a shortened 
lifespan. Furthermore, erythrocyte precursors lacking the putative PS transporter 
ATPl IC display a lower rate o f Cs-NBD-PS intemalisation than their wild-type 
counterparts. Thus, this study reveals A T P l l C as an essential flippase in red blood 
cells and highlights the important role o f phospholipid transport in maintaining the 
normal shape and survival o f erythrocytes. Multiple attempts have been made to 
isolate and identify the major aminophospholipid flippases from red blood cells and 
other membranes (Moriyama and Nelson, 1988, Morrot et al., 1990, Daleke et al.. 
1992, Auland et al., 1994b, Auland et al., 1994a). The biochemical characterisation 
suggests that the erythrocyte flippase is a Mg^^'-dependent, vanadate-sensitive 
ATPase (Moriyama and Nelson, 1988). Our finding of A T P l l C being involved in 
the maintenance of lipid asymmetry in erythrocytes is consistent with those 
biochemical findings and proposes a molecular candidate for this function. 
Exposure of PS on the outer leaflet of the erythrocyte membrane is believed to be 
one of the key signals for removal of old or damaged cells from the circulation 
(McEvoy et al., 1986, Connor et al., 1994). In ATPl IC-deficient animals there is 
increased PS-exposure at the surface of aged mature erythrocytes in the blood and 
spleen, but not of erythroblasts in the bone marrow. As shown by in vivo CFSE 
labelling, newly formed ATPl IC-deficient erythrocytes do not show increased 
binding of Annexin-V to the surface; however, over time, there is an increased 
proportion of erythrocytes that expose PS, and hence increased Annexin-V binding. 
In line with these findings, development of erythrocytes in the bone marrow of 
ATPl IC-deficient animals is normal. Similarly, the increased forward scatter of 
ATPl IC-deficient erythrocytes, indicative of increased cell size, is only observed in 
mature red blood cells, and not in reticulocytes or earlier developmental stages in the 
bone marrow and periphery. 
As cells of the immune system from ATPl IC-deficient mice demonstrated a slower 
intemalisation of a fiuorescently labelled PS analogue, a likely explanation of the 
ATPl IC-deficient erythrocyte phenotype observed in this thesis is a reduced 
intemalisation of PS. Indeed, in vitro uptake of the PS analogue C6-NBD-PS by 
mutant erythroblasts is significantly reduced; however, there was no major difference 
observed in mature erythrocytes. While this result is consistent with the fact that the 
protein is expressed predominantly during erythropoiesis (Figure 9.15) (Kingsley et 
al., 2013), it contrasts with the slow increase of PS exposure on older, but not newly 
formed, mature red cells in ATPl IC mutant mice. One possible explanation for this 
apparent inconsistency is a small defect in PS intemalisation in mature erythrocytes 
that is below the detection limit of 30 min in vitro assay becomes physiologically 
relevant over the lifespan of the erythrocyte. Alternatively, in A T P l l C deficient 
erythrocytes the reduced rate of PS Hipping during the early developmental stages 
may have a lasting change on the membrane composition, resulting in reduced 
erythrocyte deformability, increased intravascular damage and hence PS exposure. 
Elevated levels of bilirubin in A ' l 'P l lC mutant mice suggest that significant 
haemolysis does occur in these mice. Irrespective of the precise mechanism, it is 
clear from the resuhs that ATP 11C deficiency results in impaired flippase activity in 
erythroblasts, increased accumulation of PS on the surface of erythrocytes, with the 
shortened lifespan of these cells leading to anaemia in ATPl IC-deficient mice. 
Maintenance of the normal discoid shape of erythrocytes is essential for their 
function and a range of haematological disorders, arising from mutations in genes 
encoding globin, membrane or associated skeletal proteins, are characterised by 
altered erythrocyte shape (Mohandas and Gallagher, 2008, Da Costa et al., 2013). 
One of the disease-associated shape changes is stomatocytosis. In at least some cases, 
erythrocytes from patients suffering from stomatocytosis have an increased leak of 
cations across the plasma membrane, and patients have been found to carry 
mutations in the mechanosensitive ion channel protein PIEZOl (Zarychanski et al., 
2012, Bae et al., 2013, Andolfo et al., 2013, Albuisson et al., 2013), or in the 
transporter proteins SLC4A1 (Bruce et al., 2005), RHAG (Bruce et al., 2009), or 
SLC2A1 (Flatt et al., 2011). By contrast, stomatocytosis arising from mutations in 
either the ABCG5 protein or the ABCG8 protein is not associated with increased 
cation leakage (Rees et al., 2005). Interestingly, erythrocytes from ATPl IC-deficient 
mice had a normal osmotic fragility curve, no abnormality in the erythrocyte Na'^/K"' 
ratio, and no apparent temperature-sensitive K"^  leak. Furthermore, the mice had 
normal iron parameters. These observations indicate that stomatocyte formation in 
ATPl IC mutant erythrocytes is independent of cation leaks or hydration status, and 
suggest that an alternative mechanism is responsible for the stomatocytosis in these 
mice. One possibility is a mechanism similar to that responsible for Mediterranean 
stomatocytosis (Ducrou and Kimber, 1969), in which a lack of control over sterol 
absorption and excretion leads to changes in the plasma lipid composition and 
presumably the membrane lipid composition of circulating cells. Alterations in the 
relative lipid composition of the erythrocyte membrane can lead to an expansion or 
contraction of either the inner or outer leaflet, resulting in altered erythrocyte shape 
(Sheetz and Singer, 1974, Seigneuret and Devaux, 1984, Daleke and Huestis, 1985). 
In addition, reduced accumulation of PS at the cytofacial leaflet is predicted to 
interfere with the interaction between skeletal proteins and the membrane (An et al., 
2004, Manno et al., 2002). It is plausible, therefore, that a disturbance in these 
interactions underlies the observed formation of stomatocytes in the ATPl IC mutant 
mice. However , future studies are needed for investigation of this theory. 
10.4 Conclusion 
The asymmetr ical distribution of specific lipids between the two leaflets of cellular 
membranes is generated and maintained by transporters, but few genetic tools are 
available to test their funct ion within the immune system. 1 revealed in this thesis a 
critical role for the phospholipid transporter A T P l l C in B cell development in the 
bone marrow. Loss of A T P l l C blocked B cell development in a cell-autonomous 
manner at the pro-B cell to pre-B cell transition. In order to identify the molecular 
mechanisms underlying the observed phenotype in mutant animals, the further 
analysis focused on the two crucial signaling pathways that each are necessary for 
normal pre-B cell development in mice, namely signaling through the IL-7R and pre-
BCR. I found that while IL-7R signaling appears intact in isolated pro-B cells f rom 
A T P l I C mutant mice, the mutation leads to a defect in the assembly and/or signaling 
through the pre-BCR. Functional analysis of B cells revealed that while mutant 
animals showed a variably reduced primary and secondary response to T-dependent 
antigens, the response to an antigen, which requires GC formation, was severely 
reduced. Surprisingly, B cells f rom BCR transgenic ATPl IC-deficient BCR 
transgenic mice were able to mount a normal GC response upon transfer into wild-
type recipients indicating that the absent GC response in ATPl IC-deficient mice is 
caused by a B cell extrinsic effect. 
Consistent with the predicted function of A T P l l C , biochemical analysis revealed a 
critical role for A T P l l C in PS internalisation in multiple cells. The defective 
fl ippase activity in other cells of the immune system did not cause an obvious 
phenofype. However , the A T P l iC""* mutation had an impact on erythrocyte survival, 
shape and fl ippase activity. 
Taken together, the results presented in this thesis reveal an important functional role 
for A T P l I C in the immune system and erythrocyte biology, and raise the question of 
whether mutations in ATPllC serve as a previously unclassified cause of B cell 
deficiency and anaemia in humans. 
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